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Abstract 
 
To explore the effect of endotoxin as a sensitising agent prior to neonatal hypoxia 
ischemia differing doses of endotoxin (E. coli lipopolysaccharide, LPS) were given to 
neonatal mice prior to hypoxia ischemia, with sensitising effects noted at dosages of 
0.3mg/kg of LPS or higher. Varying the time interval between endotoxin administration 
and hypoxia ischemia demonstrated that LPS given between 4 and 12 hours before 
hypoxia ischemia had a sensitising effect on subsequent hypoxia ischemia. In contrast, 
LPS  given  at  the  time  of  or  24  hours  before  hypoxia ischemia  did  not.  To  help 
understand the mechanism by which this sensitising effect occurs, a dose response 
study of LPS alone was undertaken. Here, a dose dependent activation of microglia 
was demonstrated throughout the brain, particularly in the thalamus and cortex, by 12 
hours  following  endotoxin  administration.  There  was  also  evidence  of  vascular 
endothelial activation (ICAM1) as early as 4 hours after endotoxin administration. To 
study  the  role  of  the  TNF  cluster  of  cytokines  (TNF  alpha,  lymphotoxin  alpha  and 
lymphotoxin beta), animals with a deletion of the entire TNF cluster were examined. 
Deletion  of  the  TNF  cluster  was  shown  to  abolish  both  endotoxin mediated 
sensitisation  of  the  developing  brain  to  subsequent  hypoxia,  and  to  prevent 
upregulation of macrophage and vascular endothelium by endotoxin alone. 
 
This  study  also  examined  the  effects  of  hypoxia ischemia  on  intracellular  pH. 
Increasing duration of hypoxia ischemia resulted in a progressive intracellular acidosis 
within the brain, initially ipsilateral to the carotid ligation, but becoming bilateral with 
prolonged  hypoxia.  In  the  reoxygenation  phase,  there    was  a  rebound  intracellular 
alkalosis at 6 hours of reoxygenation across the whole forebrain.  Previous studies 
have suggested that this alkalosis is mediated by a Na+/H+ exchanger. Blockade of 
this transporter with N methyl isobutyl amiloride prior to hypoxia ischemia was shown 
to confer neuroprotection in the developing brain.  
2 
 
Table of Contents 
 
Chapter 1 General Introduction 
  Part 1: Epidemiology and Perspectives on Childhood Disability  12 
    Paediatrics and Cerebral Palsy: A Retrospective Perspective  13 
    Obstetrics and Birth Asphyxia: A Prospective Perspective  21 
    Neonatology & Neonatal Encephalopathy: A Bidirectional Perspective  28 
       
  Part 2: Patterns of Perinatal Brain Injury  47 
     
  Part 3: Mechanisms of Perinatal Brain Injury  53 
    The Neurotoxic Cascade  53 
    Energy changes after Hypoxia ischemia  57 
    Changes in Brain Intracellular pH after Hypoxia ischemia  58 
    The role of pro  and anti inflammatory cytokines  62 
    The role of Microglia  65 
    The role of Astrocytes  67 
    Potential Mechanisms of Synergy  68 
       
  Part 4: Perinatal Brain Protection and Repair  71 
    Primary Neuroprotection: Preventing of Damage  71 
    Secondary Neuroprotection: Intervening in the Therapeutic Window  73 
    Future Potential: Neonatal Brain Repair  76 
       
  Aims and Hypotheses   78 
     
 
 
 
 
 
 
 
 
 
 
  
3 
 
Chapter 2: General Materials and Methods   
  Surgical Procedures  80 
  Tissue Preparation  81 
  Immunohistochemistry  81 
  Antibody Specificity   83 
  Terminal transferase mediated d UTP Nick End Labeling (TUNEL)  84 
  Tyramide staining  85 
  Nissl staining  85 
  Tissue Analysis   86 
     
Chapter 3: Establishing a Murine Model of Perinatal Brain Injury   
  Introduction  91 
  Materials and Methods  93 
  Results  94 
  Discussion  108 
     
Chapter  4:  Inflammatory  Sensitisation  of  the  Developing  Brain  to 
Hypoxia ischemia 
 
  Introduction  116 
  Materials and Methods  118 
  Results  120 
  Discussion  131 
     
Chapter 5:  The  Role of the  TNF Family of Cytokines in Inflammatory 
Sensitisation of the Developing Brain to Hypoxia Ischemia 
 
  Introduction  140 
  Materials and Methods  143 
  Results  149 
  Discussion 
 
 
159  
4 
 
Chapter 6: Intracellular pH in Perinatal Hypoxic ischemic Brain Injury   
  Introduction  164 
  Materials and Methods  170 
  Results  174 
  Discussion  192 
     
Chapter 7: N methyl isobutyl amiloride  Ameliorates  Brain Injury  when 
Commenced Prior to Hypoxia ischemia in Neonatal Mice. 
 
  Introduction  199 
  Materials and Methods  201 
  Results  202 
  Discussion  208 
     
Chapter 8: General Discussion  212 
   
Chapter 9: Further Work  221 
   
References  225 
   
Appendix  263  
5 
 
Index of Figures: 
 
Figure 1.1  Putative relationship between brain injury, antepartum inflammatory 
activation and intrapartum hypoxic ischemic stress 
18 
Figure 1.2   Effect of 1 hour of isocapnic hypoxia on fetal heart rate, mean arterial 
pressure, carotid blood flow  and carotid vascular resistance. 
22 
Figure 1.3   Effect of 10 min of severe asphyxia induced by umbilical cord 
occlusion on fetal heart rate, mean arterial pressure, carotid blood 
flow, and carotid vascular resistance. 
23 
Figure 1.4  Representative brain spectra from a control infant, and 2 neonates 
with neonatal encephalopathy 
37 
Figure 1.5  Distribution of risk factors in newborn encephalopathy  39 
Figure 1.6  Frequency of positive chorioamnionic culture at varying gestation 
among women delivering by caesarean section, in spontaneous 
labour with intact fetal membranes compared to those delivering by 
caesarean section without onset of labour 
43 
Figure 1.7  Potential Pathways from Choriodecidual Bacterial Colonization to 
Preterm Delivery 
44 
Figure 1.8  Overlap of Intrapartum hypoxia ischemia, neonatal encephalopathy 
and cerebral palsy. 
46 
Figure 1.9  Three possible pathways by which an insult may lead to white matter 
injury via axonal damage and damage to oligodendrocyte precursors  
49 
Figure 1.10  Summary of the Neurotoxic Cascade  56 
Figure 1.11  Changes in brain intracellular pH following 15 minute middle cerebral 
artery occlusion in the adult rat 
59 
Figure 1.12  Brain pHi in the first 2 weeks after birth according to neuro 
developmental category 
60  
6 
 
 
Figure 2.1  Immunohistochemistry for αMβ2 integrin expression. Brain regions 
were scored for microglial activation based on the different 
appearance 
88 
Figure 2.2  Optical luminosity measurement  90 
Figure 3.1  Effect of Increasing Doses of Endotoxin on αMβ2 integrin Staining 
Intensity 
94 
Figure 3.2  Effect of Increasing Doses of Endotoxin on αMβ2 integrin Expression  95 
Figure 3.3  Effects of LPS 10  g/g i.p. after 48 hours Tyramide and IBA1 staining  96 
Figure 3.4  Effect of Carotid Occlusion and 30 minutes Hypoxia on the 
Hippocampus 
98 
Figure 3.5  Effects of Carotid Occlusion and 30 minutes hypoxia on Ipsilateral 
External Capsule 
100 
Figure 3.6  Effect of Increasing Duration of Hypoxia Following Carotid Occlusion 
(infarct volume) 
101 
Figure 3.7  Effect of Increasing Duration of Hypoxia Following Carotid Occlusion 
(injury score)   
102 
Figure 3.8  Effect of Increasing Duration of Hypoxia on White Matter Microglial 
Activation Score 
103 
Figure 3.9  Effects of permanent left carotid occlusion and exposure to 8% 
oxygen for 60 minutes at 48 hours and 28 days  
105 
Figure 3.10  Survival in Animals Exposed to Saline or Endotoxin (0.1 1  g/g) 4 
hours prior to Carotid Occlusion and 30 minutes at 8% Oxygen 
106 
Figure 3.11  Effect of 0.3  g/g LPS 4 hours prior to Carotid Occlusion and 30 
minutes 8% Oxygen 
107 
Figure 3.12  Stages of activation of microglia  109 
Figure 4.1  Effect of Increasing Interval between Endotoxin and Hypoxia 
ischemia on Survival 
120 
Figure 4.2  Effect of Increasing Interval between Endotoxin and Hypoxia 
ischemia on Infarct Volume 
121  
7 
 
Figure 4.3  Effect of Increasing Interval between Endotoxin and Hypoxia 
ischemia on Regional Infarct Volume 
122 
Figure 4.4  Effect of Increasing Interval between Endotoxin and Hypoxia 
ischemia on Injury Score 
123 
Figure 4.5  Effect of Increasing Interval between Endotoxin and Hypoxia 
ischemia on Regional Injury Score 
124 
Figure 4.6  Effect of Increasing Interval between Endotoxin and Hypoxia 
ischemia on White Matter Microglial Activation Score 
125 
Figure 4.7  Effect of 0.5  g/g Endotoxin on ICAM 1Immunoreactivity at 12 hours  126 
Figure 4.8  Effect of 0.3  g/g Endotoxin on αMβ2 Immunoreactivity at 12 hours  127 
Figure 4.9  Effect of Endotoxin on α5, α6, αM, αX, β2 integrin, IBA1, GFAP, 
ICAM1 and VCAM 1 Immunoreactivity at 4, 12 and 24 hours. 
128 
Figure 4.10  Effect of Endotoxin on the Integrity of the Blood brain Barrier.  130 
Figure 4.11  Lipopolysaccharide induced systemic inflammation is transferred to 
the brain across an intact barrier via receptor mediated prostaglandin 
production, areas with an incomplete barrier and through rupture of 
the blood–brain barrier 
135 
Figure 4.12  Microglia detected bacterial products and were rapidly activated and 
releasing TNFα, which activates endothelium to express adhesion 
molecules and allows leukocytes to roll, adhere, and enter the brain 
parenchyma 
137 
Figure 5.1  The TNF cluster which is located within the Major Histocompatability 
complex 
 
141 
Figure 5.2  Distinct  and  overlapping  physiological  functions  of  the  TNF  /  LT 
family. 
141 
Figure 5.3  β Actin PCR of cDNA confirmed the Presence of cDNA   144 
Figure 5.4  Wildtype Genotyping for Deletion of the Entire TNF Cluster  147 
Figure 5.5 
 
Knockout Genotyping for Deletion of the Entire TNF Cluster  148  
8 
 
Figure 5.6  mRNA expression of TNF (A), lymphotoxin α  (B) and lymphotoxin β 
(C) within the brain 2 24 hours after systemic endotoxin.  
150 
Figure 5.7  Effects  of  TNF  cluster  deletion  on  Endotoxin  mediated  microglial 
activation 
151 
Figure 5.8  Regional  Effects  of  TNF  cluster  deletion  on  Endotoxin  mediated 
microglial activation 
152 
Figure 5.9  Effects  of  TNF  cluster  deletion  on  Endotoxin  mediated  vascular 
endothelial ICAM1 upregulation  
153 
Figure 5.10  Regional Effects of TNF cluster deletion on LPS mediated vascular 
Endothelial ICAM1 upregulation 
154 
Figure 5.11  Knockout of the TNF cluster resulted in no increase in infarct volume 
following  pretreatment  with  endotoxin  12  hours  prior  to  hypoxia 
ischemia when compared to wildtype animals 
155 
Figure 5.12  Regional  Effects  of  Endotoxin  from  E.coli  (serotype  055:B5) 
pretreatment prior to Hypoxia ischemia 
156 
Figure 5.13  Relative quantification of TNFα mRNA in the hours following hypoxia 
ischemia alone or endotoxin pretreatment 12 hours prior to hypoxia 
ischemia. 
157 
Figure 5.14  Relative quantification of Lymphotoxin β mRNA in the hours following 
hypoxia ischemia alone or endotoxin pretreatment 12 hours prior to 
hypoxia ischemia. 
158 
Figure 5.15  Potential mechanisms for Systemic Endotoxin Mediated Sensitisation 
of the Neonatal Brain to Hypoxia ischemia 
162 
Figure 6.1  Chemical structure of 3  amino m dimethylamino 2 methylphenazine 
hydrochloride (neutral red) 
166 
 
Figure 6.2  Absorbance  of  3   amino m dimethylamino 2 methylphenazine 
hydrochloride (neutral red) at different pH   
166  
9 
 
Figure 6.3  Callibration for pH measurement: A. Photographic images  of brain 
homogenate. B: standard curve (black line) and best fit algorithm (red 
line) for absorbance at 550nm/ absorbance at 470nm against pH 
172 
Figure 6.4  Intracellular  pH  (pHi)  following  left  sided  carotid  occlusion  prior  to 
hypoxia 
175 
Figure 6.5  Time course  of  pHi  changes  following  hypoxia ischemia:  Following 
carotid occlusion (CROC) and hypoxia 
176 
Figure 6.6  Colour Balance following Carotid Occlusion (CROC) and 90 minutes 
Hypoxia  of  the  Left  (occluded)  and  Right  (non–occluded) 
hemispheres 
177 
Figure 6.7  A:  Green, B: Blue  and  C:  Green to  Blue Colour Balance  in  naïve 
animals, following carotid occlusion (CROC), carotid occlusion and 
90  minutes  Hypoxia  (CROC  HY)  and  following  2 24  hours  re 
oxygenation 
179 
Figure 6.8  Pseudo colour  reconstruction  of  coronal  brain  sections 
demonstrating intracellular brain pH (pHi) following carotid occlusion, 
15  –  90  minutes  of  hypoxia  at  8%  oxygen  and  1 24  hours  of  re 
oxygenation. 
181 
191 
Figure 6.9  Differing patency of the Circle of Willis  195 
Figure 7.1  Effects  of  MIA following  severe  hypoxia ischemia:  A.  Cresyl violet 
stained coronal sections 48 hours following carotid occlusion and 1 
hour hypoxia. 
203 
Figure 7.2  Effects  of  MIA  following  severe  hypoxia  ischemia  on  different 
forebrain regions:  
204 
Figure 7.3  Sequential  coronal  sections  stained  with  Nissl  (A)  and 
immunohistochemistry  for  αMβ2  integrin  (B)  in  the  hippocampus 
following carotid occlusion and 30 minutes hypoxia 
205 
Figure 7.4  Effects  of  MIA  following  moderate  hypoxia  ischemia  on  different  206  
10 
 
forebrain regions  
Figure 7.5  Effects of MIA on TUNEL positive cells within the Hippocampus  207 
Figure 8.1  Lipopolysaccharide signaling via Toll like receptor 4  215 
Figure 8.2  Integrin subunit association  217  
  
11 
 
Index of Tables: 
 
Table 1.1  Distribution of MRI lesions in bilateral and unilateral spastic cerebral 
palsy in term and preterm infants. 
20 
Table 1.2  Distribution of 5 minute APGAR scores in children later diagnosed with 
cerebral palsy compared to controls 
28 
Table 1.3  Neonatal (within 28 days of birth) mortality rate per 1000 live births for 
term and preterm infants according to Apgar score at 5 minutes 
29 
Table 1.4  Evidence of intrapartum hypoxia at different Apgar Scores  29 
Table 1.5  Grading of neonatal encephalopathy by clinical evaluation  30 
Table 1.6  Changes in 
1H MR spectroscopy values in neonates with neonatal 
encephalopathy that died or had a severe neurodevelopmental 
disability at 1 year compared with control 
36 
Table 1.7  Antenatal Risk Factors for Newborn Encephalopathy: the Western 
Australian Case Control Study 
38 
Table 1.8  Neurodevelopmental outcomes of the 1995 cohort of surviving babies 
born in the UK and Republic of Ireland below 26 weeks. 
41 
Table 1.9  Antenatal and Intrapartum Risk Factors for Cerebral Palsy in Very 
Preterm Singleton Babies 
42 
Table 2.1   Antibodies for Immunohistochemistry  82 
Table 2.2  Brain Injury Scoring  87 
Table 2.3  White Matter Microglial Activation Score  89 
 
  
12 
 
Chapter 1: General Introduction 
 
Part 1: Epidemiology and Perspectives on Childhood Disability 
 
A  review  of  the  historical  literature  regarding  childhood  disability  shows  that  our 
understanding began with an endpoint, the identification of a pattern of “Deformities of 
the Human Frame” by an English Orthopaedic Surgeon, William Little in 1843. The 
pattern  of  disability  described,  which  is  now  known  as  spastic  diplegia,  began  our 
recognition  of  the  disorder  of  movement  and  posture  termed  Cerebral  Palsy.  This 
endpoint defines the retrospective view on childhood disability, the perspective of the 
paediatrician, taking children diagnosed as suffering from conditions such as cerebral 
palsy, and attempting to identify the critical factors in their aetiology. 
 
A second perspective is the prospective, obstetric view which builds on the risk factors 
identified  from  the  retrospective  studies.  This  view  starts  with  the  population  of  all 
pregnant women, and their unborn children, and tries to define those babies at risk of 
future disability. Following on from this an attempt is made to intervene in order to 
prevent long term neurodisability. 
 
Between these two perspectives there exists the view of the neonatologist, a specialty 
of medicine that has only existed for some 40 years. The neonatal perspective starts 
with two clinical entities, prematurity and neonatal encephalopathy, both of which have 
been clearly associated with childhood neurodisability. From this position, research has 
looked both retrospectively, to identify antecedent factors, and prospectively, looking 
for predictive markers in the long term neurodevelopmental outcome of the neonate.   
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Paediatrics and Cerebral Palsy: A Retrospective Perspective 
A clinical syndrome comprising motor difficulties and spasticity was first described by 
William Little in a series of articles published in the Lancet between 1843 and 1844 
entitled “Deformities of the Human Frame”. The disorder described, spastic diplegia, is 
one pattern of the non progressive disorder of movement and posture, now termed 
cerebral palsy.  Little, in a lecture and subsequent paper published in 1862, went on to 
propose that the principal cause of this condition was oxygen starvation at or around 
the  time  of  birth  (Little  WJ  1862).  This  attributing  of  childhood  neurodisability  to 
perinatal events has been the subject of extensive discussion and debate ever since.  
 
As a general principal childhood mental and physical disability may have its origins in 
the  antenatal,  perinatal  or  postnatal  period.  Antenatal  causes  include  genetic  / 
chromosomal  disorders,  and  disorders  of  brain  development  and  differentiation, 
including  neuronal  migration  defects.  Perinatal  brain  injury  encompasses  injury 
sustained in labour and the immediate postnatal period. Within this group are both term 
infants and preterm infants who demonstrate differing patterns of injury related to a 
maturation dependent susceptibility to adverse stimuli. Postnatally acquired brain injury 
includes brain injury sustained through trauma, infection, inborn errors of metabolism, 
postnatal  anoxic  brain  injury,  and  possibly  following  prolonged  seizures,  (Thibeault 
Eybalin et al 2009). 
 
Cerebral palsy is defined as a permanent disorder of voluntary movement or posture 
caused  by  a  non progressive  lesion  within  the  immature  brain,  in  general  cases 
associated with either genetic or a fetal malformation syndrome and those who have a 
known  post neonatal  insult  are  excluded  from  the  definition  (Colver  et  al  2000, 
Greenwood  et  al  2005).  Various  longitudinal  studies  have  examined  the  changing 
prevalence / incidence and severity of cerebral palsy in the United Kingdom. Pharoah 
et al used cerebral palsy registers covering Scotland and 6 counties of England, and 
birth / death registers between 1984 and 1989. Over this 5 year period the neonatal  
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mortality rate was 4.6 per 1000 live births. Overall the prevalence of cerebral palsy was 
2.1 per 1000 neonatal survivors. When the data was stratified according to birth weight 
(<1000g,  1000 1499g,  1500g 2499g,  ≥2500g)  there  was  a  dramatic  effect  of  birth 
weight on prevalence of cerebral palsy ranging from 1.1 per 1000 neonatal survivors  
≥2500g  to  78.1  per  1000  neonatal  survivors  ≤1000g.  Interestingly  over  the  5  year 
period studied there was no significant change in the incidence of cerebral palsy at any 
birth  weight,  whilst  neonatal  mortality  fell  in  all  birth  weight  groups.  Colver  et  al 
examined epidemiological trends in cerebral palsy over a 30 year period 1964 to 1993 
looking at annual rates of cerebral palsy stratified by both weight and severity (Colver 
et al 2000). Similar to the findings of Pharoah there was a fall in perinatal and neonatal 
mortality  rates  over  the  period  studied.  In  those  babies  born  ≥2500g there  was  no 
significant increase in either overall rates of cerebral palsy, or in the most severe forms. 
However in babies born <2500g there was an increase in overall cerebral palsy, and it 
was the more severe forms of cerebral palsy that increased the most.  
 
Following on from Little’s assertion, epidemiological studies have attempted to assess 
the proportion of cerebral palsy attributable to perinatal hypoxia. These studies suggest 
intrapartum  hypoxia ischemia  is  the  predominant  cause  in  only  3 28%  of  cases  of 
cerebral palsy (Nelson & Ellenberg 1986, Blair et al 1988, Gaffney et al 1994 Hagberg 
et  al  2001).  Retrospective  epidemiological  studies  have  therefore  been  used  in  an 
attempt to identify other potential aetiological factors in the development of cerebral 
palsy. Multivariate analysis of prenatal and perinatal factors predicting cerebral palsy 
demonstrated that maternal mental retardation, birth weight below 2001 g, and fetal 
malformation were the leading predictors of subsequent cerebral palsy (Nelson and 
Ellenberg  1986).  In  this  study  antenatal  factors  were  much  more  predictive  of  the 
development of cerebral palsy than perinatal factors. The inclusion of information about 
the  events  of  birth  and  the  neonatal  period  (such  as  asphyxia)  accounted  for  a 
proportion of cerebral palsy only slightly higher (37%) than that accounted for when 
consideration was limited to characteristics identified before the onset of labour (34%).  
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In  addition  to  low  birth  weight,  premature  birth  is  also  significantly  associated  with 
increasing rates of cerebral palsy. In a population based study of two health districts in 
England during 1984 1993, 235 cases of cerebral palsy were identified. One third of 
the children later diagnosed with cerebral palsy were born at 32 weeks gestation or 
less, 15% of cases were born between 33 and 36 weeks, 54% of cases were born at 
37 weeks gestation or above. When combined with population data, the prevalence of 
cerebral palsy was calculated at 42 per 1000 live births at 32 weeks gestation or less, 6 
per 1000 live births 33 – 36 weeks gestation, and 1 per 1000 live births at 37 weeks 
gestation  or  above  (Greenwood  et  al  2005).  In  this  study,  markers  of  intrapartum 
hypoxia and infection were associated with an increased risk of cerebral palsy in term 
and preterm infants: Hypoxia OR 12.2, 95%CI 1.2 119 at ≤32 weeks and OR 146, 95% 
CI 7.4 3651 at ≥37 weeks; Neonatal sepsis OR 3.1, 95%CI 1.8 5.4) at ≤32 weeks and 
OR 10.6, 95%CI 2.1 51.9 at ≥37 weeks. Interestingly, in the same study, pre eclampsia 
only increased the risk of cerebral palsy in term infants. 
 
A  further  factor  complicating  the  association  between  cerebral  palsy  and  perinatal 
events is  that certain subtypes of cerebral palsy are thought to be associated with 
specific perinatal insults. Cerebral palsy is subdivided according to the pattern of motor 
involvement: Quadriplegia describes a symmetrical involvement of all 4 limbs; it is this 
form along with dyskinetic forms of cerebral palsy that are thought to relate to perinatal 
hypoxic ischemic injury. Hemiplegia where one side of the body is affected (often the 
arm more than leg), is seen predominantly in term infants and thought to represent a 
stroke like vascular accident.  In spastic diplegia both sides of the body are affected but 
the  arms  more  than  legs;  this  form  is  predominantly  seen  in  preterm  or  growth 
restricted infants.  
 
Gaffney et al undertook a case control study of children with cerebral palsy or death 
occurring during labour or after birth among singletons born ≥37 weeks of gestation  
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without evidence of congenital anomaly or severe infection in a single Health Authority 
during 1984 1987 (Gaffney et al 1994). Antenatal risk factors more common in cases of 
cerebral palsy than controls include previous poor obstetric outcome, existing maternal 
disease, induced conception, raised α fetoprotein, intrauterine growth retardation, pre 
eclampsia,  bleeding  after  20  weeks,  oligohydramnios,  polyhydramnios,  prolonged 
rupture of membranes and postmaturity. Indeed 48% of children with cerebral palsy 
had at least 1 of these antenatal characteristics. The authors described that, although 
many cases of cerebral palsy were managed optimally in perinatal period (75%), there 
was both an increased incidence of failure to respond to clinical signs of fetal distress 
(25%)  compared  with  controls  (7%)  (OR  4.5,  95%CI  2.8 8.4).  However  only  7%  of 
children  diagnosed  with  cerebral  palsy  had  a  suboptimal  response  to  fetal  distress 
followed by evidence of neonatal encephalopathy. This then suggests that improving 
obstetric  interventions  in  cases  of  fetal  distress,  when  taken  in  context  of  the 
prevalence of cerebral palsy (1 in 1000 live births at ≥37 weeks Greenwood et al 2005), 
could at very best reduce the prevalence of cerebral palsy by 1 in 14000 live births. 
 
Other than perinatal hypoxia ischemia, epidemiological studies have demonstrated that 
the  other  major  identifiable  perinatal  risk  factor  for  the  subsequent  development  of 
cerebral  palsy  is  feto  /  maternal  inflammatory  response.  Epidemiological  studies 
suggest  maternal  /  fetal  infection,  inflammation  and  possibly  endotoxin mediated 
cytokine release as antecedent factors in the development of white matter injury in 
preterm neonates (Gilles et al 1977, Leviton 1993, Nelson and Ellenberg 1985, Grether 
and Nelson 1997, Duncan et al 2002). A Meta analysis of clinical chorioamnionitis in 
preterm  infants  using  a  random  effects  model  also  demonstrated  a  significant 
association  with  cerebral  palsy  (RR  1.9,  95%CI  1.4 2.5)  and  cystic  periventricular 
leukomalacia (RR 3.0, 95%CI 2.2 4.0) When histological chorioamnionitis was studied 
in  preterm  infants  the  association  with  cerebral  palsy  was  non significant  RR  1.9, 
95%CI 0.9 2.7) but was significantly associated with cystic periventricular leukomalacia 
(RR 2.1, 95%CI 1.5 2.9) (Wu and Colford 2000). In the term neonate meta analysis of  
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clinical chorioamnionitis and cerebral palsy gave a summary relative risk of 4.7 (95%CI 
1.3 16.2) (Wu and Colford 2000) based on two studies (Nelson and Ellenberg 1985, 
Grether and Nelson 1997). A study of histological chorioamnionitis in neonates with 
neurological  impairment  showed  a  significant  independent  association  (OR  13.2, 
95%CI 1.2 144) (Redline and O’Riordan 2000). This study, which assessed placental 
lesions associated with cerebral palsy and neurological impairments, also showed an 
independent association of other lesions generally believed to have their onset in the 
antenatal  period:  extensive  avascular  villi  (OR  9.0,  95%CI  1.6 51)  and  diffuse 
chorioamnionic  hemosiderosis  (OR  74.8,  95%CI  6.3 894).  The  risk  of  neurological 
impairment  was  noted  to  correlate  with  the  number  of  lesions  present  within  the 
placenta,  particularly  if  antenatal  lesions  and  perinatal  lesions  were  present  in  the 
same  placenta  (OR  94.2,  95%CI  11.9 747).  These  findings  lend  weight  to  the 
hypothesis  of  interactions  of  multiple  antenatal  and  perinatal  aetiological  factors  in 
cerebral palsy (Blair and Stanley 1993, Grether and Nelson 1997, Badawi et al 1998, 
Nelson and Grether 1998). 
 
Animal studies have shown that either whole bacteria or endotoxin, a bacterial product, 
can  result  in  neonatal  brain  injury  when  administered  at  critical  periods  of 
neurodevelopment (Hagberg et al 2002). There is also the potential for a transplacental 
effect as demonstrated by administration of a bolus dose of endotoxin to pregnant rats, 
which results in failure of cerebral myelination in their offspring (Cai et al 2000). The 
developing  brain  appears  to  be  particularly  sensitive  to  infection  when  it  is  at  a 
premyelination stage of maturation. Whilst it is possible to cause white matter injury, 
typically observed in premature neonates, using endotoxin in immature animals, similar 
studies showing endotoxin related grey matter damage have not been reported. The 
relation  between  infection  and  term  brain  injury  may  therefore  involve  other 
mechanisms  
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The  possibility  that  infection  may  play  a  role  sensitising  the  fetus  to  the  effects  of 
hypoxia ischemia  has  been  suggested  previously  (Peebles  and  Wyatt  2002).  This 
concept  is  explored  in  Figure  1.1  where  the  curved  plot  represents  a  hypothetical 
threshold which when crossed from left to right, is associated with brain injury; factors 
that might  do  this  include  hypoxia  (indicated  by  fetus  A)  and  prenatal  exposure  to 
materno fetal infection (fetus B). In fetuses exposed to inflammatory mediators prior to 
the onset of  labour, a relatively minor  degree of  intrapartum hypoxia ischemia may 
have disastrous consequences (fetus C).  
 
Figure 1.1 Putative relationship between brain injury, antepartum inflammatory activation and 
intrapartum  hypoxic ischemic  stress.    Fetus  A  can  withstand  substantial  intrapartum  stress 
before permanent cellular injury is initiated.  Fetus B will develop permanent injury as a result of 
antepartum infection despite minimal intrapartum stress.  Fetus C is vulnerable to intrapartum 
stress and will escape permanent injury provided that the ischemic threshold is not reached. 
From Peebles and Wyatt 2002, reproduced with permission 
 
Evidence to support this hypothesis comes from both epidemiological and experimental 
studies. Epidemiological evidence suggests that exposure to combined infection and 
hypoxic ischemic insults dramatically increases the risk of developing cerebral palsy 
compared with either insult alone (OR 78, 95%CI 4.8 406) (Nelson and Grether 1998).  
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Animal  models  have  also  demonstrated  the  synergistic  effects  of  inflammatory 
responses and hypoxia ischemia. Endotoxin (lipopolysaccharide) has been shown to 
sensitise and dramatically increase the lesion size in the immature rat brain following 
hypoxic ischemic injury. Similar effects are seen in the neonatal mouse when exposed 
to E.Coli endotoxin before hypoxia ischemia. This effect is seen when endotoxin is 
administered  systemically  (Eklind  et  al  2001,  Yang  et  al  2004)  or  intracisternally 
(Coumans  et  al  2003).  Paradoxically  pre treatment  with  endotoxin  has  also  been 
shown to reduce the volume of infarct in adult rats following regional cerebral ischemia 
(Ahmed et al 2000) and under certain circumstances in the neonatal rat (Eklind et al 
2005).  It  is  unclear  whether  this  apparently  conflicting  neuroprotective  effect  of 
endotoxin is due to the exact time relationship of the insults, and whether there are 
differing  effects  on  immature  and  adult  brains.  It  is  plausible  that  the  inflammatory 
status of the brain, particularly in terms of the pro /anti  inflammatory cytokine response 
may  be  quite  different  at  different  time points  following  endotoxin  administration.  It 
therefore appears that a combination of antenatal and perinatal factors may act as 
antecedents  of  cerebral  palsy,  and  it  is  entirely  possible  that  there  may  be  an 
interaction  between  antenatal  /  perinatal  factors,  and  additionally  specific  genetic 
susceptibilities  leading  to  a  theory  of  multifactorial  aetiology  in  the  development  of 
cerebral palsy.  
 
Imaging  of  children  born  at  term  with  cerebral  palsy  has  provided  little  help  in 
establishing  either  the  aetiology  or  timing  of  the  antecedents  to  their  disability,  as 
lesions are variable and dependent on the pattern of cerebral palsy and gestation at 
birth. In a systematic review of magnetic resonance imaging in children born at term 
diagnosed with bilateral spastic cerebral palsy 25% had normal MRI scans, 24% had 
grey matter lesions, 20% had periventricular white matter lesions and 18% showed 
patterns of brain maldevelopment. This was in contrast to preterm babies and babies 
with  spastic  hemiplegia  (see  Table  1.1;  Krägeloh Mann  and  Horber  2007).  It  is 
possible, however, that in time, with serial scans from birth through to childhood, that  
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the nature of some of the observed lesions can be better characterised and further 
information about the aetiology deduced.   
 
  Bilateral Spastic Cerebral Palsy  Spastic Hemiplegia 
  Term  Preterm  Term  Preterm 
Normal MRI  25% (33)  4% (8)  14% (6)  0% (0) 
GM Lesion  24% (32)  4% (7)  41% (18)  0% (0) 
PWM Lesion  20% (26)  90% (167)  20% (9)  86% (12) 
Maldevelopment  18% (24)  2% (3)  16% (7)  14% (2) 
Miscellaneous   5% (7)  1% (1)  9% (4)  0% (0) 
 
Table 1.1: Distribution of MRI lesions in bilateral and unilateral spastic cerebral palsy in term 
and preterm infants. GM grey matter, PWM periventricular white matter lesion (from Krägeloh 
Mann and Horber 2007) 
 
More than 150 years after Little’s original publications, it now appears that cerebral 
palsy  is  the  clinical  manifestation  of  multiple,  and  interacting,  aetiological  and 
pathophysiological  pathways  which  encompass  antenatal,  perinatal  and  postnatal 
factors. This complex multifactorial background to cerebral palsy may explain some of 
the  apparent  conflicts  in  the medical  literature,  especially  surrounding  the  timing  of 
insults, and the apparent failure to impact on the incidence of childhood neurodisability. 
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Obstetrics and Birth Asphyxia: A Prospective Perspective 
The observation that an inadequate supply of “oxygen and materials for nutrition,” or 
insufficient  removal  of  “carbon  and  other  residues”  may  lead  to  brain  injury  in  the 
neonate was first made by William Little in a lecture and paper later referred to as a 
“learned  bombshell”  (Jensen  et  al  1991).  The  exact  relationship  between  hypoxia 
ischemia and brain injury has remained a topic of extensive debate ever since.  
 
One of the significant difficulties in establishing the role and impact of hypoxia ischemia 
on  neuro developmental  outcome  relates  to  the  definition  and  use  of  terms  in  the 
medical literature. Hypoxia is defined as a reduction in oxygen tension which may be 
further defined as to where it occurs (hypoxaemia, tissue hypoxia). Ischemia is the 
reduction in blood delivery to the tissues which in turn leads to a reduction in substrate 
(glucose)  delivery.  The  definition  of  birth  asphyxia  is  very  variable  in  the  medical 
literature and in clinical medicine. A task force for the World Federation of Neurology 
Group defined asphyxia as “a condition of impaired blood gas exchange leading, if it 
persists, to progressive hypoxemia and hypercapnia” (Bax and Nelson 1993). Defining 
and quantifying these characteristics is essential to aid in the management of women in 
labour. Whilst epidemiological studies suggest that perinatal hypoxia is responsible for 
only  a  small  proportion  of  childhood  neurodisability,  it  remains  the  single  most 
important cause of perinatal brain injury (du Plessis and Volpe 2002). Indeed perinatal 
animal models have consistently demonstrated that, in previously healthy animals, a 
brief period of severe and acute hypoxia ischemia can initiate the causal sequences 
leading to neuronal death (Gunn et al 1992).  
 
Even an apparently “normal” labour involves a degree of hypoxic stress on the fetus. 
However, the incidence of moderate or severe encephalopathy after birth is low at less 
than 3.8 per 1000 live births
 (Badawi et al 1988). The normal term fetus is able to 
mount a complex range of haemodynamic and metabolic compensatory mechanisms 
to protect the brain from hypoxia (Peebles et al 2002). Hypoxia and hypercapnia in the  
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fetus initially causes a redistribution of cardiac output to the brain, heart and adrenal 
glands mediated by the sympathetic adrenergic nervous system.  These physiological 
compensation  mechanisms  have  been  demonstrated  in  animal models.  In  the  fetal 
sheep isocapnic hypoxemia for 1 hour (reduction of the maternal FiO2 to 9 to 10%) 
results initially in a fall in the fetal heart rate (FHR) which then gradually returns to 
normal. At the same time there is a rise in mean arterial pressure (MAP) and in carotid 
blood flow (CaBF) with a corresponding fall in carotid vascular resistance (CaVR; see 
Figure  1.2).  Only  when  these  mechanisms  are  overwhelmed  by  very  severe  or 
prolonged hypoxia is there cerebral hypoperfusion and a fall in high energy phosphate 
metabolism initiating a cellular and molecular cascade of events leading to neural cell 
death (Niijima et al 1988, Vannucci RC 1990, Jensen and Berger 1991, Gunn et al 
1992).  
Figure  1.2  Effect  of  1  hour  of  isocapnic 
hypoxia  on  fetal  heart  rate  (FHR),  mean 
arterial pressure (MAP), carotid blood flow 
(CaBF),  and  carotid  vascular  resistance 
(CaVR).  The  shaded  region  denotes  the 
period  of  hypoxia.  Values  are  means  ± 
SEM, # p < 0.05; ** p < 0.005, for individual 
time points or intervals of data (black bars). 
There is a significant rise in CaBF  during 
hypoxia, which is associated with a fall in 
CaVR and a rise in MAP (from Bennet et al 
1998 reproduced with permission) 
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In contrast the responses to pure ischemia tend towards a reduction of cerebral blood 
flow which may exacerbate brain injury (see Figure 1.3).  
 
Figure  1.3  Effect  of  10  min  of  severe 
asphyxia  induced  by  umbilical  cord 
occlusion on fetal heart rate (FHR), mean 
arterial pressure (MAP), carotid blood flow 
(CaBF),  and  carotid  vascular  resistance 
(CaVR).  The  shaded  region  denotes  the 
period  of  asphyxia.  Values  are  means  ± 
SEM  (black  bars,  #  p  <  0.05;  p  <  0.01). 
Note the progressive fall in CaBF and the 
associated  rise  in  CaVR  at  a  time  when 
MAP is significantly elevated (from Bennet 
et al 1998 reproduced with permission) 
 
 
 
 
Whilst intrapartum events likely to cause a complete disruption of maternal fetal gas 
exchange, such as cord prolapse and placental abruption do occur, and can lead to 
neonatal encephalopathy and brain injury, (Nelson & Ellenberg 1986) (Blair et al 1988) 
in clinical practice this sequence of events is rare. Hypoxia severe enough to result in 
brain injury is usually accompanied by evidence of other end organ damage, such as of 
the heart, liver and kidneys. Indeed the effects of hypoxia on cardiac contractility and 
hence  cardiac  output  may  be  critical  in  disrupting  the  normal  compensatory 
mechanisms  to  hypoxia.  In  animal  models  disruption  of  these  compensatory 
mechanisms results in death or worsened brain injury. For example, impairing normal 
vasoconstrictor  mechanisms  by  sympathectomy  or  α adrenergic  blockade  results  in  
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impaired fetal survival during acute hypoxia, and blocking A1 adenosine receptors prior 
to hypoxia worsens the extent of brain injury (Hunter et al 2003).  
 
One of the key problems for obstetric practice is how to assess for the presence of 
asphyxia  i.e.  “impaired  blood  gas  exchange  leading  to  progressive  hypoxemia  and 
hypercapnia”  severe  enough  to  lead  to  damage  to  the  fetus,  allowing  timely 
intervention. Generally in the United Kingdom assessment of the fetus in the perinatal 
period is by fetal heart rate monitoring often as part of a continuous cardiotocogram 
(CTG). In selected cases, more invasive testing in the form of fetal blood sampling for 
direct assessment of fetal acid base balance is used. The findings from these forms of 
monitoring are then compared to immediate outcome measurements in the neonate, 
such as condition at birth (assessed for example by the APGAR score), intermediate 
neonatal  outcome  measures  such  as  the  presence  and  severity  of  neonatal 
encephalopathy, and finally with long term neurodevelopmental outcomes, such as the 
presence of cerebral palsy. 
 
Fetal heart rate monitoring originated from research papers published  in the  1960s 
describing  various  patterns  thought  to  be  associated  with  the  early  stages  of  fetal 
asphyxia. A number of attempts were made over the subsequent decades to formalise 
definitions  and  nomenclature  for  the  various  patterns  of  fetal  heart  rate  such  that 
appropriate interventions could be put in place. In 1997 the National Institute of Child 
Health and Human Development (NICHD) Research Planning Workshop published a 
paper attempting to describe “standardized and unambiguous definitions for fetal heart 
rate  tracings”  They  described  that  the  interpretation  of  the  fetal  heart  rate  tracing 
involves  several  characteristics,  baseline  fetal  heart  rate  (FHR),  baseline  FHR 
variability, presence of accelerations, periodic or episodic decelerations and changes 
or  trends  of  FHR  patterns  over  time  (NICHD  Research  Planning  Workshop  1997). 
From  a  clinical  perspective  they  described  that  a  normal  FHR  tracing  would 
demonstrate a normal baseline rate, normal [moderate] FHR variability, presence of  
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accelerations,  and  absence  of  decelerations.  Tracings  thought  to  be  predictive  of 
severe asphyxia, placing the fetus at risk of neurological damage or death, include 
recurrent late or variable decelerations or substantial bradycardia, with absent FHR 
variability.  In  a  retrospective  case  control  study,  the  features  of  a  FHR  tracing 
associated with increased risk of the subsequent development of cerebral palsy, were 
multiple late decelerations in the heart rate, (slowing of the heart rate well after the 
onset of a uterine contraction) (OR 3.9, 95%CI 1.7 9.3), and decreased FHR variability 
(OR  2.7,  95%CI1.1 5.8).    These  features  were  present  in  27%  of  children  who 
subsequently developed cerebral palsy, but were also present in 9.3% of those who did 
not. However, when this is extrapolated to a population level, with an incidence (in this 
study)  of  cerebral  palsy  at  2  per  1000  live  births  (>2500g),  then  FHR  findings  of 
multiple late decelerations and / or decreased FHR variability would have a 99.8% false 
positive rate (Nelson et al 1996). Thus, the use of fetal heart rate monitoring has the 
potential  to  dramatically  increase  obstetric  intervention  rates  with  minimal  and 
conflicting  evidence  for  impact  on  rates  of  neonatal  encephalopathy  and  long term 
neurodisability.  
 
Interestingly when pregnancies with evidence of intrauterine bacterial infection (clinical 
chorioamnionitis plus either positive blood cultures or signs of infection in the neonate) 
were studied, the cerebral palsy rate was much higher than normal at 11%. In this 
group  of  139  pregnancies  “non reassuring”  FHR  patterns  including  recurrent  late 
deceleration,  severe  variable  deceleration,  and  prolonged  deceleration  occurred  in 
24%,  but  the  incidence  of  cerebral  palsy  was  not  different  according  to  the  FHR 
deceleration patterns or umbilical pH values, thus suggesting that, in the presence of 
infection, an abnormal FHR trace may have even less predictive value for subsequent 
neurodisability. 
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Potentially the most direct assessment of fetal condition comes from direct assessment 
of  fetal  blood  pH,  carbon  dioxide  and  base  deficit  /  excess.  This  assessment  is 
commonly performed in the immediate postnatal period from the umbilical cord vessels, 
and less commonly in the latter stages of delivery from a fetal scalp blood sample. 
Whilst correlation of pH to long and short term neurodevelopmental outcome is, at best, 
weak,  the  metabolic  component  of  acidosis  (using  base  deficit)  demonstrates  the 
strongest association (ACOG Committee Opinion 2006). Low et al studied children with 
base deficits of 4 8 mmol/L, 8 12 mmol/L, and 12 16 mmol/L and obtained evidence of 
neonatal central nervous, respiratory, cardiovascular, and renal complications which 
were each scored for severity. They demonstrated that an umbilical arterial base deficit 
of  12  mmol/L  represented  a  threshold  when  moderate  or  severe  newborn 
complications may occur and further worsening of metabolic acidosis was associated 
with increasing severity of newborn complications (Low et al 1997). 
 
In  an  attempt  to  define  an  acute  intrapartum  hypoxic  event  as  sufficient  to  cause 
cerebral  palsy,  the  American  Academy  of  Pediatrics  and  American  College  of 
Obstetricians and Gynecologists have defined 4 criteria all of which must be fulfilled 
(modified from MacLennan 1999): 
1.  Evidence of a metabolic acidosis in fetal umbilical cord arterial blood obtained at 
delivery (pH <7 and base deficit ≥12 mmol/L) 
2.  Early onset of severe/moderate neonatal encephalopathy in infants born ≥34 weeks  
3.  Cerebral palsy of the spastic quadriplegic or dyskinetic type 
4.  Exclusion of other identifiable aetiologies, such as trauma, coagulation disorders, 
infectious conditions, or genetic disorders 
 
Thus, to  define childhood neurodisability as  having resulted from perinatal hypoxia 
ischemia, evidence is required from birth, the neonatal period and long term follow up. 
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In addition to the difficulty in identification and quantification of fetal hypoxia ischemia, 
the  diagnosis  and  interpretation  of  chorioamnionitis  also  remains  a  challenge.  In 
practice  chorioamnionitis  may  be  differentiated  into  microbiological  chorioamnionitis 
(culture  positive),  clinical  chorioamnionitis,  or  histological  chorioamnionitis.  In  the 
clinical setting, timely diagnosis may have to be made prior to the culture result being 
available,  and,  at  the  present  time,  histological  chorioamnionitis  is  a  retrospective 
diagnosis. The diagnosis of clinical chorioamnionitis generally includes criteria such as 
maternal fever ≥38°C, raised C reactive protein, leukocytosis, uterine tenderness, foul 
smelling amniotic fluid, and fetal or maternal tachycardia. Whilst easy to diagnose if 
multiple  features  are  present,  in  practice,  clinical  chorioamnionitis  often  presents  a 
diagnostic challenge, and the decision to intervene and facilitate delivery, especially in 
the preterm period, remains a matter of clinical judgement.  
 
In  addition  to  chorioamnionitis,  intrapartum  fever  itself  has  been  shown  to  be 
independently  associated  with  an  increased  risk  of  development  of  unexplained 
neonatal seizures (a strong predictor of neurological impairment in term infants) (OR 
3.4 95%CI 1.03 10.9) (Lieberman et al 2000) and neonatal encephalopathy (OR 4.72, 
95% CI 1.28 17.4) (Impey et al 2001). It is not clear whether these effects are just 
because pyrexia is serving as a marker for infection / inflammation or whether non 
infectious pyrexia, related to epidural usage, may also be damaging, particularly if the 
fetus is hypoxic.   
 
The challenge from the obstetric perspective remains immense. Starting with the large 
population  of  all  pregnant  women,  most  of  which  will  have  a  normal  outcome,  the 
obstetrician needs to not only identify the very small number of babies with hypoxia 
ischemia sufficient to risk neurological damage, but also to intervene to prevent this 
outcome  without  exposing  women  to  unnecessary  interventions,  which  themselves 
have the potential for harm.   
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Neonatology and Neonatal Encephalopathy: A Bidirectional Perspective 
William  Little  described  in  1861  that,  in  addition  to  prematurity  and  difficulties  in 
parturition, a delay in establishing “pulmonary respiration” in the immediate postnatal 
period  may  lead  to  brain  damage.  The  neonatal  perspective  on  neurodisability  is 
related to two main clinical entities, prematurity and neonatal encephalopathy. 
 
Assessment of the newborn begins with an immediate assessment of condition at birth. 
Measurements  such  as  Apgar  scores  at  1,  5  and  10  minutes,  time  to  onset  of 
spontaneous  respirations,  or  need  for  resuscitation  have  been  used  in  attempt  to 
provide a quantifiable measure of the condition of the neonate. The Apgar score was 
first  proposed  more  than  50  years  ago  and  has  become  a  standard  method  of 
assessing the condition of a neonate at birth (Apgar 1953). This assessment entails the 
scoring from 0 2 of 5 physiological characteristics: pulse, respiration, colour, muscle 
tone and response to stimulation. Retrospective analysis of Apgar scoring in children 
with cerebral palsy does demonstrate that a low score is a statistically significant risk 
factor for developing cerebral palsy (see Table 1.2) (Nelson and Ellenberg 1981). 
 
Apgar Score   
  0 3  4 6  7 10 
Controls   1%  3%  96% 
Cerebral Palsy  15%  12%  73% 
 
Table  1.2:  Distribution of  5 minute  APGAR  scores  in  children  later  diagnosed  with  cerebral 
palsy compared to controls (from Nelson and Ellenberg 1981) 
 
Whilst  it  is  clear  that  children  who  are  later  diagnosed  with  cerebral  palsy  have  a 
greater chance of having a low Apgar score at 5 minutes, the predictive value of the 
score for cerebral palsy is very low. 73% of children later diagnosed with cerebral palsy 
had an Apgar score 7 10 at 5 minutes and, even with an Apgar score as low as 0 3 at 
10 minutes, only 16.7% of children went on to develop cerebral palsy, i.e. 83.3% of  
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children with an Apgar score of 0 3 at 10 minutes were free of major disability at early 
school age (Nelson and Ellenberg 1981).  The Apgar score has also been shown to 
correlate with neonatal mortality (death within the first 28 days of life) in both term and 
preterm infants (see Table 1.3). In this study the relative risk of neonatal death using 
the five minute Apgar score of 0 3 was 1460, 95% CI 835 2555, this was eight times 
the relative risk with an umbilical artery blood pH ≤7.0 (RR 180; 95% CI 97 to 334). 
 
Apgar Score   
  0 3  4 6  7 10 
Preterm (26 36wk)  315  72  5 
Term (≥37wk)  244  9  0.2 
 
Table 1.3: Neonatal (within 28 days of birth) mortality rate per 1000 live births for term and 
preterm infants according to Apgar score at 5 minutes (Casey et al 2001) 
 
In an attempt to establish the proportion of cases of low Apgar scores that can be 
attributed to asphyxia, Hogan et al used a case control and cohort study to look for 
evidence  of  hypoxia  (Hogan  et  al  2007).  The  authors  used  abnormalities  in  CTG, 
interventions for fetal distress, cord pH and evidence of HIE or death (see Table 1.4). 
 
5 minute Apgar Score   
<4 
(n=30) 
4–6 
(n=143) 
Controls 
(n=182) 
Abnormal admission CTG  38%  8%  0.6% 
Abnormal CTG before birth  28%  6%  0.6% 
Interventions for fetal distress  83%  48%  9% 
Cord artery pH below 7.15  69%  54%  7% 
HIE or hypoxic death  70%  14%  0% 
 
Table 1.4: Evidence of intrapartum hypoxia at different Apgar Scores (from Hogan et al 2007) 
 
However, as with many studies into this area, there are some difficulties with drawing 
definite conclusions from these data. As discussed earlier, changes in FHR tracings  
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may arise from conditions other than hypoxia. Whilst cord artery acid base status is 
important, as described previously, use of the metabolic component (base deficit) is 
generally considered to be a more accurate reflection of intrapartum hypoxia ischemia 
with a threshold at base deficit 12mmol/L or above (Low et al 1997) as this is the 
threshold above which there is significant risk of neonatal complications. In the group of 
neonates  with  an  Apgar  score  <4,  19%  had  mild  neonatal  encephalopathy  (Sarnet 
grade  I)  and  41%  had  moderate     severe  neonatal  encephalopathy  (Sarnet  II III) 
contrasting with the group of neonates with Apgar 4 6 who had 9% with mild neonatal 
encephalopathy and 3% with severe neonatal encephalopathy (Hogan et al 2007).  
 
Assessment of the newborn within minutes of delivery whilst a useful measure to alert 
the clinician to  potential evidence of an intrapartum  event  severe  enough  to cause 
neonatal and long term complication, is not able to either give prognostic information or 
establish the cause of any depression of consciousness noted at birth. 
 
Neonatal Encephalopathy and Term Perinatal Brain Injury 
The clinical picture of neonatal encephalopathy is well described and graded according 
to Sarnet and Sarnet 1976 (see Table 1.5). The relationship with hypoxia ischemia is 
somewhat more complicated.   
  Mild (I)  Moderate (II)  Severe (III) 
Level of Conciousness  Hyperalert  Lethargic  Stuporose 
Neuromuscular Control       
Muscle tone  Normal  Mild Hypotonic  Flaccid 
Posture  Normal  Flexion  Decerebrate 
Tendon reflex  Hyper reflexia  Hyper reflexia  Absent 
 
Clonus  Present  Present  Absent 
Pupils  Dilated  Constricted  Poorly reactive 
Seizures  None  Common  Frequent/ intractable  
Moro Reflex  Strong  Weak/ incomplete  Absent  
Suck Reflex  Normal/weak  Weak/ absent  Absent  
 
Table 1.5: Grading of neonatal encephalopathy by clinical evaluation (modified from Sarnet and 
Sarnet 1976)   
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Combining  the  available  data  from  the  medical  literature  regarding  long term 
neurodevelopmental outcome related to severity of neonatal encephalopathy, it is clear 
that there is “dose response” effect of worsening encephalopathy with increasing long 
term major disability and death (for review see Collins and Paneth 2002). Overall the 
risk of death or major disability in neonates diagnosed with mild encephalopathy was 
2%,  moderate  encephalopathy  19%  and  severe  encephalopathy  was  63%.  In  a 
population  based  study  in  Sweden,  moderate  neonatal  encephalopathy  had  a 
prevalence of 0.06%. Of the surviving individuals, 30% had cerebral palsy (similar to 
that  reported  in  other  studies);  interestingly,  however,  of  the  70%  who  were  not 
diagnosed with cerebral palsy, 71% had definite cognitive difficulties, and 18% hearing 
impairment. Indeed only 8% of those individuals who had been diagnosed with grade II 
neonatal  encephalopathy  who  did  not  have  cerebral  palsy  were  free  of  impairment 
when tested at 15 19 years (Lindström et al 2006). It is clear, therefore, that significant 
intrapartum  hypoxia ischemia  results  in  neonatal  encephalopathy  and  may,  in  turn, 
lead to long term neurodisability.  
 
Following on from clinical evaluation of neonatal encephalopathy, additional prognostic 
information has, more recently, been described from electroencephalograms (EEG) / 
amplitude integrated encephalograms (aEEG) and from magnetic resonance imaging 
and spectroscopy. Amplitude integrated electroencephalogram (aEEG) monitoring with 
the cerebral function monitor (CFM) was first described almost 40 years ago (Maynard 
et al 1969). The aEEG allows continuous long term monitoring of background activity, 
which compares well with the background on simultaneous conventional EEG. aEEG 
has  gained  widespread use in the care  of  neonates with encephalopathy  as  it  has 
allowed  early  prediction  of  neurodevelopmental  outcome,  especially  when  used  in 
conjunction with clinical neurological evaluation (al Naqeeb et al 1999) with a combined 
specificity (94%) and positive predictive value (85%) for persisting moderate to severe 
encephalopathy  at  5  days  (Shalak  et  al  2003).  Correlation  of  aEEG  voltage  and 
pattern,  to  long term  neurodevelopmental  outcome  has  also  been  demonstrated  in  
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children  with  hypoxic ischemic  encephalopathy.  aEEG  recordings  made  at  3  and  6 
hours after birth were compared with neurodevelopmental outcome at 30 months or 
older. The sensitivity of a low baseline voltage to poor outcome was 33% at 3 hours, 
and 42% at 6 hours, but the association was only significant at 6 hours. In contrast, 
sensitivity of burst suppression pattern to poor outcome was 83% at 3 hours and 75% 
at 6 hours (Shanay et al 2006).  
 
The  aEEG  also  has  the  potential  to  identify  those  infants  who  would  benefit  from 
therapeutic interventions such as therapeutic cooling (Gluckman et al 2005, Shankaran 
et al 2005) and may allow selection of specific neonates for different interventions. The 
2 channel  aEEG  quantified  into  median  values  of  minimum,  mean,  and  maximum 
amplitude has been shown to have a negative relationship with MRI abnormalities, i.e. 
the lower the amplitude the worse the MRI findings (Shah et al 2006). The authors 
suggest that a minimum amplitude of 4  V gives a specificity of 75%, which may allow 
its use for early prognosis (in conjunction with clinical examination and neuroimaging), 
whereas a minimum amplitude of 6  V could be used for diagnostic purposes or for 
consideration for neuroprotective interventions. The other main use of the aEEG has 
been in identifying seizure activity in babies even after administration of neuromuscular 
blockade. Most seizure activity can be detected by the aEEG, especially with modern 
monitors that allow review of raw EEG data either continuously or on review of possible 
seizure activity. However some short or localised seizures may be missed (Hellstrõm 
Westas and Rosén 2002).  
 
Magnetic  resonance  imaging  is  rapidly  becoming  a  standard  of  care  in  the 
management of both preterm infants, and term infants with neonatal encephalopathy. 
Scanning of infants following hypoxic ischemic insults can give important prognostic 
information  and  guide  ongoing  clinical  care  (for  review  see  Rutherford  2002).  MRI 
studies  have  identified  basic  patterns  of  injury  following  hypoxia ischemia.  Acute  
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severe  insults  result  in  cortico subcortico  involvement  in  the  basal  ganglia,  thalami, 
brain stem, hippocampus and the corticospinal tracts around the central fissure.  
 
Chronic or repetitive insults result in cortical and white matter damage in a parasagittal 
distribution,  which  represents  the  watershed  region  between  major  arterial  supplies 
(Rutherford 2002). Early findings within the first week include: 
•  Signs of brain swelling (loss of extracerebral space, loss of sulcal markings, 
closure of the Sylvian fissures, narrow interhemispheric fissure, slit like anterior 
horns of the lateral ventricles)  
•  loss of normal signal in the posterior limb of the internal capsule (PLIC)  
•  abnormal signal intensities in the basal ganglia and thalami 
•  Loss of grey / white differentiation 
•  Cortical highlighting on T1 weighted sequences 
 
From  a  prognostic  perspective  the  presence  of  brain  swelling  alone  does  not 
necessarily represent permanent injury. If, once the swelling resolves, the underlying 
brain  is  normal,  there  is  no  association  with  a  poor  neurodevelopmental  outcome. 
However, a loss or change in the signal intensity from myelin in the posterior limb of the 
internal capsule has been shown to be very sensitive (0.91) and specific (1.0) for an 
abnormal  outcome. Furthermore  these changes,  when  present more  than 48 hours 
after insult, can correctly predict motor outcome in 93% of infants, born ≥38 weeks 
gestation, with grade II hypoxic ischemic encephalopathy (Rutherford et al 1998). The 
severity  of  lesions  within  the  basal  ganglia  and  thalami  are  related  to 
neurodevelopmental outcome. Most authors suggest that interpretation of basal ganglia 
and thalamic lesions should be undertaken in association with PLIC signal anomalies. 
Mild focal basal ganglia lesions are generally associated with normal signal intensity 
within  the PLIC; these findings correlate with mild motor difficulties. Moderate focal 
basal  ganglia  lesions  are  generally  associated  with  equivocal  or  abnormal  signal 
intensity  within  the  PLIC;  these  findings  are  associated  with  the  development  of  
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athetoid quadriplegia; however intellect is normally preserved. Severe diffuse lesions 
are always associated with abnormal signal intensity within the PLIC, these correlate 
with  spastic  quadriplegia,  severe  intellectual  delay,  secondary  microcephaly  and 
persistent  refractory convulsions  (Rutherford 2002,  Rutherford et al 2006,  Jyoti  and 
O’Neil 2006). The other early MR findings of cortical highlighting and loss of grey / 
white differentiation occur in conjunction  with the  other findings and,  as such, their 
extent represents part of the overall spectrum of injury detectable on MRI. 
 
Advanced  MR  techniques  have  been  used  in  hypoxic  ischemic  encephalopathy 
including diffusion weighted imaging, diffusion tensor imaging and magnetic resonance 
spectroscopy.  
 
Diffusion weighted imaging (DWI) provides a visual image of the random motion of 
water  within  a  tissue.  This  motion  or  diffusivity  can  be  quantified  as  an  apparent 
diffusion coefficient (ADC). Visual abnormalities on DWI are most obvious 1 to 4 days 
after hypoxic ischemic insult, when conventional imaging may appear normal. However 
when  there  has  been  widespread  injury,  DWI  images  may  be  apparently  normal, 
possibly  because  there  is  no  normal  tissue  for  comparison.  In  this  context, 
measurement of ADC values is essential to detect the presence of ischemic tissue 
(Rutherford et al 2005). Studies using DWI in infants following hypoxia ischemia have 
produced conflicting results (Forbes et al 2000, Rutherford et al 2005, Boichot et al 
2006, Dağ et al 2006). ADC values are typically reduced in the first week following 
severe injury to white matter or basal ganglia / thalamus but normalise at the end of the 
first week. ADC values in the posterior limb of the internal capsule have been shown to 
be significantly associated with survival and to correlate with motor outcome (Hunt et al 
2004).  Early  DWI  and  ADC  values  may,  however,  be  normal  in  the  presence  of 
moderate but significant basal ganglia / thalamic lesions (Rutherford et al 2005).  
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Diffusion  tensor  imaging  measures  the  anisotropy  or  directional  diffusivity  within  a 
tissue.  Anisotropy  normally  increases  with  age  as  myelination  decreases  radial 
diffusivity perpendicular to WM tracts (Rutherford et al 2005). In a series of 20 infants 
with hypoxic ischemic encephalopathy Ward et al demonstrated decreased fractional 
anisotropy values in both severe and moderate white matter and basal ganglia thalamic 
injury during the first week, whereas ADC values were reduced only in severe white 
matter damage and some severe basal ganglia thalamic damage. In comparison to 
ADC  values,  which  appear  to  normalise  during  the  second  week  after  hypoxia 
ischemia, fractional anisotropy values continued to decrease (Ward et al 2006). 
 
Magnetic  resonance  spectroscopy  (MRS)  allows  quantitative  analysis  of  chemical 
composition and structure using atomic nuclei such as phosphorus (
31P) and hydrogen 
1 (proton, 
1H), the magnetic resonance signal derived can be resolved into a frequency 
spectrum by the mathematical Fourier Transformation. Phosphorus (
31P) MRS provides 
data on high energy phosphate molecules, including ATP; it is usually taken from the 
whole brain and has been used to demonstrate the biphasic nature of energy changes 
following  hypoxic  ischemic  insults  (see  later).  Additionally  shift  in  the  Pi  peak  (Pi 
relative to phosphocreatine) can derive pHi values and has been used to demonstrate 
rebound alkalosis following  neonatal hypoxia ischemia (see  later). Proton (
1H)  MRS 
provides data on choline, creatine, NAA and lactate, and unlike 
31P MRS, 
1H MRS can 
give information from different brain regions. Two recent studies have looked at the 
prognostic value of proton (
1H) magnetic resonance spectroscopy. 11 term newborns 
with encephalopathy had 
1H spectroscopy of the basal ganglia and thalami two weeks 
after  hypoxia ischemia.  Abnormal  neurodevelopmental  follow up  at  9  months  was 
detected in 45%; here there was a trend towards a low mean NAA / creatine ratio, 
although  this  was  not  statistically  significant.  Furthermore  the  presence  of  a  raised 
lactate  peak  was  associated  with  adverse  neurological  outcome  relative  risk  7.0 
(95%CI 1.1 42.9) (da Silva et al 2006). A second study looked at the value of early (day 
1 3) 
1H MR spectroscopy in 17 infants with neonatal encephalopathy and 10 controls.  
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Neurodevelopmental outcomes were assessed at 1 year and graded as mild/ normal or 
severe fatal.  A number of  concentrations and ratios were  shown to be significantly 
changed in the severe / fatal group compared see Table 1.6 and Figure 1.4 (Cheong et 
al 2006).  
 
Quantification  Increased  Decreased 
Metabolite Peak Area Ratios 
 
Lactate / NAA 
Lactate /Choline,  
Lactate / Creatine  
NAA/ Creatine  
NAA/ choline  
Metabolite T2 Relaxation 
 
Lactate , NAA, Creatine    
Metabolite Absolute Concentrations 
 
[Lac]   [Cho], [Cr], [NAA] 
Metabolite Concentration Ratios 
 
[Lac]/[NAA]   
 
Table 1.6: Changes in 
1H MR spectroscopy values in neonates with neonatal encephalopathy 
that  died  or  had  a  severe  neurodevelopmental  disability  at  1  year  compared  with  control 
(Cheong et al 2006). 
 
Comparison of the normal/mild outcome group with controls revealed no differences in 
peak area  ratios,  relaxation  times,  or  concentration  ratios,  but  decreased  absolute 
concentrations  of  [NAA],  [Cho],  and  [Cr].  Conventional  and  advanced  magnetic 
techniques  can  act  as  complementary  tools  alongside  clinical  and 
electroencephalogram  evaluation  for  predicting  the  individual  outcomes  of  term 
neonates with neonatal encephalopathy.  
  
37 
 
 
Figure 1.4: Representative brain spectra from 
a control infant, and 2 neonates with neonatal 
encephalopathy acquired from an 8 mL voxel 
centered on the thalami. The dashed lines are 
the spectrum analysis Lorentzian profiles fitted 
to  the  peaks  (from  Cheong  et  al  2006 
reproduced with permission) 
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The aetiology and timing of the brain injury resulting in neonatal encephalopathy has 
been subject to more debate. In 1998 Badawi et al published two papers in the British 
Medical  Journal  describing  antepartum  and  intrapartum  risk  factors  for  neonatal 
encephalopathy in Western Australia (Badawi et al 1998). 164 cases of moderate or 
severe  encephalopathy  were  identified  over  a  2  year  period  and  compared  to  400 
randomly selected unmatched controls. In this study the birth prevalence for neonatal 
encephalopathy was 3.8 per 1000 term live births, and there was a fatality rate of 9.1%. 
In the preconception and antenatal periods are shown in Table 1.7 
 
  Adjusted OR  95% CI 
Unemployed  3.6  1.1   11.8 
Unskilled manual worker  3.8  1.4   10.3 
Maternal Characteristics 
Housewife  2.5  1.1   5.4 
Seizures  2.6  1.3   4.9  Family History 
Neurological disorders  2.7  1.2   6.4 
Infertility treatment  4.4  1.1   17.6 
Maternal thyroid disorder  9.7  2.0   47.9 
Severe pre eclampsia  6.3  2.3   17.6 
Bleeding during pregnancy  3.6  1.3   9.9 
Clinical diagnosis viral illness  3.0  1.5 – 5.8 
Not drinking alcohol  2.9  1.7   5.0 
Pregnancy Features 
Abnormal placenta  2.1  1.2   3.7 
Between 3
rd and 9
th centile  4.4  1.4   13.4  Birth weight 
Below 3
rd centile  38.2  9.4   154.8 
    
Table 1.7: Antenatal Risk Factors for Newborn Encephalopathy: the Western Australian Case 
Control Study (Badawi et al 1998)  
 
In the accompanying paper Badawi et al also looked at intrapartum risk factors, after 
adjustments for all the antepartum risk factors previously identified. In this paper they 
identified maternal pyrexia, persistent occipito posterior position and acute intrapartum 
events  (haemorrhage,  maternal  convulsions,  uterine  rupture,  snapped  cord,  birth 
before arrival to hospital) as independent risk factors for the development of neonatal 
encephalopathy. The authors attempted to estimate the proportion of infants exposed  
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to  significant  intrapartum hypoxia,  using  fetal heart rate  tracings,  presence  of fresh 
meconium at delivery and Apgar scores. Cord pH was not included in their assessment 
as  it  was  not  routinely  performed  at  that  time.  Using  these  features,  the  authors 
estimated that only 29% of infants with moderate – severe neonatal encephalopathy 
had evidence of intrapartum hypoxia. Conversely 94% of infants had at least one of the 
antenatal risk factors identified in the previous study (Badawi et al 1998) see Figure 
1.5. 
 
 Figure 1.5: Distribution of risk factors in newborn 
encephalopathy.  The  Western  Australia  Case 
Control Study (Badawi et al 1998) 
 
 
 
 
 
 
 
This  study  questioned  the  widespread  view  that  most  risk  factors  for  newborn 
encephalopathy occurred in the intrapartum period. However, it should be noted that 
the  definition  of  neonatal  encephalopathy  used  was  broad.  Moderate  or  severe 
encephalopathy  included  all  babies  with  either  seizures  alone  or  any  two  of  the 
following  lasting  for  longer  than  24  hours:  abnormal  consciousness,  difficulty 
maintaining  respiration  (of  presumed  central  origin),  difficulty  feeding  (of  presumed 
central origin) or abnormal tone and reflexs. Futhermore, the authors included babies 
who developed these signs within the first week of life. This relatively broad definition 
may potentially underestimate the role of intra partum hypoxia in the development of 
neonatal encephalopathy. More recent evidence suggests that whilst the risk factors 
may be predominantly  antenatal, the timing of the brain injury itself remains clearly 
during  the  acute  perinatal  period.  In  2003  Cowan  et  al  used  magnetic  resonance  
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imaging to study neonates with neonatal encephalopathy and evidence of intrapartum 
hypoxia,  and  infants  with  early  seizures  without  other  features  of  neonatal 
encephalopathy.  Neonatal  encephalopathy  was  defined  by  abnormal  tone  pattern, 
feeding difficulties, and altered alertness. Evidence of intrapartum hypoxia with at least 
three of: 
1.  late decelerations on fetal monitoring or meconium staining  
2.  delayed onset of respiration  
3.  arterial cord blood pH less than 7.1  
4.  Apgar scores less than 7 at 5 min  
5.  multi organ failure. 
Scans were performed within 2 weeks of birth, most in the first week. In the group of 
neonates with encephalopathy and evidence of intrapartum hypoxia, 80% of neonates 
had evidence of acutely evolving lesions that were compatible with a hypoxic ischemic 
insult,  whereas  established  injury  was  seen  in  less  than  1%.  The  lesions  most 
commonly seen were bilateral abnormalities in basal ganglia, thalami, cortex, or white 
matter. In the second group of infants with seizures in the first 72 hours of life but not 
fulfilling  the  criteria  for  neonatal  encephalopathy  and  preceding  hypoxia ischemia, 
acute ischemic or haemorrhagic lesions were seen in 69% of infants. Within this group, 
evidence  of  concomitant  antenatal  injury  was  present  in  only  3%  of  cases.  In  the 
remaining 31%, almost half had scan findings indicating a specific, non hypoxic non 
ischemic  diagnosis.  Of  these,  most  had  either  hypoglycaemia  or  what  was  later 
diagnosed  to  be  a  persisting  seizure  disorder.  Overall  90%  of  term  infants  with 
neonatal  encephalopathy,  seizures,  or  both,  had  evidence  of  acute  perinatal  brain 
injury and there was a very low rate of established antenatal brain injury (Cowan et al 
2003). 
 
Seemingly, neonatal encephalopathy, like cerebral palsy, may therefore represent a 
combination  of  antepartum  and  intrapartum  risk  factors,  but  the  evidence  from 
magnetic resonance imaging suggest that the damage  itself  occurs in the  perinatal 
period. It is entirely possible that antepartum and genetic factors predispose to both a  
41 
 
difficult  delivery,  and  increased  susceptibility  to  intrapartum  events  that  would  not 
normally be enough to result in injury. This multifactorial / multi hit hypothesis may go 
someway to explain the apparent conflicts in the medical literature with regard to the 
timing and aetiology of neonatal encephalopathy.  
 
Premature Birth and Brain Injury  
The epidemiological studies of Colver, Pharoah and others have demonstrated that, 
over the last 30 years, not only is cerebral palsy rising in incidence and severity but this 
rise is almost entirely within low birth weight and premature neonates (Pharoah et al 
1998, Colver et al 2000). Viewed from the neonatal perspective, it is clear that there is 
an increase in prevalence and severity of neurodisability with increasing prematurity. 
The EPICure study followed the 1995 cohort of all babies born in the UK and Republic 
of Ireland born below 26 weeks. Their neurodevelopmental outcome has been studied 
and published at discharge, 30 months and 6 years (Wood et al 2000, Costeloe et al 
2000, Wood et al 2005, Marlow et al 2005) see Table 1.8. Currently, the 2006 cohort of 
all babies born  in  the  UK and Republic of Ireland born  below  26  weeks  are being 
studied, to see if there have been improvements in outcome over the last decade. 
 
Gestation  ≤23 weeks  24 weeks  25 weeks 
No Disability 
12%  14%  24% 
Mild Disability (e.g. low normal IQ, wears 
glasses & has squint, mild hearing loss, 
minor neurological abnormalities) 
25%  36%  35% 
Moderate Disability (e.g. moderate 
learning problems, cerebral palsy but 
walking, hearing aids, some visual deficit) 
38%  22%  22% 
Severe Disability (e.g. severe learning 
problems, cerebral palsy and not walking, 
profound deafness, blindness 
25%  29%  18% 
 
Table 1.8: Neurodevelopmental outcomes of the 1995 cohort of surviving babies born in the UK 
and Republic of Ireland below 26 weeks. The EPICure study group (Wood et al 2000, Costeloe 
et al 2000, Wood et al 2005, Marlow et al 2005) 
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In an attempt to identify specific risk factors for the development of cerebral palsy in the 
preterm population, Murphy et al used a case control analysis of all children born over 
a 6 year period in 2 regions of England. 59 cases of cerebral palsy were identified in 
singleton  infants  born  below  32  weeks,  and  235  random  unmatched  controls 
(approximately  4  controls  per  case)  were  identified  born  below  32  weeks  without 
evidence of cerebral palsy. Overall the survival rates of preterm infants increased with 
increasing  gestational  age  and  birth  weight.  The  rates  of  cerebral  palsy  among 
surviving infants decreased with increasing gestational age and birth weight. There was 
a  complex  relationship  between  cerebral  palsy  and  method  of  delivery.  Caesarean 
delivery without labour was associated with a decreased risk of cerebral palsy (OR 0.3, 
95%CI  0.2 0.7).  Conversely,  caesarean  delivery  in  labour  was  associated  with  an 
increased  risk  of  cerebral  palsy  (OR  2.7,  95%CI  1.2 6.1).  Of  note  there  was  no 
significant  difference  in  the  number  of  abnormal  fetal  heart  rate  tracings  (OR  1.0, 
95%CI 0.9 1.1) or umbilical artery pH ≤7.10 (OR 2.3, 95%CI 0.8 6.8). The other risk 
factors for cerebral palsy identified are shown in Table 1.9; however, it is important to 
note  that  only  3%  of  cases  and  6%  of  controls  received  antenatal  steroid  therapy 
(Murphy et al 1995) 
 
  OR  95% CI 
Maternal Factors  Parity >5  4.3  1.2 15 
Prolonged rupture of membranes  2.3  1.2 4.2 
Chorioamnionitis  4.2  1.4 12.0 
Antenatal Factors 
Maternal Infection  2.3  1.2 4.5 
Neonatal Factors  Apgar Score ≤ 3 at 5 Mins  5.3  1.4 21 
    
Table 1.9: Antenatal and Intrapartum Risk Factors for Cerebral Palsy in Very Preterm Singleton 
Babies (Murphy et al 1995)  
 
Whilst  it  is  clear  that  increasing  prematurity  is  associated  with  increasing  risks  of 
cerebral  palsy  and  brain  injury,  premature  neonates  are  a  heterogeneous  group  of 
patients. Epidemiological studies have identified a number of factors associated with  
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the  onset  of  preterm  labour  including  black  race,  teenage  or  older  mothers,  low 
education and low socio economic status, cigarette smoking, unmarried or not living 
with a partner, heavy and/or stressful occupation, low maternal pre pregnancy body 
mass index. Medical and obstetric complications associated with preterm birth include 
multi fetal pregnancy, gestational or pre existing diabetes, pregnancy induced or pre 
existing  hypertension,  placenta  praevia  and  placental  abruption  (Wen  et  al  2004). 
However, many cases of preterm birth related to either maternal illness or developing 
fetal compromise are iatrogenic. In North West Thames during 1988 2000 almost 50% 
of  babies  delivered  between  28 31  weeks  resulted  from  induced  labour  or  elective 
caesarean section (Steer 2005).  
 
The  single  most  identifiable  clinical  risk  factor  for  spontaneous  preterm  labour  is 
infection, which is particularly prevalent in babies born below 30 weeks with histological 
involvement of the fetal membranes (see Figure 1.6; Goldberg et al 2000). 
 
 
Figure 1.6: Frequency of positive chorioamnionic culture at varying gestation among women 
delivering by caesarean section in spontaneous labour with intact fetal membranes, compared 
to  those  delivering  by  caesarean  section  without  onset  of  labour  (Goldberg  et  al  2000). 
Copyright  ©  [2000]  Massachusetts  Medical  Society.  All  rights  reserved.  Reproduced  with 
permission  
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Bacterial invasion of the chorio decidual space results in the production of cytokines, 
including interleukin 1α (IL 1α), interleukin 1β (IL 1β), interleukin 6 (IL 6), interleukin 8 
(IL 8),  tumour  necrosis  factor  (TNF α)  and  granulocyte  colony  stimulating  factor 
(GCSF)  by  the  deciduas  and  fetal  membranes.  There  is  also  synthesis  of 
prostaglandin,  which  stimulates  uterine  contractions,  and  metalloprotease  release 
which can both lead to cervical softening and rupture of the chorioamniotic membranes 
(see Figure 1.7; Goldenberg et al 2000). 
 
Figure 1.7: Potential Pathways from Choriodecidual Bacterial Colonization to Preterm Delivery 
(from Goldenberg et al 2000) Copyright © [2000] Massachusetts Medical Society. All rights 
reserved. Reproduced with permission 
 
Bacterial components, such as endotoxin, are potent activators of the cytokine network 
and it is now accepted that pro inflammatory cytokines such as IL 1β, IL 6 and TNF α, 
of both fetal and maternal origin play a critical dual role in initiating preterm labour as 
well as directly contributing to perinatal brain injury (Duggan et al 2001, Yoon et al  
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1996,  Gomez  et  al  1998).  It  has  also  been  demonstrated  that  single  nucleotide 
polymorphisms within tumour necrosis factor, interleukin 1β, and IL 6, are associated 
with spontaneous preterm labour (Engel et al 2005) and preterm birth and may also 
make the preterm neonate susceptible to brain injury (Varner et al 2005) (see later: The 
role of pro  and anti inflammatory cytokines). 
 
Summary 
 
The relationship between intrapartum hypoxia ischemia, neonatal encephalopathy and 
cerebral palsy is more complex than that originally described by Little 150 years ago. 
Hypoxia ischemia is detectable in up to 2.5% of pregnancies, 15% of which is defined 
as  moderate to severe.  Moderate–to severe  neonatal  encephalopathy  has  a 
prevalence of 3.8 per 1000 live term births (Badawi et al 1998). Cerebral palsy has a 
prevalence  of  1  per  1000  live  term  births  (Greenwood  et  al  2005).  There  is 
considerable  overlap  between  these  conditions,  with  up  to  30%  of  cerebral  palsy 
having hypoxia ischemia as a significant antecedent, but 7% of children with cerebral 
palsy and evidence of intrapartum hypoxia ischemia not having evidence of neonatal 
encephalopathy (Gaffney et al 1994). Neonatal encephalopathy may arise without any 
evidence  of  intrapartum  hypoxia ischemia  (Badawi  et  al  1998).  An  attempt  to 
summarise  the  overlap  between  intrapartum  hypoxia ischemia,  neonatal 
encephalopathy and cerebral palsy is shown in figure 1.8. The estimate of the overlap 
between neonatal encephalopathy and intrapartum hypoxia ischemia, is taken from the 
data from Cowan’s MRI imaging (Cowan et al 2003), rather than the data from the 
Western Australia Case Control Study (Badawi et al 1998). It is important to recognise 
that, whilst this study was not population based and relied on timing of injury from MR 
imaging, a more rigorous definition was used for neonatal encephalopathy.  
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Figure  1.8:  Overlap  of  intrapartum  hypoxia 
ischemia, neonatal encephalopathy and cerebral 
palsy. 
 
 
 
 
 
 
Perinatal brain injury in term infants is consistently associated with the presence of 
hypoxia ischemia  and  feto  /  maternal  inflammation.  Prematurity  is  commonly 
associated with the presence of bacteria in the uterus, the consequence of which may 
not only lead directly to preterm birth but also to neuronal damage and perinatal brain 
injury.   
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Part 2: Patterns of Perinatal Brain Injury 
 
A number of patterns of injury have been described in the neonatal brain. Different 
patterns of injury are thought to arise due to a combination of differing insults, and a 
maturation dependent selective vulnerability of differing cell populations.  
White  matter  injury  in  neonates  was  first  described  by  Virchow  in  1867  from  post 
mortem specimens with macroscopically pale, softened areas of degeneration within 
the  periventricular  region,  which  he  termed  congenital  encephalomyelitis  (Virchow 
1967). The term periventricular leukomalacia was first introduced in 1962 by Banker 
and Larroche, again from post mortem specimens. They described microscopic lesions 
consisting of coagulative  necrosis surrounded by  areas of liquefaction  and  a  highly 
vascularised periphery. Lesions occurred within the subcallosal white matter, superior 
fronto occipital & superior longitudinal fasciculi; the external and internal sagittal strata 
of the temporal and occipital horns of the lateral ventricles; and to a lesser extent the 
corona  radiata.  Key  to  the  understanding  of  the  neuropathology  and  aetiology  of 
periventricular  leukomalacia  is  the  recognition  of  a  specific  window  of  sensitivity 
between  23 32  weeks  of  gestation  (Rezaie  and  Dean  2002).  At  these  dates  the 
developing brain is pre myelination and the subcortical white matter is predominantly 
populated  with  oligodendrocyte  precursors  (McQuillen  and  Ferriero  2004),  and  it  is 
these precursors that are thought to be particularly sensitive to injury (Volpe 2001). 
Much of the research into periventricular leukomalacia during the 4 decades since the 
description by Baker and Larroche has focused on the focal necrotic cystic lesions they 
described and specifically used cranial ultrasound scans to demonstrate their presence 
(Volpe 2001). More recently, however, advances using magnetic resonance techniques 
have demonstrated diffuse white matter injury manifest as diffuse excessive high signal 
intensity (DEHSI) and increased apparent diffusion coefficient (ADC) as a much more 
frequent  finding  in  preterm  infants  at  term equivalent  age  (Maalouf  et  al  1999), 
(Counsell et al 2003).   
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In a study comparing serial cranial ultrasound scans with magnetic resonance imaging 
at term, in babies born below 1500g (gestational age 27.9 ± 2.4 weeks) only 4% of 
neonates  had  evidence  of  cystic  periventricular  leukomalacia,  all  of  which  was 
identifiable  on  cranial  ultrasound  scan  prior  to  MRI  at  term;  35%  of  infants  had 
evidence of non cystic white matter injury. Of note, the cranial ultrasound finding of 
prolonged (>7 days) echodensity in the white matter (often termed periventricular flare) 
had  a  low  sensitivity  (26%)  and  low  positive  predictive  value  (36%)  for  diffuse 
periventricular leukomalacia (Inder et al 2003). In a study of 119 infants born between 
22 and 30 weeks, Dyet et al found that 80% of infants had diffuse excessive high signal 
intensity within the white matter on T2 weighted MRI scans at term. Developmental 
follow up  using  the  Griffiths  Mental  Development  Scales  showed  a  significant 
relationship between the presence of DEHSI and overall developmental quotient (no 
DEHSI: 111 ±20, DEHSI: 94 ±11.6, severe DEHSI: 92 ±7.5; P =0.027). When infants 
with both DEHSI and other abnormalities were excluded there was still a significant 
difference in developmental quotient between infants with and without DEHSI (normal 
scan: 105, DEHSI: 91, P =0.023) (Dyet et al 2006).  
 
The recognition  of this distinct diffuse  pattern of  injury in addition to  the previously 
described  focal  cystic  lesions  have  led  some  authors  to  suggest  a  change  in 
terminology  from  periventricular  leukomalacia  to  “cerebral  leukoencephalopathy”  to 
more  accurately  encompass  both  patterns  of  injury  (Volpe  2003),  or  more  recently 
encephalopathy  of  prematurity  (Volpe  2009).  However,  the  terms  cystic  PVL  and 
diffuse PVL remain in common use both in the literature and in clinical practice. From a 
clinical perspective the major sequelae of focal cystic periventricular leukomalacia is 
spastic diplegia, as a result of disruption to the corticospinal tracts within the posterior 
limb of the internal capsule, whereas the more diffuse white matter damage is probably 
the cause of cognitive and behavioural abnormalities that are seen commonly after 
preterm birth (Volpe 2001, Marlow et al 2005).  
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From a neuropathological perspective, it is thought that white matter injury results from 
a combination of incomplete development of the vascular supply to the cerebral white 
matter,  a  maturation dependent  impairment  of  cerebral  blood  flow  regulation  and  a 
gestational  dependent  specific  vulnerability  of  oligodendrocyte  precursors,  as 
compared to mature myelinating oligodendrocytes, to a variety of pro apoptotic stimuli 
such  as  free  radicals,  excessive  glutamate  and  pro inflammatory  cytokines  (Volpe 
2001). It is likely that inflammation, ischemia and subsequent reperfusion may be key 
features  in the  underlying  pathophysiology (Volpe  2001). However, recent  evidence 
from  the  preterm  sheep  model  has  challenged  the  existence  of  these  vascular 
boundary  zones  (McClure  et  al  2008).  In  addition  to  cellular  damage,  disruption  of 
axons within the white matter was also described in the original classification of PVL 
(Banker and Larroche 1962). It is, at present, unclear whether the primary insult is to 
axons,  oligodendrocyte  precursors  or  both  (see  Figure  1.9)  and  it  is  possible  that  
differing insults affect axons and oligodendrocyte precursors to differing degrees, but 
with  the  final  common  outcome  being  diffuse  of  cystic  periventricular  leukomalacia 
dependent on the type and severity of insult.  
 
Figure 1.9: Three possible 
pathways by which an insult may 
lead to white matter injury via 
axonal damage and damage to 
oligodendrocyte precursors (OLP) 
(from Dammann et al 2001) 
reporduced with permission  
50 
 
Other than the gestational age, other factors have been identified in the aetiology of 
PVL. Many of these relate to episodes of reduced cerebral perfusion, such as hypoxic 
ischemic insults, apnoea with hypoxia, and episodes of bradycardia (Rezaie and Dean 
2002). Epidemiological studies have consistently identified hypocarbia as a strongly 
associated risk factor for the development of cystic periventricular leukomalacia (Resch 
et  al  2004)  OR  3.3;  95%  CI:2.6 6.5  (Saliba  and  Marret  2001)  and  it  has  been 
postulated that this may also occur as a result of hypocarbia mediated vasoconstriction 
and, hence, reduction in cerebral blood flow. Other than cerebral ischemia the other 
factor most closely linked with white matter damage is intrauterine infection (Dammann 
and Leviton 1997, Yoon et al Saliba and Marrett 2001, Resch 2000, Rezaie and Dean 
2002), and it is the dual role of infection as a stimulus for preterm labour and perinatal 
brain injury that is gaining increasing recognition. 
 
Further potential clues to the aetiology of white matter injury can be drawn from the 
animal models used in the study of white matter injury (for review see Hagberg and 
Peebles  2002).  These  have  used  infectious,  hypoxic ischemic,  excitotoxic  or 
combination insults to generate injury resembling cystic periventricular leukomalacia. 
Studies  of  the  effect  of  inflammation  using  endotoxin,  a  potent  initiator  of  the 
inflammatory response, have demonstrated a transient hypoxemia and hypotension, 
with a fall in arterial pH and PaO2, and a rise in lactate within arterial blood in the fetal 
sheep, at a gestation equating to 24 25 week in the human fetus. Cerebral white matter 
injury  was observed in histological sections of all LPS treated animals, with diffuse 
injury  seen  in  all  animals,  and  lesions  characteristic  of  focal  cystic  periventricular 
leukomalacia  in  2/6  animals  (Duncan  et  al  2002).  In  rat  pups,  chronic  ischemia 
achieved by bilateral carotid artery occlusion on day 1 results in ventriculomegaly and 
rarefaction  within  the  corpus  callosum,  associated  with  a  reduction  in  myelin  basic 
protein staining and microglial activation (Cai et al 2001).   
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Chronic hypoxia during the prenatal period achieved by exposing pregnant rats to 10% 
oxygen between embryonic day 5 and 20 also results in cystic white matter changes 
with lipid peroxidation, activation of macrophage and delayed myelination (Baud et al 
2004). In the neonatal rat models of white matter injury using either hypoxia ischemia 
or  excitotoxins,  6 nitro 7 sulfamoyl benzo[f]quinoxaline 2,3 dione  (NBQX),  an  AMPA 
receptor antagonist, has been shown to be protective to oligodendrocyte precursors 
and reduce white matter injury, as measured by myelin basic protein immunoreactivity 
(Follett  et  al  2000).  This  suggests  a  role  for  glutamate  receptor mediated 
oligodendrocyte damage in the aetiology of preterm white matter brain injury.  
 
Pro and anti inflammatory cytokines have been clearly implicated in the pathology of 
white matter injury (Volpe 2001). IL 18 deficient mice have been demonstrated to be 
protected  against  hypoxia ischemia  mediated  white  matter  damage  with  increased 
neurofilament and myelin basic protein immunoreactivity 3 days after injury (Hedtjärn et 
al  2005).  In  a  rat model  of maternal  chorioamnionitis  using  intrauterine  injection  of 
Escherichia  coli,  subsequent  administration  of  intravenous  IL 10  prevented  the 
symmetrical  periventricular  white  lesions  that  were  seen  in  29%  of  the  offspring  of 
dams that did not receive IL 10 (Rodts Palenik et al 2004). These studies suggest that 
in  both  infection  and  hypoxia–ischemia,  inflammatory  responses  may  be  a  final 
common pathway, and the modulation of this response may provide an opportunity for 
therapeutic  neuroprotection  in  the  neonate.  This  also  raises  the  possibility  that,  in 
keeping with the triggering of preterm labour, single nucleotide polymorphisms within 
the  inflammatory  response  may  make  a  particular  infant  more  susceptible  to  white 
matter injury (Nelson et al 2005) in a similar way as has been demonstrated in multiple 
sclerosis (Pleasure et al 2006).  
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In contrast to the white matter injury seen in the preterm neonate, hypoxic ischemic 
brain injury occurring in term infants results in damage predominantly within the deep 
grey matter of the thalamus, basal ganglia and para saggital cerebral cortex (Sie et al 
2000),  (Johnston  et  al  2001).  These  infants  are  born  post myelination,  and  the 
oligodendrocytes which have matured are relatively resistant to injury compared to the 
oligodendrocyte  precursors  that  predominate  in  the  preterm  infant.  Severe  damage 
results in neuronal death due to a failure of mitochondrial oxidative phosphorylation, a 
process  that  occurs  more  rapidly  in  the  brain  of  term  compared  to  preterm  animal 
models of hypoxia (Berger et al 1992). Injury that is not severe enough to immediately 
cause neuronal death initiates a variety of events including the neurotoxic cascade, 
disruption  of  cellular  energetics  and  changes  in  intracellular  pH  (pHi),  which  may 
eventually  result  in  further  neuronal  loss  through  necrosis,  apoptosis  or  combined 
mechanisms.   
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Part 3: Mechanisms of Perinatal Brain Injury 
The Neurotoxic Cascade 
Most  synapses  within  the  brain  use  the  excitatory  amino  acid  glutamate  as  their 
neurotransmitter.  Normally,  glutamate  is  removed  from  the  synapse  following 
depolarisation  by  perisynaptic  glial  glutamate  reuptake  pumps.  Raised  levels  of 
glutamate and glycine have been demonstrated following asphyxia in animal models 
and in the CSF of neonates following severe hypoxic ischemic insult (Johnston et al 
2002). The energy for the perisynaptic glial glutamate reuptake pumps is derived from 
the  anaerobic  metabolism  of  glucose  (Magistretti  et  al  1999).  Episodes  of  severe 
hypoglycaemia  have  been  shown  to  result  in  high  levels  of  extracellular  glutamate 
(Ichord et al 1999). Further evidence for the role of excitatory neurotransmitters in the 
pathogenesis of perinatal brain injury comes from the observation that areas of the 
term  neonatal  brain  susceptible  to  damage  have  the  highest  density  of  glutamate 
utilising  synapses.  These  areas  include  the  putamen,  the  thalamus  and  the  peri 
Rolandic cerebral cortex (Sie et al 2000), (Johnston et al 2001).  Ischemia reduces the 
levels  of  glucose  within  the  brain  resulting  in  the  failure  of  reuptake  of  excitatory 
neurotransmitters. This correlates in turn with the clinical findings of hyperalertness and 
hypereflexivity  in  neonates  following  hypoxic ischemic  insults  (Sarnat  and  Sarnat 
1976). Acute hypoxia causes a failure of mitochondrial oxidative phosphorylation more 
rapidly in the brain of term compared to preterm animal models of hypoxia (Berger et al 
1992). Attempts to maintain energy supply by anaerobic metabolism are insufficient to 
maintain  ATP  such  that  there  is  a  failure  of  transmembrane  ion  pumping  and  a 
reduction in the membrane potential (Johnston et al 2001).  
 
These  two  signals  (elevated  excitatory  neurotransmitters  and  reduced  membrane 
potential) interact at the N-methyl D aspartate (NMDA) receptor, which functions as a 
transmembrane  calcium  channel.  This  receptor  integrates  multiple  signal  pathways 
requiring the simultaneous binding of glutamate and glycine to open. The loss of the  
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membrane  potential  prevents  the  voltage dependent  magnesium  blockade  of  the 
NMDA  receptor  channel  and  allows  the  excitatory  amino  acids  to  act  persistently, 
resulting  in  calcium  influx  and  subsequent  neuronal  damage  (Novelli  et  al  1988). 
Further evidence for the role of NMDA and AMPA (non NMDA glutamate receptors) 
come  from  studies  showing  receptor  blockade  significantly  reduces  brain  damage 
following  a  hypoxic ischemic  insult  (Hagberg  et  al  1994).  The  stimulation  of  NMDA 
receptors  and  voltage dependent  AMPA  receptors  results  in  a  massive  influx  of 
calcium into neurones. Normally mitochondria buffer intracellular calcium. However, the 
calcium ‘overload’ that follows  the locking  open of the NMDA  and  AMPA  receptors 
causes mitochondrial dysfunction (Kristian et al 1996, Stout et al. 1998, Johnston et al 
2002).  In  severe  cases  rapid  loss  of  mitochondrial
  function  and  cessation  of  ATP 
production, causes loss of nuclear and cytoplasmic membranes (cell necrosis). Less 
severe  insults  without  loss  of  mitochondrial  membranes  may  result  in  apoptosis 
through the release of cytochrome c
, which activates proteases and caspases causing 
DNA  fragmentation.  Blockade  of  caspases  has  been  shown  to  afford  significant 
neuroprotection following hypoxic ischemic insults (Cheng et al 1998). 
 
Calcium entering the cell has a further role in the aetiology of damage via activation of 
neuronal  nitric  oxide  synthase.  Newly  formed  nitric  oxide  interacts  with  radicals 
released from damaged mitochondria to form peroxynitrite (Beckman 1991). Inhibition 
of nitric oxide synthase has been shown to reduce infarct size following middle cerebral 
artery occlusion in the rat pup (Ashwal et al 1995) and neonatal mice lacking neuronal 
nitric  oxide  synthase  have  been  shown  to  be  less  vulnerable  to  hypoxic ischemic 
damage  (Ferriero  et  al  1996).  Furthermore,  the  selective  inhibition  of neuronal  and 
inducible nitric oxide synthase improves long term outcome in neonatal rats following 
hypoxia ischemia (van den Tweel et al 2002). The role of free radicals in the neuronal 
injury  has  been  further  studied  in  hypoxic ischemic  injury  using  melatonin,  a 
neurohormone secreted from the pineal gland which has potent anti oxidant activity. In  
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adult  rats  following  middle  cerebral  artery  occlusion  melatonin  significantly  reduced 
ischemic  lesion  volume  and  reduced  levels  of  oxidative  stress  markers 
(malondialdehyde and reduced glutathione) (Sinha et al 2001, Pei et al 2003). In this 
model melatonin has also been shown to reduce nitric oxide levels without affecting the 
integrity of the blood brain barrier (one suggested mechanism by which free radicals 
have  been  postulated  to  act  in  cerebral  ischemia)  (Pei  et  al  2003).  In  fetal  rats, 
melatonin has been shown to have a potential neuroprotective effect on ischemia / 
reperfusion injury achieved by bilateral utero ovarian artery occlusion and release with 
reduced oxidative mitochondrial damage in the fetal rat brains (Wakatsuki et al 2001). 
In addition melatonin has been shown to be neuroprotective in excitotoxic brain injury 
in  newborn  mice  (Husson  et  al  2002).  However,  some  of  the  effects  of  melatonin 
neuroprotection  may  result  from  inhibition  of  the  inflammatory  response  (Pei  et  al 
2004). 
 
In summary hypoxia ischemia triggers a cascade of neurotoxic events that centres on 
the  excitotoxins  glutamate  and  glycine  which,  along  with  a  reduced  membrane 
potential, act to lock open the NMDA receptor and allow an influx of calcium into cells. 
This leads to further mitochondrial dysfunction and production of free radical species 
which combine to initiate further neuronal damage through both necrosis and apoptosis 
(see Figure 1.10).  
  
56 
 
 
 
 
 
Figure 1.10: Summary of the neurotoxic cascade 
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Energy changes after Hypoxia Ischemia 
 
 
Over the last 20 years, studies using using phosphorus (
31P) and (
1H) proton magnetic 
resonance  spectroscopy  (MRS)  in  both  infants  with  neonatal  encephalopathy  and 
experimental models have characterised the changes in cerebral energetics that occur 
in the hours following hypoxia ischemia. (Hope et al 1984, Younkin et al 1984, Laptook 
et al 1989, Lorek et al 1994, Penrice et al 1997). During the hypoxic ischemic insult 
there  is  a  profound  failure  in  cerebral  energetics  which  resolves  rapidly  with 
resuscitation and reperfusion. However, 8 24 hours later there follows a progressive 
decline in phosphocreatine / inorganic phosphate (PCR/Pi) and adenosine triphosphate 
associated with a rise in lactate. These changes were termed delayed or secondary 
energy failure to distinguish them from the primary energy failure that occurs during the 
acute  hypoxic ischemic  insult.  The  magnitude  of  this  secondary  disruption  of  brain 
energetics has been shown to correlate with long term neurodevelopmental outcome in 
neonates (Hope et al 1984, Azzopardi et al 1989, Roth et al 1992).  
 
The identification of this second phase of energy changes demonstrated that the injury 
following  acute  hypoxia ischemia  in  the  neonatal  brain  is  an  ongoing  process  after 
resuscitation / reperfusion. This observation introduced the concept of a therapeutic 
window, during which intervention has the potential to change the neuropathological 
course of brain injury and, hence, the long term neurodevelopmental outcome for the 
infant.  
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Changes in Brain Intracellular pH after Hypoxia Ischemia 
 
Another  series  of  changes  in  cellular  physiology  during  hypoxia ischemia  and 
reperfusion that may play a critical role in brain injury relate to changes in intracellular 
pH (pHi) of the brain. These changes were identified alongside the changes in cerebral 
energetics using 
31P and 
1H magnetic resonance spectroscopy. 
 
Under physiological conditions, brain pHi is maintained at around 7.03 (LaManna 1996) 
some 0.3 – 0.4 pH units below that of the extracellular compartment. Crucial to the 
regulation of intracellular pH is the Na
+/H
+ exchanger (NHE) which tightly regulates 
both pHi and cell volume by extruding protons from and taking sodium up into cells 
(Masreel  et  al  2003).  Tissue  hypoxia  results  in  a  switch  from  aerobic to  anaerobic 
respiration  and  results  in  the  production  of  lactic  acid  which  in  turn  results  in  an 
intracellular acidosis. This tissue acidosis has been demonstrated in animal models 
using the creatine kinase equilibrium. Middle cerebral artery occlusion (MCAO) in adult 
rats results in a profound intracellular acidosis which is proportional to the accumulation 
of intracellular lactate (Mabe et al 1983). Whilst it has been suggested that acidosis 
may have a direct toxic effect on neurones through denaturation of proteins and nucleic 
acids, in vitro studies using mixed neuronal and glial cell cultures only resulted in cell 
death on exposure to lactic acidosis of pH 5.2 for 1 hour (Goldman et al 1989). This 
suggests that in the clinical setting, the direct effect of acidosis is unlikely to be involved 
in the mechanism of brain injury (LaManna 1996). However, in the reperfusion phase 
following hypoxia ischemia there is a rapid normalisation of pHi, followed by a rise in 
pHi above baseline. In the adult MCAO studies this was observed after 60 minutes and 
continued for up to 3 hours following reperfusion (see Figure 1.11)  (Mabe et al 1983).  
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Figure  1.11:  Changes  in  brain  intracellular  pH 
before,  during  and  after  15  minute  middle  cerebral 
artery occlusion in the adult rat (Mabe et al 1983). 
 
 
 
 
 
 
 
 
 
 
Subsequent  animal  studies  using  phosphorus 
(
31P)  MRS have shown that more severe hypoxic ischemic insults are associated with 
more rapid and prolonged rebound alkalosis following tissue reperfusion (Chopp et al 
1990). Adult clinical studies have demonstrated brain alkalosis in the subacute stage 
after traumatic brain injury (Hugg et al 1992), and in areas of chronic infarction after 
stroke (Levine et al 1992). These studies also demonstrated a significant correlation 
between the magnitude of brain alkalosis and the subsequent neurological outcome, 
with the worst outcome seen in patients with the greatest rebound alkalosis (Welch et 
al 1990).   
 
In  human  neonates  with  neonatal  encephalopathy,  a  similar  relationship  between 
alkalosis  and  the  severity  of  brain  injury  has  also  been  observed  (see  fig  1.12) 
(Robertson et al 2002). Infants with the most severe changes on MRI within the first 2 
weeks after birth, and the worst neurodevelopmental outcome at one year, had the 
most alkaline brain pHi. Interestingly this brain alkalosis was seen to persist for some 
months in those with the worst outcome (Robertson et al 1999).   
60 
 
 
Figure  1.12:  Brain  pHi  in  the  first  2  weeks  after  birth  according  to  neuro developmental 
category.  There  was  a  significant  difference  between  the  normal  and  severe  /  died  groups 
(p<0.05) (from Robertson et al 2002 reproduced with permission) 
 
It is of note that brain alkalosis occurred at a time of high lactate (normally associated 
with  acidosis)  and  it  has  been  suggested  that  the  elevated  lactate  may  represent 
ongoing  mitochondrial  dysfunction  resulting  in  anaerobic  respiration,  and  may 
represent  continuing  low grade  cellular  injury  months  after  the  original  hypoxic 
ischemic insult (Wyatt 2002). 
 
It is at present unclear however, whether the observed rebound alkalosis is a marker of 
brain injury, or is itself is a contributor to the injury observed. However, if it can be 
demonstrated that rebound alkalosis contributes to, or exacerbates brain injury it may 
represent  a  novel mechanism for  neuroprotection.  There  are  a  number  of  potential 
mechanisms  by  which  a  rise  in  brain  intracellular  pH  may  exacerbate  injury;  for 
example, increased N methyl D aspartate (NMDA) receptor activation (Traynelis et al  
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1990,  Giffard  et  al  1992)  of  intracellular  phospholipases  and  proteases  (Mellgren 
1987),  or  alterations  to  the  balance  of  pro   and  anti apoptotic  triggers  within 
mitochondria.  The  Na
+/H
+ exchanger (NHE) is also  implicated in the mechanism of 
rebound alkalosis (LaManna et al 1987). During the lactic acidosis that accompanies 
hypoxia ischemia excess intracellular protons activate the NHE, resulting in extrusion 
of hydrogen ions from the cell, along the sodium gradient. However it appears that this 
mechanism  does  not  switch  off  once  the  pHi  of  the  cell  has  returned  to  normal, 
resulting in an alkali overshoot.  The mechanism of NHE activation following hypoxia 
ischemia  is  thought  to  be  mediated  through  extracellular signal related kinase 
(ERK1/2)  and  mitogen associated  protein  kinase  (MEK)  (Luo  et  al  2007).  MEK  is 
known to activate the NHE through ERK (Schramek et al 1997), which phosphorylates 
p90 ribosomal S6 kinase, which, in turn, phospohorylates the NHE (Takahashi et al 
1999).  
 
Following the lactic acidosis that occurs during hypoxia ischemia there is activation of 
NHE through the MEK ERK pathway resulting in extrusion of hydrogen ions from the 
cell and a normalisation of pHi. A failure of the NHE to switch off when the pHi reaches 
normal results in an alkaline overshoot termed rebound alkalosis. The magnitude of 
this rebound alkalosis is associated with a worsening of neurodevelopmental outcome. 
This sequence of observations raises the possibility that interventions aiming to prevent 
or  minimise  rebound  alkalosis,  for  example  through  blockade  of  the  NHE  following 
hypoxia ischemia may confer neuroprotection following hypoxia ischemia.   
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The Role of Pro  and Anti inflammatory Cytokines 
One  mechanism  by  which  both  hypoxia ischemia  and  infection  may  result  in  brain 
injury  is by  activation  of the cytokine network. Indeed cytokines may act as a final 
common pathway to injury from a number of insults, such as hypoxia ischemia and 
infection. This pathway may, therefore, represent one mechanism by which a number 
of aetiological factors may  interact to  result  in  brain injury.  Studies  of children with 
cerebral palsy have consistently shown raised levels of pro inflammatory cytokines in 
the blood and CSF taken around the time of birth. Using archived blood spots from the 
newborn  screening  programme,  Nelson  et  al  compared  cytokine  and  coagulation 
factors in children with spastic cerebral palsy (most born at term) with controls. Higher 
concentrations of interleukins 1, 6, 8, 13 and tumour necrosis factor α, were seen in 
children who subsequently developed cerebral palsy than in any control child (Nelson 
et al 1998). This association was especially seen in children with spastic diplegia, and 
is  consistent  with  previous  observations  relating  intrauterine  infection  with  risk  of 
cerebral palsy. Interestingly, however, in very preterm infants, levels of inflammatory 
cytokines in neonatal blood have not been shown to distinguish between children who 
subsequently developed cerebral palsy from controls (Nelson et al 2005). 
 
Bacterial components are known to be potent activators of the cytokine network. Pro 
inflammatory cytokines such as interleukin 1β (IL 1β), interleukin 6 (IL 6) and tumour 
necrosis factor (TNF α) of both fetal and maternal origin are known to initiate preterm 
labour and to contribute to neonatal complications such as PVL (Duggan et al 2001, 
Yoon et al 1996, Gomez et al 1998). Pro inflammatory cytokines are also released in 
response to hypoxia ischemia, trauma and labour (Savman et al 1998, Hagberg et al 
1996,  Bona  et  al  1999,  Silveira  et  al  2003,  Shalak  et  al  2002).  Pro inflammatory 
cytokines,  including  TNFα  IL 1β  and  interferon γ  (IFN γ)  have  a  variety  of  cerebral 
effects  including  a  direct  toxic  effect  on  neurones  and  vulnerable  oligodendrocyte 
precursor  populations  (Volpe  2001),  astrogliosis  with  release  of  nitric  oxide  and  
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mitochondrial dysfunction
 (Bal Price et al 2001). In addition there is microglial activation 
with release of nitric oxide, superoxide and a variety of other inflammation associated 
molecules (Raivich et al 1999). Further evidence for the role of these cytokines comes 
from experimental animal models. IL 1 receptor antagonist has been shown to reduce 
hypoxic ischemic brain damage. Pre treatment reduced brain injury and post treatment 
increased  the  proportion  of  animals  devoid  of  brain  injury  (Hagberg  et  al  1996). 
Furthermore in animals with a deficiency in IL 1 converting enzyme, which is required 
for  IL 1  activation,  had  reduced  brain  injury  after  hypoxia ischemia  compared  to 
controls. However, this neuroprotective effect was detectable after moderate hypoxia 
ischemia, but not after severe hypoxia ischemia (Liu et al 1999). Deletion of IL 18 (a 
member of the IL 1 family of cytokines) has also been shown to reduce brain injury 
when deleted alone (Hedtjärn et al 2002) and in combination with IL 1β (Hedtjärn et al 
2005). 
 
Stimuli  such  as  cerebral  ischemia,  excitotoxicity,  trauma  and  various 
neurodegenerative disease (Raivich et al 1999) (Kiefer et al 1995) also result in the 
release  of  a  second  group  of  cytokines,  including  transforming  growth  factor  beta1 
(TGF β1) and interleukin 10 (IL 10), which have broadly anti inflammatory properties. 
However, unlike the pro inflammatory cytokines listed above, they are not up regulated 
following  exposure  to  the  inflammatory  mediators  of  bacterial  infection  such  as 
lipopolysaccharide (Xiao et al 1996). TGF β acts as an immunosuppressive factor that 
inhibits the activation of lymphocytes, macrophages and related cell types, such as 
brain microglia (Suzumura et al 1993), and also inhibits the microglial production of 
potentially neurotoxic molecules such as nitric oxide, superoxide and IL 1 (Vincent et al 
1997).  In  vivo  application  of  TGF β1  strongly  reduces  the  infarct  size  in  cerebral 
ischemia in adult (Vincent et al 1997) as well as in adolescent animals
 (Gross et al 
1993).  The  anti inflammatory  cytokine  IL 10  may  also  play  an  important  role  in 
regulating the inflammatory response to infectious and hypoxic insults. This cytokine  
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exerts its effect by reducing production of pro inflammatory cytokines such as IL 1 and 
TNF α (Terrone et al 2001). It too has a neuroprotective role, improving outcome after 
both traumatic and ischemic injury in the adult rat
 (Spera et al 1998). In newborn mice, 
systemic administration of IL 10 following intracerebral ibotenate significantly reduced 
the size of the excitotoxic brain lesion (Mesples et al 2003).  
 
It  therefore  appears  that  the  balance  between  these  groups  of  cytokines  may  be 
critical, with a relative abundance of pro inflammatory cytokines favouring neuronal cell 
death  whilst  a  relative  abundance  of  anti inflammatory  cytokines  may  be 
neuroprotective. Variations in this cytokine balance may therefore make a fetus more 
susceptible to development of brain injury, especially in the context of superimposed 
hypoxia ischemia.  Single  gene  polymorphisms  within  cytokines  may  alter  the  fetal 
inflammatory  response  and,  hence,  favour  either  a  pro  or  anti inflammatory  profile 
(Amory et al 2001). It has also been suggested that changes in the fetal inflammatory 
response due to polymorphisms may account for the apparent genetic susceptibility to 
preterm  labour  in  the  context  of  the  frequent  association  of  preterm  labour  with 
histological  evidence  of  infection/  inflammation  (Vaner  et  al  2005).  Changes  in  the 
balance between pro  and anti inflammatory cytokines may also result from the type, 
timing and severity of insult. In the human neonate a two phase inflammatory response 
has been described in with an antenatal wave of pro inflammatory cytokines and a 
postnatal anti inflammatory response
 (Dammann et al 2001). These data suggest that, 
in some neonates, levels of IL 1, IL 6, IL 8 and TNFα are high immediately following 
delivery and then fall to baseline levels by one week; conversely, anti inflammatory 
cytokines (GM CSF and TGF β) increased continuously during the first week from low 
levels post delivery.  
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The Role of Microglia  
 
The recognition of the role of the fetal inflammatory response as a key mediator in the 
onset  of  preterm  labour,  and  as  an  important  factor  in  the  aetiology  and 
pathophysiology  of  perinatal  brain  injury,  has  led  to  research  into  the  role  of  the 
resident immune cell within the brain – the microglia. Activation of resident microglia 
has  been  demonstrated  in  neonatal  autopsy  specimens  and  animal  models  of 
periventricular leukomalacia, excitotoxic and hypoxic ischemic brain injury (Ohno et al 
1995, Rezaie et al 2002, Hagberg et al 2002). 
 
Microglia are a specific subpopulation of cells related to monocytes and dendritic cells 
that have many roles within the central nervous system in health and disease. In their 
resting state microglia are highly ramified cells with a tertiary and quaternary branching 
structure which is integral to their role in immune surveillance (Raivich 2005). Trans 
cranial  two photon  laser scanning  microscopy  has  been  used  to  demonstrate  that, 
whilst  the  cell  body  of  microglia  is  normally  static,  their  elaborate  ramifications  are 
undergoing continuous extension and retraction (Nimmerjahn et al 2005, Davalos et al 
2005) allowing them to sample the extracellular space in a seemingly random fashion 
(Raivich 2005).  Tissue damage results in a rapid targeting of the injured area by the 
microglial branches from the surrounding microoglia (Nimmerjahn et al 2005, Davalos 
et al 2005). Therefore, microglia are able to surround the injured area with a dense 
sphere of branches, effectively walling it off from the surrounding undamaged tissue 
(Raivich 2005).  Microglia can exist morphologically in a number of states. In addition to 
the  resting  highly  ramified  cell,  microglia  can  take  on  a  deramified,  amoeboid 
phagocytic phenotype. However, an intermediate or ‘alert’ state between the resting 
and  phagocytic  morphology  has  also  been  defined  with  increased  integrin 
immunoreactivity,  swelling  of  the  microglial  cell  body,  thickening  of  the  proximal 
processes and loss of the distal processes (Kloss et al 2001). Activation of microglia 
may  occur  as  a  result  of  various  stimuli,  such  as  tissue  disruption  due  to  trauma, 
endotoxin, infection or ischemia. In addition to upregulation of cell adhesion molecules  
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which facilitate the migration of microglia to the site of injury, activation also results in 
the  production  of  extracellular  matrix  degrading  enzymes,  major  histocompatibility 
complex I & II, so that microglia can act as antigen presenting cells, cytokines such as 
IL1α, IL1β,  IL6, IL12, TNF  to recruit further immune  cells,  early components  of the 
complement  cascade  and  nitric  oxide  and  prostaglandins  to  attack  invading  micro 
organisms  (Chew  et  al  2006).    Microglia,  therefore,  have  specific  roles  in  immune 
surveillance,  cytokine  production,  antigen  presentation,  complement  activation  and 
phagocytosis within the developing central nervous system and their role in perinatal 
brain injury has yet to be fully understood. Further evidence of the role of microglia in 
the pathogenesis of perinatal brain injury has been shown using minocycline, a semi 
synthetic, second generation tetracycline antibiotic which has good CNS penetration 
and reduces microglial activation (Yrjänheikki et al 1998, Yrjänheikki et al 1999, Tikka 
et al 2001, Zemke and Majid 2004).  Initial studies of minocycline in the rat model of 
neonatal  hypoxic ischemic  injury  demonstrated  almost  complete  prevention  of  brain 
injury when administered prior to, or 2.5 hours after hypoxia ischemia. Neuroprotection 
was associated with prevention of caspase 3, a known effector of apoptosis (Arvin et al 
2002). However, in the same model using neonatal mice minocycline has been shown 
to worsen injury after hypoxia ischemia (Tsuji et al 2004). Whilst the reason for this 
conflicting effect is unknown, the effect of minocycline on macrophages is different in 
rats  (decreased  prostaglandin  E2  and  cyclo oxygenase 2  production)  and  mice 
(increased  prostaglandin  E2  and  cyclo oxygenase 2  production).  Additionally,  in  the 
mouse,  minocycline  also  reduces  angiogenesis  which  may  impair  compensatory 
mechanisms after hypoxia ischemia (Tsuji et al 2004, Diguet et al 2004).    
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The Role of Astrocytes 
Astrocytes  are  characteristic  star shaped  glial  cells  which  provide  mechanical  and 
metabolic support for neurons. They are also responsible for the formation of the glial 
scar that occurs in areas of CNS tissue loss.  
 
The prevalence of astrocytosis within the white matter at neonatal autopsy is 15 40% 
and  generally  occurs  following  hypoxia ischemia  (Rezaie  et  al  2002). However,  the 
exact  contribution  of  reactive  astrocytes  to  brain  pathology,  such  as  periventricular 
leukomalacia,  remains  unclear.  Although  reactive  astrogliosis  is  seen  in  damaged 
periventricular white matter,  it is  unclear whether this  is a direct effect of astrocyte 
damage or if this is a response to damage to oligodendrocytes and axons (Sen et al 
2006).  It  is  also  unknown  whether  the  activated  astrocytes  result  in  the  release  of 
protecting or damaging factors. Astrocytes have the potential to produce free radicals 
and TNFα but, conversely, under certain circumstances, can produce anti inflammatory 
factors  such  as  TGFβ  within  focal  PVL  lesions  (Meng  et  al  1999).  It  has  been 
suggested that there may be a biphasic response by astrocytes, with early responses 
favouring the production of neuro  and oligo toxins and a subacute response producing 
neuroprotective molecules and enhancing tissue regeneration.  Establishing the exact 
timecourse of astrocyte activation within the neuropathology of white matter injury may 
help identify their role in the disease process (Sen et al 2006). Astrocyte activation is 
also seen in animal models of hypoxic ischemic brain injury. In these models, however, 
this  activation  occurs  some  days  after  the  activation  of  microglia,  possibly  as  a 
response to microglial derived interleukin 1 (IL 1) (Ohno et al 1995).  In adult mice, 
astrocytes have a neuroprotective role following middle cerebral artery transection, with 
increased infarct size in mice deficient in glial fibrillary acidic protein and vimentin (Li et 
al  2008).  However,  an  inhibitory  effect  on  neural  regeneration  has  also  been 
demonstrated with the same deficiency (Kinouchi et al 2003).   
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Potential Mechanisms of Synergy 
Whilst  epidemiological,  experimental  and  clinical  data  suggest  that  feto maternal 
inflammation  may  have  a  sensitising  effect  on  the  neonatal  brain  to  subsequent 
hypoxia ischemia (see Figure 1.1), the mechanism by which this interaction occurs is 
largely unexplained. 
 
 Animal models have been used to demonstrate the synergistic effects of inflammatory 
responses and hypoxia ischemia. Endotoxin (lipopolysaccharide) has been shown to 
sensitise and dramatically increase the lesion size in the immature rat brain following 
hypoxic ischemic  injury.  This  effect  is  seen  when  endotoxin  is  administered 
systemically (Eklind et al 2001, Yang et al 2004, Ikeda et al 2004) or intracisternally 
(Coumans et al 2003). There appears to be an  effect of the time interval  between 
endotoxin  and  subsequent  hypoxia ischemia  as  endotoxin  has  also  been  shown  to 
reduce the volume of infarct in adult rats when given 24 hours prior to regional cerebral 
ischemia (Ahmed et al 2000). There also appears, under certain circumstances, to be a 
biphasic sensitising / neuroprotective response to endotoxin in the neonatal rat (Eklind 
2005).  These  findings  may  correlate  with  the  biphasic  pro inflammatory  /  anti 
inflammatory cytokine response seen in the perinatal period (Dammann et al 2001) and 
raise the possibility that it is the inflammatory status of the brain, and specifically the 
balance  between  pro  and  inflammatory  cytokines,  that  modulates  the  outcome  of 
hypoxic ischemic injury.  
 
From  the  animal  studies  to  date,  it  is  likely  that  microglia  have  a  key  role  in 
inflammatory sensitisation of the brain. These cells are activated in endotoxin models 
through toll like receptors (TLR 4), and it is through this mechanism that endotoxin can 
have a direct neurotoxic effect (Lehnardt et al 2003).  It is possible that the cytokines 
produced by endotoxin activated microglia, therefore, sensitise the developing brain to 
subsequent  hypoxia ischemia.  An  alternative  hypothesis  to  explain  the  interaction 
between endotoxin, microglia and hypoxia ischemia has also been suggested. In cell  
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culture  the  addition  of  microglia  to  neuronal  culture  provides  significant  neuronal 
protection against oxygen glucose deprivation involving microglial migration and close 
cell to cell contact with neurones. Interestingly this neuroprotective function is lost in 
both  CD11a deficient  microglia  and  endotoxin  pretreated  microglia  (Neumann  et  al 
2006). This study suggests that, rather than endotoxin activation increasing neuronal 
damage in hypoxia ischemia through increased neurotoxic activity, there may be loss 
of the normal neuroprotective function of microglia through LPS stimulation.  
 
An alternative mechanism of the synergistic effect of the fetal inflammatory response 
on  subsequent  hypoxic ischemic  injury  may  be  mediated  through  the  effects  of 
cytokines on the blood brain barrier. Although the blood brain barrier is thought to be 
intact from an early stage of fetal development, the integrity of this selective barrier 
may be altered by the presence of inflammatory mediators such as TNFα and IL 1β 
(Rezaie  et  al  2002).  Systemically  administered  endotoxin  results  in  an  influx  of 
granulocytes into the brain of adult mice, a process which is dependent on the up 
regulation of vascular endothelial ICAM 1. In this experimental model, endotoxin also 
opens  the  blood brain  barrier  to  large  proteins  such  as  albumin  (Bohatschek  et  al 
2001).  It  is  possible,  therefore,  that  the  fetal  inflammatory  response  affects  the 
microenvironment  within  the  developing  brain  through  the  action  of  inflammatory 
mediators on the blood brain barrier, and hence this results in influx of leukocytes into 
the central nervous system, potentially along with other factors which make the brain 
sensitive to subsequent hypoxia ischemia.  
 
Another  possible  mechanism  whereby  inflammation  could  modulate  the  effects  of 
hypoxia is through alterations in fetal temperature. Intrapartum fever has been shown 
to be independently associated with an increased risk of development of unexplained 
neonatal  seizures  (OR  3.4  95%CI  1.03 10.9)  (Lieberman  et  al  2000)  and  neonatal 
encephalopathy (OR 4.72, 95% CI 1.28 17.4)
 (Impey et al 2001). It is not clear whether 
these effects are just because pyrexia is serving as a marker for infection/inflammation  
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or whether non infectious pyrexia, for example in relation to epidural usage, may also 
be damaging, particularly if the fetus is hypoxic.  Finally, it is also possible that the fetal 
inflammatory response and specifically pro inflammatory cytokines may attenuate the 
normal compensatory responses exhibited by the fetus to a hypoxic insult.  
 
Summary 
In the hours following a hypoxic ischemic insult in the neonate a number of cellular 
events are occurring which may eventually lead to neuronal survival or death. It seems 
likely that the exact nature of the insults, timing and state of the brain at the time of 
insult  may  be  critical  in  defining  the  long term  neurodevelopmental  outcome. 
Specifically,  the  inflammatory  status  of  the  central  nervous  system  may  affect  the 
sensitivity of neurones to subsequent hypoxic ischemic insults. The hours that follow 
such insults are characterised by a cascade of neurotoxic events, a wave of pro and 
possibly  subsequent  anti inflammatory  cytokines,  a  delayed  failure  of  cerebral 
energetics and a relative alkalosis within the intracellular compartment of the brain. 
Clinically these events are characterised by the findings of neonatal encephalopathy, 
the magnitude of which corresponds to both the severity of perinatal insult and the 
long term  neurodevelopmental  outcome.  At  the  time  of  maximal  secondary  energy 
failure, the brain is at its most alkalotic, and clinically this corresponds to the onset of 
seizures, the presence of which raises the relative risk for development of cerebral 
palsy 71 times (Nelson and Ellenberg 1979). 
 
However, the realisation that some of the neuronal injury that occurs following hypoxia 
ischemia is delayed for at least a few hours after the initial insult has led to the potential 
therapeutic  window  during  which  intervention  could  ameliorate  neuronal  loss  and 
improve the neurodevelopmental outcome after hypoxic ischemic insults. 
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Part 4: Perinatal Brain Protection and Repair 
 
 
An understanding of epidemiology, aetiology and molecular mechanisms involved in 
childhood neurodisability and  perinatal  brain injury raises the  prospect  of strategies 
aimed at perinatal brain protection and repair. 
 
Primary Neuroprotection: Preventing of Damage 
As described previously, the biggest challenge for primary neuroprotection in hypoxic 
ischemic  brain  injury  is  the  accurate  and  timely  identification  of  the  at risk  fetus. 
Currently, the main tool used is continuous fetal heart rate monitoring which, whilst 
sensitive in identifying babies who have early hypoxia ischemia, carries a 99.8% false 
positive  rate  in  predicting  infants  who  will  develop  cerebral  palsy.  In  the  future, 
identification of additional risk factors in the woman and fetus, and hence stratification 
in the interpretation of fetal heart rate tracings, may allow more targeted intervention to 
prevent neurodisability whilst keeping overall interventions to a minimum.  
 
If,  as  suggested  by  both  epidemiological  and  animal models, there  is a  synergistic 
interaction  between  inflammation  and  hypoxia ischemia  in  the  development  of 
neurodisability,  then  avoidance  of  intrapartum  hypoxia  might  be  neuroprotective  in 
women “at risk”. In term deliveries, elective caesarean section has been shown to be 
associated  with  a  highly  significant reduction  in  term neonatal  encephalopathy  (OR 
0.17, 95%CI 0.05 0.56) whereas emergency caesarean section is associated with an 
increased risk (Badawi et al 1998). A similar relationship between elective /emergency 
caesarean section and cerebral palsy has been shown in preterm infants (Murphy et al 
1995). However, it  is interesting that the incidence of  cerebral palsy  has not fallen 
despite  substantial  recent  increases  in  the  caesarean  section  rate  over  the  last  20 
years. Again, a more accurate identification of the “at risk” fetus should allow obstetric 
intervention to be targeted and inappropriate intervention reduced. 
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Materno/fetal infection and inflammation remains the other single most identifiable risk 
factor  for  development  of  brain  injury  in  both  the  term  and  preterm  neonate.  It  is 
therefore  important  to  consider  the  potential  to  intervene  antenatally  to  reduce  the 
effects of a pro inflammatory milieu and other harmful effects of infection. The effect of 
maternal antibiotics on infection related preterm brain injury is not clear. One study has 
shown a correlation between maternal antibiotic use and white matter injury (Leviton et 
al 1999). However, this may be because antibiotic use acts as a marker of severe 
maternal infection, rather than that brain injury is a direct consequence of antibiotic 
use.  A  feto toxic  effect  of  maternal  antibiotics  has  been  demonstrated  with  the 
increased incidence of neonatal necrotising enterocolitis in pregnancies treated with 
co amoxiclav, compared with erythromycin. This is thought to be a result of certain 
antibiotics causing a greater release of endotoxin by damaged bacteria than others 
(Kenyon  et  al  2001).  Maternal  antibiotics  are  given  for  intrapartum  pyrexia  for 
prevention of congenital infection with Group B streptococcus; however, there is no 
evidence that intrapartum antibiotics influence neonatal neurological outcome.  
 
The  significant  role  of  the  feto maternal  inflammatory  response  in  both  initiation  of 
preterm labour and in perinatal brain injury also raises the possibility of intervention 
with agents that modify the inflammatory response. However, as most of the target 
molecules remain in a delicate balance with other pro / anti inflammatory mediators, 
and because all molecules within the inflammatory response have multiple functions, 
blocking of their activity may in fact be harmful. There has to date been no report of a 
clinical trial of inflammation modulators to reduce brain damage in the human neonate 
(Dammann and Leviton 2000).  
 
The observation that maternal pyrexia is associated with neonatal encephalopathy and 
seizures raises the  possibility that relatively simple interventions  to aid temperature 
reduction may confer neuroprotection. There are a variety of theoretical reasons why 
trying  to  keep  pyrexial  mothers  normothermic  during  labour  may  protect  against  
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neonatal  encephalopathy: maternal intrapartum pyrexia  clearly increases  the  risk  of 
abnormal  neonatal  neurology;  animal  studies  suggest  that  hypothermia  is 
neuroprotective and that hyperthermia exacerbates hypoxic brain injury. Of note the 
fetal temperature is on average 1°C higher than maternal temperature. However, a 
randomised  controlled  trial  designed  to  show  a  neuroprotective  effect  of  maternal 
cooling has yet to be performed.  
 
 
Secondary Neuroprotection: Intervening in the Therapeutic Window 
The observation of the biphasic nature of changes in cerebral energetics that follow 
neonatal hypoxic ischemic insults has raised the possibility of a therapeutic window in 
the  first  few  hours  of  neonatal  life.  As  described  above,  many  cellular  and 
neurochemical  processes  occur  in  the  hours  that  follow  hypoxia ischemia  which 
potentially define whether individual neurones will survive or progress to cell death. It 
has long been the hypothesis that intervention to disrupt the sequence of events within 
this  window  would  allow  a  greater  number  of  neurones  to  survive  and,  hence, 
ameliorate the effects of hypoxia ischemia. One of the most exciting advances in the 
field of perinatal brain injury since Little’s original descriptions of 1840 1870 has been 
the recent publication of 2 therapeutic hypothermia trials both of which demonstrated 
the  potential  for  therapeutic  intervention  in  babies  with  neonatal  encephalopathy  to 
prevent long term neurodisability. 
 
Gluckman et  al  used selective head cooling using a  water filled cooling cap for  72 
hours in neonates with encephalopathy following hypoxia ischemia. (Gluckman et al 
2005). At 18 month follow up, the primary outcome was defined as unfavourable if an 
infant  died  or  had  severe  disability  defined  as  severe  neuromotor  disability,  Bayley 
motor disability index <70, or bilateral cortical visual impairment. Infants were stratified 
according  to  the  severity  of  their  amplitude  integrated  EEG  (aEEG)  at  time  of 
randomisation.  There  was  no  benefit  in  the  outcome  in  infants  with  severe  aEEG  
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abnormalities at randomisation. However, in the infants with moderate abnormalities in 
the aEEG, there was  an  overall significant reduction  in  unfavourable outcome from 
66% to 48%. There was also a reduction from 28% to 12% in incidence of severe 
neuromotor disability. In a subsequent paper, the authors evaluated the role of various 
factors in determining the response to head cooling treatment. Interestingly in the non 
cooled babies weight was important with increased rates of unfavourable outcome with 
increasing weight, and, conversely, increased favourable outcome in smaller infants. 
However, cooling was highly significantly protective in infants >25th percentile but not 
in those <25th percentile. The authors suggested that these findings may be accounted 
for if either the smaller babies were over cooled by the coolcap, and /or the possibility 
that larger babies tend to overheat if not cooled. These findings necessitate further 
studies  of  regional  brain  temperature  following  hypoxia ischemia,  and  in  babies 
undergoing therapeutic cooling, in an attempt to allow therapeutic hypothermia to fulfil 
its neuroprotective potential.  
 
Total  body  cooling  has  also  been  shown  to  be  neuroprotective  following  hypoxia 
ischemia. (Shankaran et al 2005). In this large NIH funded multi centre trial, infants 
were cooled to a rectal temperature of 33.5ºC for 72 hours, after which they underwent 
a gradual re warming process. Overall death or moderate severe neurodisability was 
reduced in the cooled group from 62% to 44% at 18 22 month follow up. Interestingly, 
in this study, aEEG studies were not performed. However, the on going MRC funded 
total body hypothermia (ToBy) trial, which is soon to report, will allow stratification of 
outcome  by  aEEG  in  babies  who  have  undergone  total  body  cooling  for  hypoxic 
ischemic encephalopathy. 
 
In a comparison of the patterns of brain injury seen on MRI scanning in infants treated 
with selective head cooling or total body cooling, both methods resulted in reduced 
basal ganglia and thalamic injury. However, in the selective head cooling group there 
was also a decrease in severe cortical lesions (Rutherford et al 2005). Animal studies  
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of cooling suggest that we may not yet have achieved optimal results from the studies 
performed to date. The piglet model of neonatal hypoxia ischemia has demonstrated 
that  different  areas  of  the  brain  require  different  temperatures  for  optimal 
neuroprotection (Iwata et al 2005). In this model, cooling of the brain to 35ºC resulted 
in a 25% increase in viable neurones in the superficial cortical grey matter and a 39% 
increase in viable neurones in the deep grey matter; however, cooling to 33ºC resulted 
in a 55% increase in neurones in the superficial cortical grey matter but no increase in 
viable neurones in the deep grey matter. These findings suggest that a temperature 
gradient across the brain with superficial structures cooler than deeper structures may 
provide optimal neuroprotection. Many questions remain unanswered with regard to the 
use  of  hypothermia  in  the  treatment  of  neonatal  encephalopathy,  including  the 
technique to achieve hypothermia, and the depth and duration of hypothermia. These 
questions  have  led  a  number  of  authors  to  conclude  that  therapeutic  hypothermia 
should  not  be  indiscriminately  introduced  in  routine  neonatal  care  before  further 
research is completed (Wyatt et al 2005, Edwards et al 2006, Blackmon et al 2006) 
 
Although  to  date  no  clinical  trials  have  been  performed  for  pharmacological 
interventions  in  neonatal  hypoxic ischemic  encephalopathy,  a  number  of  potentially 
neuroprotective agents have been identified in animal models. Recently, the prospect 
that pharmacological agents may improve hypothermia has also been demonstrated. In 
rats, topiramate, whilst not neuroprotective as a single agent, was able to extend the 
therapeutic window for initiating hypothermia beyond the time it normally ceases to be 
effective (Liu et al 2004). Xenon and hypothermia in combination have been shown to 
provide  synergistic  neuroprotection  following  hypoxia ischemia  in  vitro  in  cultured 
neurones and in vivo in neonatal rats (Ma et al 2005). Interestingly, the same group 
have demonstrated that the synergistic neuroprotection of xenon with hypothermia is 
maintained when the treatments are administered asynchronously (Martin et al 2007). 
In this study neither hypothermia at 35°C for 2 hours or inhalation of 20% xenon for 90 
minutes were neuroprotective alone. However, if the xenon inhalation occurred either 1  
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or  5  hours  after  hypothermia  there  was  a  significant  reduction  in  infarct  volume. 
Combined  treatment  with  hypothermia  and  xenon  in  the  human  neonate  following 
hypoxia ischemia are planned to start in the near future. As described previously, the 
neuroprotective effects of melatonin, a naturally occurring neurohormone secreted from 
the  pineal  gland,  which  has  potent  anti oxidant  activity,  has  been  demonstrated  in 
animal  models.  The  effects  of  melatonin  as  a  neuroprotective  agent  against  white 
matter injury in preterm neonates are currently under evaluation. 
 
 
Future Potential: Neonatal Brain Repair 
The potential for the neonatal brain to exhibit cortical plasticity through compensation 
and reorganisation has been recognised for many years. For example, in the motor 
tracts, large unilateral lesions result in the preservation of ipsilateral projections from 
the uninjured hemisphere; however, as these normal physiological connections are lost 
in late gestation, infants with lesions occurring after this time will not demonstrate such 
connections.  Lesions  in  the  left  hemisphere  of  the  brain  lead  to  a  redistribution  of 
language function to the uninjured right hemisphere without functional deficit. However, 
lesions  to  the  optic  radiations  or  visual  cortex  demonstrate  limited  compensatory 
potential (Krägeloh Mann 2004). Further understanding of the mechanisms of cortical 
plasticity  and  neuronal  regeneration  may  allow  intervention  to  improve  functional 
outcome and limit disability. 
 
The other potential strategy for brain repair following injury involves the use of stem 
cells – cells with the ability both to self renew and to give rise to cell types different 
from themselves. Much work is underway to unlock the potential of exogenous stem 
cells to repair injured brain tissue in animal models, particularly as in animal models 
stem  cells  transplanted  into  the  neonatal  brain  migrate  widely  in  comparison  to 
transplantation into the adult brain (Olsson et al 1997). In various models, the potential 
for stem cells to produce functional and histological improvement in both injury and  
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neurodegenerative conditions has been well established and this strategy may provide 
a  therapeutic  avenue  for  perinatal  brain  injury  in  the  future  (Hodges  et  al  1997, 
Björklund and Lindvall 2000, Santner Nanan et al 2005). An alternative approach to the 
use  of  exogenous stem  cells arises from the  recognition of endogenous stem cells 
which are present in the developing brain. Recent evidence from the rodent neonatal 
hypoxia ischemia  model  demonstrates  an  expansion  of  endogenous  neural  stem  / 
progenitor cells within the sub ventricular zone on the injured side (Yang et al 2006). 
Furthermore,  this  expansion  is  associated  with  regeneration  of  neurones,  with 
migration of stem cells from the sub ventricular zone into the injured neocortex over a 
period of weeks to months following injury (Yang et al 2007). Of note in this and other 
studies,  around  85%  of  the  newly formed  neurones  die  before  reaching  maturity, 
raising the possibility that manipulation of the micro environment and trophic support 
will  allow  a  greater  proportion  of  cells  to  reach  maturity  and  potentially  improve 
functional outcome following perinatal brain injury. 
 
Summary 
Although the fact that childhood neurodisability may arise from perinatal events has 
been  recognised  for  over  150  years,  it  has  only  been  in  the  last  few  years  that 
postnatal intervention to ameliorate long term brain injury has been possible. It is likely, 
however,  that  our  current  understanding  of  cooling  strategies  for  hypoxic ischemic 
injury  represents  only  the  first  step  in  neuroprotection.  Based  on  current  research 
programmes, it is probable that, in the future, a combination of prevention, amelioration 
and  regeneration  /  repair  strategies  will  be  increasingly  available  to  reduce  the 
incidence and severity of perinatal brain injury.  
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Aims 
Inflammatory Sensitisation of the Neonatal Brain: 
In order to further our understanding of the multifactorial nature of perinatal brain injury, 
further studies are required to understand the mechanism of injury and, hence, the 
potential for neuroprotective strategies. From an aetiological perspective, the role of 
inflammatory  sensitisation  to  subsequent  hypoxia ischemia  remains  of  particular 
interest. If this mechanism can be fully understood then further strategies for primary 
prevention may  be  identified  and,  hence,  the  incidence  and  severity  of  brain  injury 
reduced. To build on previous studies, a number of hypotheses were formulated as the 
basis for the current study: 
 
1.  Endotoxin will act as a sensitising agent prior to hypoxia ischemia in a murine 
model  of  neonatal  hypoxic ischemic  brain  injury;  moreover,  endotoxin  pre 
treatment will result in significant histological injury following levels of hypoxia 
ischemia not normally associated with brain injury when occurring in isolation. 
The time interval between endotoxin administration and subsequent hypoxia 
ischemia will be critical in determining the histological outcome. 
 
2.  Endotoxin  administered  alone  will  result  in  detectable  changes  within  the 
developing brain which  may be part of the process underlying the observed 
sensitisation to subsequent hypoxia ischemia. 
 
3.  As  pro inflammatory  cytokines,  including  the  TNF  family  of  cytokines,  are 
produced  in  response  to  endotoxin  and  hypoxia ischemia,  and  have  a 
neurotoxic effect, these may be critical to inflammatory sensitisation. Hence, 
deletion  of  the  TNF  family  of  cytokines  will  prevent  endotoxin  mediated 
sensitisation of the developing brain to subsequent hypoxia ischemia.  
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Intracellular pH in Perinatal Hypoxic Ischemic Brain Injury: 
Current neonatal practice in the care of babies following hypoxic ischemic brain injury 
aims to restore normal physiological parameters, including pH, in the hours following 
the hypoxic ischemic insult. However, studies have demonstrated a rebound alkalosis 
during re oxygenation following hypoxia ischemia, the magnitude of which corresponds 
to  long term  neurodevelopmental  outcome.  This  may  suggest  that  prevention  of 
rebound alkalosis and, indeed, maintenance of a mild acidotic intracellular pH, will have 
a neuroprotective effect in comparison to current clinical practice. To further explore 
these effects a number of hypotheses were formulated: 
 
1.  Rebound  alkalosis  will  be  demonstrable  within  the  brain  of  neonatal  mice 
following hypoxia ischemia. 
 
2.  Previous  studies  suggest  that  this  alkalosis  results  from  the  action  of  the  
Na
+  /  H
+  transporter  which  is  located  in  the  cell  membrane  and  normally 
functions  to  maintain  intracellular  pH  and  cell  volume.  Blockade  of  this 
transporter  prior  to  hypoxia ischemia  will  result  in  reduced  brain  injury  in 
comparison to hypoxia ischemia alone.  
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Chapter 2: General Materials and Methods 
Chemicals 
Unless otherwise stated, all chemicals used in this study were purchased from Sigma. 
Animals 
C57/Bl6 females (Charles River laboratories UK) and males (Harlan UK) were mated 
in house and the offspring were used for all experiments. The Home Office approved 
the  animal  experiments  and  care  protocols.  All  animal  procedures  were  performed 
according to the UK Animals (Scientific Procedures) Act 1986. 
 
Surgical Procedures 
Hypoxia ischemia 
Animals were anaesthetised with isofluorane (5% induction, 1.5% maintenance). The 
left  common  carotid  artery  was  exposed  via  a  midline  neck  incision  using  blunt 
dissection. Permanent occlusion was achieved using 8/0 polypropylene suture and the 
wound was closed using tissue glue. The surgical procedure was completed within 5 
minutes and the total duration  of  anaesthesia was less  than 10 minutes. Following 
surgery the mice were recovered at 36˚C before being returned to the dam to nurse for 
2 hours. The mice were then placed in a sealed hypoxia chamber and exposed to a 
constant flow of 2 L/min of 36˚C, humidified 8% oxygen balanced with nitrogen. The 
temperature  inside  the  chamber  was  monitored  and  maintained  at  36˚C.  Following 
hypoxic exposure, pups were allowed to recover for 30 minutes at 36˚C before being 
returned to their dams. 
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Tissue Preparation 
At  specific  time points,  animals  were  anaesthetised  by  intraperitoneal  injection  with 
pentabarbital sodium. The heart was exposed and the animals perfused intracardially 
with 30 ml of phosphate buffered saline (PBS) at a rate of 6 ml per minute. The brains 
were extracted and post fixed in 4% paraformaldehyde (PFA) on a rotator (8 rpm) for 1 
hour at 4˚C, followed by cryoprotection overnight by rotating immersion in 30% sucrose 
(Fluka) at 4˚C as described before (Möller et al 1996). Brain tissue was mounted frozen 
on dry ice, and stored at  80˚C until required. The brains were cut on a cryostat into 40 
 m sequential coronal sections starting 1 mm from the frontal cortex. Each section was 
collected onto a warm 0.5% gelatin coated slide, refrozen on dry ice and stored at  
80˚C until required. 
 
Immunohistochemistry 
All sections belonging to the same experiment were stained together at the same time 
to  prevent  differences  in  staining  intensity  as  described  before  (Möller  et  al  1996). 
Sections were rehydrated in double distilled water (ddH2O), spread with fine brushes 
under a dissecting microscope and allowed to dry at room temperature for 15 minutes. 
The sections were surrounded by a delineating pen and fixed in 4% formaldehyde in 
phosphate buffer (PB) for 5 minutes and then washed in 0.1M PB where they remained 
until all the slides had been fixed. Where appropriate (see Table 2.1) the tissue was 
defatted and permeabilised by passing the slides through cuvettes of 50% 100% and 
50% acetone (2 minutes in each) and then washed twice in 0.1M PB and once in 0.1% 
bovine  serum  albumin  in  phosphate  buffer  (PB/BSA).  The  slides  were  placed  in  a 
humid chamber and the sections were blocked for 30 minutes in 5% goat serum to 
prevent non specific binding of the secondary antibody. Sections were then incubated 
with the appropriate primary antibody at 4˚C overnight (see Table 2.1). 
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Antigen  Acetone  Primary 
antibody 
Dilution  Secondary 
antibody 
Dilution 
CD 11b (αMβ2 
Integrin) 
Yes  Rat anti mouse 
(Serotec 
MCA711) 
1:5000  Goat anti rat 
(Vectorlabs) 
1:100 
CD 49d (α4 Integrin)  No  Rat anti mouse 
(Pharmingen 
01271D) 
1:1000  Goat anti rat 
(Vectorlabs) 
1:100 
CD 49e (α5 Integrin)  No  Rat anti mouse 
(Pharmingen 
01741D) 
1:200  Goat anti rat 
(Vectorlabs) 
1:100 
CD 49f (α6 Integrin)  Yes  Rat anti mouse 
(Serotec 
MCA699) 
1:3000  Goat anti rat 
(Vectorlabs) 
1:100 
CD 11c (αX Integrin)  Yes  Hamster anti 
mouse (Endogen 
MA 11C5) 
1:400  Goat anti hamster 
(Vectorlabs) 
1:100 
β2 Integrin  Yes  Rat anti mouse 
(Serotec 
MCA1032G) 
1:400  Goat anti rat 
(Vectorlabs) 
1:100 
IBA 1  Yes  Rabbit anti mouse 
(**) 
1:400  Goat anti rabbit 
(Vectorlabs) 
1:100 
Glial Fibrillary Acidic 
Protein (GFAP) 
Yes  Rabbit anti cow 
(Dako Z0334) 
  
1:6000  Goat anti rabbit 
(Vectorlabs) 
1:100 
CD 54 (ICAM1) 
 
Yes  Hamster anti 
mouse 
(Pharmingen 
01541D) 
1:3000  Goat anti hamster 
(Vectorlabs) 
1:100 
VCAM1  No  Rat anti mouse 
(Serotec 
MCA1229) 
1:400  Goat anti rat 
(Vectorlabs) 
1:100 
Myelin Basic Protein 
(MBP) 
Yes 
 
 
Rat anti cow 
(Chemicon 
MAB395) 
1:200  Goat anti rat 
(Vectorlabs) 
1:100 
Human Albumin 
 
 
Yes  Rabbit anti 
human 
(Sigma A 0433 
1: 
100000 
Goat anti rabbit 
(Vectorlabs) 
1:100 
Human 
Immunoglobulin 
 
Yes  Rabbit anti 
human 
(Sigma I 2136 
1:10000  Goat anti rabbit 
(Vectorlabs) 
1:100 
 
Table 2.1: Antibodies for Immunohistochemistry 
** Kind gift from Dr. Y Imai, National Institute of Neuroscience, Japan 
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After incubation, the sections were washed in PB/BSA, twice in 0.1M PB and once 
PB/BSA. The sections were then incubated for 1 hour with the appropriate biotinylated 
secondary  antibody  (see  Table  1)  which  had  been  previously  blocked  with  normal 
mouse  serum  for  30  minutes.  Visualisation  was  achieved  using  the  ABC  system 
(Vector Lab). The avidin biotin enzyme complex solution (ABC solution) was prepared 
as  per  the  manufacturer’s  instructions.  The  tissue  sections  were  washed  twice  in 
PB/BSA and twice in 0.1 M PB. The sections incubated with then incubated with the 
ABC solution for 1 hour at room temperature. The sections were washed four times in 
10 mM PB and then were placed in 0.05% diaminobenzidine (DAB) in the presence of 
0.01% hydrogen peroxide for 2 15 minutes depending on the colour visualised. The 
reaction was stopped by transferring the slides to 10 mM PB, and the sections were 
washed by transfer through 2 cuvettes of double distilled water. The sections were 
dehydrated in 70%, 90%, 95% and 100% ethanol, isopropanol, and twice in xylene 2 
minutes in each before being covered using Depex (BDH). 
 
Antibody Specificity 
The  specificity  of  the  antibody  raised  against  αMβ2  integrin  has  been  previously 
confirmed in our laboratory using appropriate knockout animals (Makwana et al 2009 in 
press).  Homozygous  alphaM  null  mice  and  littermate  controls,  obtained  through 
collaboration  with  Dr  Tanya  Mayadas  Norton  (Boston,  MA,  USA),  showed  the 
disappearance of all microglial alphaM immunoreactivity, throughout the brain of the 
alphaM null mice. The antibody specificity for α4, α5 α6 αM and β2 integrin subunit 
have  been  confirmed,  in  our  laboratory,  by  Western  blotting  using  un fractionated 
tissue  homogenates  from  trigeminal  ganglia,  brainstem,  spleen  and  heart  muscle 
(Makwana et al 2009 in press). In the case of rat monoclonal antibodies raised against 
alpha4 (CD49d), alpha 5 (CD49e), and alpha 6 (CD49f), previous studies have also 
detailed  a  massive  upregulation  of  encoding  mRNAs  species  following  facial  nerve 
axotomy in the mouse facial motor nucleus, corresponding with strong increase in the  
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appropriate  immunoreactivity  (Kloss  et  al.,  1999;  Werner  et  al.,  2000).  All  the 
monoclonal antibodies used in the current study are well defined, with long established 
functional  characterization  for  alpha4  (Holzmann  and  Weissman,  1989),  alpha5 
(Uhlenkott  et  al.,  1996),  alpha6  (Helmler  et  al.,  1988)  alphaX  (Bulloch  et  al  2008) 
integrin subunits, as well as IBA1 (Okere and Kaba 2000), GFAP (Jakovcevski et al 
2007), myelin basic protein (Tiwari Woodruff et al 2007), ICAM1 (Martınez Sanz et al 
2008), VCAM1 (Matter et al 2006).  
 
Terminal Transferase Mediated d UTP Nick End Labeling (TUNEL) 
TUNEL staining was performed as described previously (Gavrieli et al 1992). Sections 
were rehydrated, spread and fixed as described for immunohistochemistry. The slides 
were  incubated  in  3%  hydrogen  peroxide  in  methanol  for  15  minutes  to  block 
endogenous peroxidase and then washed 4 times in 0.1M PB. Sections were defatted 
and permeabilised in 50%, 100% and 50% acetone (2 minutes in each) before being 
washed twice in 0.1M PB and once in PB/BSA. Slides were then placed in a humid 
chamber and incubated with terminal deoxytransferase (TdT) solution (see appendix) 
for 2 hours at 37˚C. The reaction was stopped by incubating the slides for 10 minutes 
in 300 mM sodium chloride / 300 mM sodium citrate (TUNEL stop solution). Slides 
were  washed  3  times  in  0.1  M  PB  and then  incubated for  1  hour  in  ABC  solution 
(Vector Labs) at room temperature. The slides were washed 4 times in 10 mM PB and 
then incubated in DAB solution with nickel cobalt in the presence of 0.01% hydrogen 
peroxide (see appendix) for 150 seconds. The reaction was stopped in 10mM PB and 
the sections washed twice in double distilled water. The sections were dehydrated in 
70%, 90%, 95% and 100% ethanol, isopropanol, and twice in xylene 2 minutes in each 
before being covered using Depex. 
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Tyramide Staining 
The  cut  tissue  was  spread,  fixed,  defatted  and  permeabilised  as  described  for 
immunohistochemistry.  The  granulocyte  myeloperoxidase  enzyme  was  detected  as 
follows. The slides were incubated with 100  L 0.1% biotinylated tyramide solution in 
the presence of 0.001% hydrogen peroxide (see appendix) for 10 minutes at room 
temperature to allow covalent binding. The sections were washed 4 times in 0.1 M PB, 
the slides dried and the sections incubated with 100 L ABC solution for 1 hour at room 
temperature. Visualisation, dehydration and mounting of the sections were carried out 
as for immunohistochemistry (see above) 
 
Nissl Staining 
Cut sections were removed from the freezer onto dry ice and rehydrated with double 
distilled water. The tissue was spread with fine brushes and the slides were allowed to 
dry at room temperature overnight. The sections were then fixed in 4% PFA overnight 
and dehydrated in 70% alcohol overnight. The staining procedure was carried out by 
transferring the slides through cuvettes of: Nissl stain, ddH2O, ddH2O, 70% ethanol, 
90% ethanol, 96% ethanol, 96% ethanol with 5 7 drops glacial acetic acid in a 300 ml 
cuvette for destaining, 100% ethanol, isopropanol, and 3 cuvettes of xylene. Except for 
the Nissl stain, in which the slides remained for 10 minutes, and the ethanol with acetic 
acid, in which they remained for 3 10 minutes according to colour, the slides spent 2 
minutes  in  each  of  the  other  cuvettes.  The  tissue  sections  were  covered  with  a 
coverslip using Depex, and the slides were allowed to dry in the fume cupboard.  
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Tissue Analysis 
Infarct Size 
15 sections cresyl stained sections from each forebrain (200  m apart) were scanned 
and imported into Optimas 6.2 image analysis software. The areas of intact staining in 
the  cortex,  hippocampus,  striatum  and  thalamus  were  outlined  and  measured 
bilaterally.  Surviving  brain  tissue  was  calculated  by  converting  the  measured  left 
(injured)  and  right  (uninjured)  areas  into  mm
2  and  then  converting  to  a  volume  by 
multiplying  by  200   m. The  sum  of  these  volumes  was  then  used to  calculate  the 
percentage  surviving  brain  tissue  as  left/right  volume  x  100,  or  infarct  size  (right 
left)/right x 100. 
 
Injury Score 
Initial pilot studies showed that, in the neonatal mouse, hypoxic ischemic insults were 
associated with histological injury, particularly severe in the hippocampus, but also in 
the  cortex,  striatum,  and  thalamus.  Although  severe  injury  resulted  in  a  clearly 
definable  infarct,  which  could  be  quantified  by  measurement,  less  severe  injury 
resulted in a more diffuse pattern of neuronal loss. Here, infarct size, as described 
above,  was  not  able  to  demonstrate  the  apparent  injury  seen  on  subjective 
assessment. In an attempt to detect this mild, diffuse pattern of injury, an injury score 
was devised. Microglia, the resident immune cell within the brain, are known to be 
activated, and to upregulate adhesion molecules in response to tissue damage (Ohno 
et al 1995,  Kloss  et al 1999, Raivich  2005). To identify this microglial activation,  5 
coronal sections per brain (600  m apart), were stained using immunohistochemistry 
for αMβ2 integrin (Kloss et al 1999). The αMβ2 immunoreactivity in areas of tissue 
damage was scored for each brain region (cortex, hippocampus, thalamus, striatum) by 
an observer blinded to the treatment of the individual animal (see Table 2.2 and Figure 
2.1).  The  extent  of  the associated  tissue damage  was  also  scored from the cresyl 
stained sections, (see Table 2.2) and the two scores combined to give a total 0 7 point  
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injury score. Whilst this score was used in an attempt to define milder forms of brain 
injury, it should be recognised that the major component of this measurement was a 
subjective  score  from  the  cresyl  stained  sections,  i.e.  the  amount  of  histological 
damage.  The  score  may,  therefore,  not  have  additional  value  over  the  infarct 
measurement. Due to these limitations brain injury score was only used in addition to 
another analysis of injury, either infarct volume or TUNEL staining.  
 
Score  5C6 (αMβ2 integrin) Immunoreactivity 
0  No activation (see Fig 2.1A) 
1  Focal activation (see Fig 2.1B) 
2  Mild diffuse activation, occasional amoeboid macrophages (see Fig 2.1C) 
3  Widespread activation, predominant amoeboid macrophages (see Fig 2.1D) 
  
Score  Nissl (Cresyl Violet) Staining 
0  No damage 
1  Minimal evidence of damage without evidence of infarct 
2  Small infarct, <50% of the affected region 
3  Large infarct, >50% of the affected region 
4  Total Neuronal Loss 
 
Table 2.2: Brain Injury Scoring 
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Figure 2.1: Immunohistochemistry for αMβ2 integrin expression. Brain regions were scored for 
microglial activation based on the different appearance as negative (A), focal activation (B), 
widespread activation predominant ramified morphology (C), or widespread activation 
predominant amoeboid morphology (D). 
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To quantify injury in the white matter a scoring system for microglial activation within 
the external capsule was devised using the 5 coronal sections per brain stained using 
immunohistochemistry for αMβ. Scores (see Table 2.3) were then allocated for left 
(ipsilateral) and right (contralateral) external capsule by an observer blinded to the 
treatment of the individual animal. The two scores were then added together to give a 
total 0 4 point white matter microglial activation score. 
 
 
Score  5C6 (αMβ2 integrin) Immunoreactivity 
0  No activation  
1  Mild activation occasional ameboid macrophages 
2  Diffuse activation with multiple ameboid macrophages 
  
Table 2.3 White Matter Microglial Activation Score 
 
Staining Intensity 
For  quantification  of  immunohistochemical  staining  intensity,  3  coronal  sections  per 
brain  (800   m  apart)  were  used.  From  each  section,  images  of  the  cortex, 
hippocampus,  thalamus  and  striatum  were  scanned  into  a  computer,  using  a  Sony 
AVT horn video camera. Images were then imported into Optimas 6.2 image analysis 
software. The region of interest was delineated using the free hand tool, and the mean 
and standard deviation of the optical luminosity values were measured (see figure 2.2). 
The optical luminosity histogram was reviewed to ensure measured luminance values 
were within the measureable range (OLV; RGB 0 255).  
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Figure  2.2:  Optical  luminosity  measurement.  The  region  of  interest,  here  the  striatum,  was 
delineated using the freehand tool (shown in green). The luminance histogram was reviewed to 
check values were within the range 0 255. The mean and standard deviation values (shown in 
the red box) were transferred into an Excel spread sheet.  
 
The raw staining intensity was determined for each brain region, on each section, using 
the  mean     standard  deviation  algorithm  (Möller  et  al  1996,  Kloss  et  al  2001).  In 
addition, the background staining intensity was measured on each slide using the same 
algorithm.  The final staining intensity was calculated by the difference between the raw 
staining intensity and the background staining intensity.  
 
Cell Death 
To  quantify  cell  death  involving  DNA  fragmentation  the  number  of  TUNEL  positive 
nuclei  was  counted  in  each  brain  region.  The  sections  were  also  scanned  into  a 
computer and the area in which the cells were counted was measured using Optimas 
6.2 image analysis software. The results were expressed as number of TUNEL positive 
cells per mm
2.  
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 Chapter 3: Establishing a Murine Model of Perinatal Brain Injury 
 
Introduction 
From the earliest descriptions of perinatal brain injury and the resultant neurodisability, 
birth asphyxia  (hypoxia ischemia)  has been recognised as an  important aetiological 
factor. However, more recently, epidemiological studies have attempted to assess the 
proportion of cerebral palsy attributable to pure birth asphyxia, with estimates ranging 
between 8% and 28% (Nelson and Ellenberg 1986, Blair and Stanley 1988, Hagberg et 
al  2001).  There  is  a  growing  body  of  evidence  that  perinatal  brain  injury  is  of 
multifactorial aetiology with an interaction of various risk factors influencing eventual 
neurodevelopmental outcome. Other potential factors include infection / inflammation, 
coagulopathy and genetic causes (Nelson and Willoughby 2000). 
 
In order to study perinatal brain injury, various animal models have been used. These 
have been performed in various animals and often use bacteria, endotoxin, viruses, 
excitotoxins or hypoxia ischemia (for review see Hagberg et al 2002). More recently, 
research  has  begun  to use  combinations  of  such  insults  to  better  study  how  other 
factors influence the outcome following hypoxia ischemia (Eklind et al 2001, Coumans 
et  al  2003,  Yang  et  al  2004)  The  most  commonly  used  rodent  model  of  perinatal 
hypoxia ischemia was originally described some 25 years ago (Rice et al 1981).  This 
model involves permanent carotid occlusion and timed exposure to hypoxia in a 7 day 
old rat. Individually, carotid occlusion or hypoxia was not sufficient to cause histological 
damage.  However,  in  combination,  carotid  occlusion  followed  by  hypoxia  led  to 
histological evidence of brain injury in 90% of animals and an infarct in 56% (Rice et al 
1981). From a neurological perspective, the seven day old mouse or rat is considered 
to  be  a  reasonable  representation  of  the  human  neonate  at  term;  specifically  this 
relates to the process of myelination (Hagberg et al 2002). Unlike the human neonate, 
mice  and  rats  are  born  pre myelination,  but  undergo  rapid  myelination  in  the  first  
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postnatal week. The pattern of brain injury in the 7 day old rodent model is indeed 
similar to that seen in the term neonate following hypoxia ischemia with damage to the 
ipsilateral cerebral cortex, thalamus, striatum, hippocampus as well as subcortical and 
paraventricular white matter (Roohey et al 1997) 
 
It  is,  therefore,  clear  that  in  animal  models  and  human  neonates,  both  hypoxia 
ischemia and infection / inflammation can, if severe enough, result in permanent brain 
injury. However, it has been suggested that much milder combinations of these insults, 
not sufficient alone to cause injury, may result in permanent brain injury (Peebles and 
Wyatt  2002). This interaction may be  further complicated by  the age  of the  animal 
(Ahmed et al 2000) and the exact temporal relationship of the different insults (Eklind et 
al 2005).  
 
In order to study the effects of combinations of hypoxia ischemia and inflammation it 
was first necessary to examine the effects of each insult alone, and to establish a level 
at  which  the  insults  produce  little  or  no  permanent  brain  injury.  Further  to  these 
experiments, a combination of endotoxin given 4 hours prior to hypoxia ischemia (a 
time interval previously shown to sensitise the developing brain to hypoxia ischemia) 
(Eklind  et  al  2001)  was  used  to  investigate the  synergy  between  inflammation  and 
hypoxia ischemia in the development of perinatal brain injury. 
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Materials and Methods 
 
Lipopolysaccharide / Endotoxin (LPS) Injections 
22 C57/Bl6 mouse pups at postnatal day 7 (P7) were randomly allocated to receive 
LPS (Escherichia coli, serotype 055:B5, Fluka) or vehicle (0.9% saline) intraperitoneal 
injections. Doses of 0.5  g/g (n=2), 2  g/g (n=3), 5  g/g (n=4), 10  g/g (n=5) and 20 
 g/g (n=4) LPS were used diluted in normal saline such that all animals received a 
single 10  l/g injection. The mice were then returned to their dams for 48 hours after 
which they were killed, perfused and brains extracted as described previously. A further 
5 animals receiving normal saline, and 9 receiving 10mg/kg LPS were assessed 5 days 
after injection. 
 
Hypoxia Ischemia  
21 C57/Bl6 mouse pups at postnatal day 7 (P7) underwent unilateral carotid artery 
occlusion followed by exposure to 8% oxygen for 30 minutes (n=5), 45 minutes (n=6) 
or 60 minutes (n=10) as described above. At 48 hours animals were killed and their 
brains extracted as described previously. A further six mice that underwent unilateral 
carotid artery occlusion and hypoxia for 30 minutes (n=3) or 60 minutes (n=3) were 
examined 28 days after the insult.   
 
Combined LPS – Hypoxia ischemia 
To explore the effect of endotoxin as a sensitising agent prior to hypoxia ischemia, 
differing doses of endotoxin (LPS) were given prior to hypoxia ischemia. 
 
Tissue Preparation 
48  hours after insult the  animals were  killed,  their brains  extracted, and amount of 
injury quantified as described before (see materials and methods).  
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Results 
Endotoxin 
Survival following endotoxin injection was almost 100% up to 10  g/g (100% 0 5  g/g, 
93%  10   g/g)  but  was  0%  at  a  dose  of  20   g/g.  At  48  hours  after  endotoxin 
administration no histological damage was seen on cresyl violet stained sections of the 
forebrain at any dose. TUNEL staining did not reveal any increase in TUNEL positive 
nuclei  compared  with  saline  treated  animals.  The  effect  of  endotoxin  was  then 
assessed  on  microglial  activation  using  αMβ2  integrin  (Raivich  et  al  1994).  Here 
increasing  doses  of  endotoxin  resulted  in  increasing  αMβ2  integrin  expression,  as 
quantified by optical luminosity values (OLV) using a mean S.D. algorithm as described 
before (Möller et al 1996) (see Figure3.1). At the highest dose (10  g/g) there was the 
focal appearance of small round non ramified, αMβ2 positive cells (arrows) in addition 
to  the  ramified  microglial  (hatched  arrows)  especially  in  the  cerebral  cortex  and 
thalamus (see Figures 3.2). 
 
Figure  3.1:  Effect  of  Increasing Doses  of Endotoxin  on  αMβ2 Staining Intensity.  Increasing 
doses of endotoxin resulted in increasing  αMβ2 integrin immunoreactivity at 48 hours, most 
notable in the cortex and hippocampus (p<0.05 ANOVA with post hoc Tukey) 
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Figure 3.2: Effect of Increasing Doses of Endotoxin on αMβ2 integrin Expression. A. Control, B. 
2  g/g, C. 5  g/g, D 10  g/g. At the highest dose (10  g/g) there was the focal appearance of 
small  round  non ramified,  αMβ2 positive  cells  (arrows)  in  addition  to  the  ramified  microglial 
(hatched arrows) especially in the cerebral cortex and thalamus.  
 
In an attempt to identify these small round non ramified, αMβ2 positive cells, further 
sections were stained for the microglial / macrophage marker IBA1 and for endogenous 
peroxidase using tyramide, a marker of granulocytes. 48 hours after 10  g/g LPS there 
were  some  endogenous  peroxidase positive  cells  suggestive  of  granulocyte  influx. 
IBA1 staining also revealed both ramified and non ramified cells within the thalamus 
and cortex similar to those seen with αMβ2, suggesting that some of these small round 
non ramified cells were of macrophage / microglial origin (see Figure 3.3).  
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Figure 3.3. Effects of LPS 10  g/g i.p. after 48 hours. A: Tyramide staining showed small round 
cells expressing endogenous peroxidase; inset high magnification view of cells with multi lobe 
nucleus  suggestive  of  granulocytes.  B.  IBA1  staining  demonstrated  both  ramified  (hatched 
arrows) and non ramified (arrows) IBA1 positive cells in the thalamus and cortex similar to those 
seen with αMβ2 staining 
 
Five days after injection with 10  g/g LPS there was no longer any increased in αMβ2 
immunoreactivity compared with saline treated animals, and the previously seen small 
round  non ramified  αMβ2  /IBA1  expressing  cells  were  no  longer  present.  Sections 
stained with cresyl violet showed no histological damage, and there was no increase in 
TUNEL positive cells compared with saline treated animals.  
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Hypoxia Ischemia 
Animal  survival  was  dependent  on  the  duration  of  hypoxia  after  carotid  occlusion; 
100%  survival  at  30  minutes,  83%  at  45  minutes  and  50%  at  60  minutes.  Infarct 
volume  was  measured  48  hours  following  hypoxia ischemia  in  animals  that  had 
undergone carotid occlusion and hypoxia for 30 minutes (n=5), 45 minutes (n=5) and 
60 minutes (n=5).   
 
Pattern of Brain Injury following Hypoxia Ischemia  
Histological sections stained with cresyl violet, immunohistochemistry for the microglial 
activation marker αMβ2 integrin, and DNA fragmentation using the TUNEL reaction 
were examined in animals exposed to carotid occlusion and 15   60 minutes hypoxia. 
The pattern and distribution of brain injury were noted. 
 
 
Cortex 
Histology (cresyl violet) showed no evidence of cortical damage following 30 minutes 
hypoxia ischemia; however, there were small focal areas of microglial activation with 
αMβ2 expressing ramified cells in 80% of animals. In animals exposed to 45 minutes 
hypoxia small foci of neuronal loss were evident, most commonly in the ventro lateral 
cortex in the region supplied by the middle cerebral artery. Similarly distributed cortical 
foci of activated microglia were present in all 5 animals.  Following 60 minute hypoxia 
ischemia, all 5 animals showed a large ipsilateral cortical infarct with sparing of the 
parasagittal region. Throughout the cortex, there were activated macrophages of both 
ramified and de ramified morphology demonstrating strong αMβ2 immunoreactivity.   
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Hippocampus 
In  animals  exposed  to  30  minutes  hypoxia  there  was  patchy  neuronal  loss  in  the 
pyramidal  cell  layer  of  the  hippocampus,  particularly  in  CA1 3.  αMβ2  integrin 
immunoreactive and TUNEL positive cells  were seen in the same area. There was 
consistent sparing of the dentate gyrus (see Figure 3.4). 
 
 
Figure  3.4:  Effect  of  Carotid  Occlusion  and  30  minutes  Hypoxia  on  the  Hippocampus  
A.  Microglial  activation  (αMβ2  integrin  immunoreactivity)  is  seen  in  the  ipsilateral  outer 
molecular and CA2 pyramidal cell layers. B. TUNEL staining shows DNA fragmentation in the 
pyramidal cell layer of the hippocampus.  
 
Following 45 minute hypoxia, more diffuse neuronal loss was seen in CA1 3, with a 
small  infarct  and  complete  neuronal  loss  in  CA1  seen  in  one  animal.  There  were 
associated diffuse activated microglia seen in CA1 3 and the outer molecular layer in 
all  animals.  Cells  were  predominantly  ramified,  although  occasional  de ramified 
phagocytic  cells  were  evident.  60 minute  hypoxia  produced  extensive  hippocampal 
infarcts with almost total tissue loss.   
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Striatum 
No evidence of histological damage was seen after 30 minutes of hypoxia. However, 
80%  of  animals  had  diffuse  activated  ramified  microglia  evident  throughout  the 
striatum. In animals exposed to 45 minute hypoxia there was diffuse loss of neurones 
with  a  generalised  decrease  in  neuronal  density  throughout  the  striatum.  This  was 
associated  with  more  extensive  activation  of  microglia,  and  occasional  de ramified 
phagocytic cells were observed. Following 60 minute hypoxia, diffuse loss of neurones 
progressed to the formation of a large infarct with predominantly de ramified phagocytic 
microglia present. 
 
Thalamus  
No histological damage was seen in the thalamus of animals that exposed to 30 or 45 
minutes  hypoxia.  Following  60 minute  hypoxia,  thalamic  infarcts  were  seen  in  the 
superio lateral  region  of  all  animals.  These  infarcts  were  associated  with  activated 
ramified microglia, and occasional de ramified phagocytes.   
 
White Matter Tracts 
No histological changes were evident in the white matter tracts with any duration of 
hypoxia. In 60% of animals that were exposed to 30 minute hypoxia, ramified microglia 
were  evident  in  the  ipsilateral  external  capsule.  TUNEL  staining  identified  DNA 
fragmentation in the ipsilateral layer 7 of the cerebral cortex and caudate putamen only. 
Electron  microscopy  of  the  microglia  within  the  external  capsule  demonstrated  the 
presence  of  amorphous  debris  within  vacuoles  suggesting  these  cells  were  active 
phagocytes. Electron microscopy was performed by Professor Raivich (see Figure 3.5).  
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Figure  3.5:  Effects  of  Carotid  Occlusion  and  30  minutes  of  hypoxia  on  Ipsilateral  External 
Capsule.  Microglial  activation  was  noted  in  the  external  capsule  (A).  TUNEL  staining 
demonstrated DNA fragmentation in the ipsilateral layer 7 of the cerebral cortex and caudate 
putamen  only  (B).  Electron  microscopy  revealed  amorphous  debris  within  the  cytoplasm  of 
activated  macrophage  in the external  capsule (C).  (Ctx   cortex,  E.C.   external  capsule,  Str  
striatum) 
 
More  diffuse  activated  microglia  were  present  in  all  animals  following  45 minute 
hypoxia with involvement of the corpus callosum seen in 1 animal. Diffuse ipsilateral 
αMβ2 immunoreactive cells were seen in the ipsilateral external capsule extending into 
the contralateral tract following 60 minutes of hypoxia. This contralateral activation was 
most  evident  adjacent  to  the  midline,  becoming  less  evident  laterally.  Activated 
microglia were also present in the anterior commisure in two of the five animals.   
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Quantification of Injury following Hypoxia ischemia  
Brain injury was first quantified using infarct volume measurements (see Chapter 3: 
Materials  and  Methods).  Overall,  the  separate  regions  of  the  forebrain  (cortex, 
hippocampus, striatum and thalamus) showed different sensitivity in their response to 
the carotid occlusion and hypoxia (F3,43=14.79 p<0.05) with damage particularly severe 
in  the  hippocampus  compared  with  the  cortex,  striatum  and  thalamus.  Increasing 
duration of hypoxia led to a significant increase in infarct volume (F2,57=101.81, p<0.05 
see Figure 3.6).  Using the post hoc Tukey test there was a significant difference in 
infarct volume between each of the three durations of hypoxia (p<0.05).  When each 
forebrain region was analysed separately, a similar overall increase in infarct volume 
was  seen:  cortex  F2,12=60.22,  p<0.05;  hippocampus  F2,12=20.69,  p<0.05;  thalamus 
F2,12=52.32, p<0.05; striatum F2,12=28.48, p<0.05. Post hoc analysis in these smaller 
sub samples revealed a statistically significant difference between 60 minute hypoxia 
infarct volumes and 30 or 45 minute hypoxia infarct volumes. The post hoc difference 
between 30 and 45 minute infarct volumes was not statistically significant.  
 
Figure 3.6: Increasing duration of hypoxia led to an overall increase in infarct volume (p<0.05 
ANOVA with post hoc Tukey).  A similar overall increase in infarct volume was seen when each 
region was analysed separately <0.05.   
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The animals were also analysed using the brain injury score (see Chapter 3: Materials 
and  Methods).  Here  again,  increasing  duration  of  hypoxia  resulted  in  a  statistically 
significant  worsening  of  the  overall  injury  score  (F2,43=216.4,  p<0.05  ANOVA)  (see 
Figure 3.7), with a significant difference between the three time points (p<0.05 post 
hoc Tukey). When each brain region was analysed separately there was the same 
increase  in  injury  score:  cortex  F2,12=651,  p<0.05,  hippocampus  F2,12=19.6,  p<0.05, 
thalamus  F2,12=54.875,  p<0.05  and  striatum  F2,12=48.875,  p<0.05.  As  with  infarct 
volume measurements, post hoc analysis revealed a statistically significant difference 
between 60 minute hypoxia and 30 or 45 minute hypoxia injury scores.  Similarly, the 
post hoc  difference  between  the  30  and  45  minute  scores  was  not  statistically 
significant,  most  likely  due  to  the  smaller  difference  in  scores  and  smaller  overall 
sample size. 
 
Figure 3.7: Effect of Increasing Duration of Hypoxia Following Carotid Occlusion.  Increasing 
duration of hypoxia led to an overall increase in injury  score (p<0.05 ANOVA with post hoc 
Tukey).    
103 
 
 To quantify the effect of hypoxia ischemia on the white matter of the external capsule, 
the  brain  the  white  matter  microglial  score  was  used  (see  under  Materials  and 
Methods). A score was allocated to each of the 5 histological sections per animal and 
then an average score calculated for each animal. In keeping with the findings from the 
infarct volume and brain injury score, increasing duration of hypoxia following carotid 
occlusion  resulted  in  increasing white matter microglial  activation score  (see Figure 
3.8b).  
 
 
 
Figure  3.8b:  Effect  of  Increasing  Duration  of  Hypoxia  on  White  Matter  Microglial  Activation 
Score.  Increasing  duration  of  hypoxia  following  carotid  occlusion  (CROC)  resulted  in  a 
statistically  significant  increase  in  white matter  microglial activation  score (* p<0.05  ANOVA 
followed by Tukey post hoc) 
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Long term effects of Carotid Occlusion and Hypoxia  
 
To assess the long term histological outcome following hypoxia ischemia a further six 
animals that underwent unilateral carotid artery occlusion and hypoxia for 30 minutes 
(n=3) or 60 minutes (n=3) were examined 28 days after the initial insult.   
 
Carotid occlusion and 30 minutes Hypoxia at 8% oxygen: 
Patchy  neuronal  loss  was  seen  in  the  pyramidal  cell  layer  of  the  hippocampus 
especially  within  CA1  and  2  on  cresyl  violet  staining.  Of  note  there  was  complete 
preservation of the dentate gyrus in all animals. This preservation still occurred despite 
almost complete loss of the remaining hippocampal tissue in one animal.  Staining for 
myelin  basic  protein  (MBP)  showed  no  disruption  of  myelination  and  normal 
architecture  of  the  white  matter  tracts.  No  differences  were  noted  in  MBP  staining 
between the injured and uninjured hemispheres.   
 
Carotid occlusion and 60 minutes Hypoxia at 8% oxygen: 
A large porencephalic cyst replaced the large infarcted areas seen at 48 hours after 
injury, when examined at 28 days after hypoxia ischemia (see Figure 3.9).  Complete 
absence of hippocampal tissue, except for the dentate gyrus, was seen in all animals. 
Extensive loss of cortical tissue was evident and the ventral lateral nuclear complex of 
the thalamus was absent.  Staining for myelin basic protein revealed severe disruption 
of  the  external  capsule  white  matter  tract  and  complete  loss  of  myelin  from  the 
inferolateral cortex (see Figure 3.9 B). Myelin was also absent from the cortex ventral 
to the cystic spaces. Staining with GFAP revealed extensive astrogliosis and scarring 
in the cortex, particularly lateral to the cystic space and lining the porencephalic cyst 
(see Figure 3.9 C).        
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Figure  3.9:  Effects  of  permanent  left  carotid  occlusion  and  exposure  to  8%  oxygen  for  60 
minutes at 28 days.  
A. Cresyl violet staining shows extensive infarction in the cortex, hippocampus thalamus and 
striatum previously seen at day 2 has been removed leaving a large porencephalic cyst. There 
is complete loss of the hippocampus and striatum, extensive loss in the cortex, and loss of 
ventrolateral thalamic nuclei.  
B. Immunohistochemistry for myelin basic protein reveals disruption of the external capsule and 
complete loss of myelin from the inferolateral cortex.  
C. Immunohistochemistry for glial fibrillary acidic protein demonstrates extensive astrogliosis in 
the cortex and lining the large porencephalic cyst. 
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Combined Endotoxin and Hypoxia Ischemia 
 
Animals were given saline (n=5) or endotoxin (0.1  g/g n=6, 0.3  g/g n=6, 1  g/g n=4) 
4 hours prior to carotid occlusion and hypoxia at 8% oxygen for 30 minutes. Survival 
was dependent on the dose of endotoxin given; 100% in saline treated animals, 83% 
0.1  g/g, 67% at 0.3  g/g and 25% at 1  g/g (see Figure 3.10) 
 
 
Figure 3.10: Survival in Animals Exposed to Saline or Endotoxin (0.1 1  g/g) 4 hours prior to 
Carotid Occlusion and 30 minutes at 8% Oxygen.  
 
Pretreatment with 0.3  g/g endotoxin 4 hours prior to carotid occlusion and hypoxia 
resulted  in  increased  histological  damage  compared  to  saline  pre treated  animals. 
When damage was quantified using brain volume measurements, there was increased 
injury in all forebrain regions measured (cortex, hippocampus, striatum and thalamus). 
Overall,  pretreatment  with  0.3   g/g  endotoxin  at  4  hours  prior  to  hypoxia ischemia 
resulted in a highly significant increase in infarct volume F3,19=6.37 p<0.01 (ANOVA) 
see Figure 3.11  
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Figure 3.11: Effect of 0.3  g/g LPS 4 hours prior to Carotid Occlusion and 30 minutes 8% 
Oxygen.    A.  Effects  of  hypoxia ischemia  alone  and  4  hours  following  LPS  pre treatment. 
Hypoxia ischemia alone caused focal cortical (Ctx) damage (arrows) and loss of neurones from 
the pyramidal cell layer of the hippocampus (Hip). LPS pretreatment resulted in a large cortical 
infarct (dashed arrows) and increased damage in the hippocampus, thalamus (Thl) and striatum 
(Str). There was a resultant increase in size of the lateral ventricle (LV). B. LPS pretreatment 
resulted  in  an  overall  sensitising  effect  to  hypoxia ischemia  with  increased  infarct  volume 
expressed as percentage of contralateral hemisphere F3,19=6.37 p<0.01  
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Discussion 
The effects of systemic endotoxin (LPS) on the developing brain 
Intra  peritoneal  injections  of  endotoxin  (LPS)  result  in  increased  αMβ2  integrin 
immunoreactivity on microglia within the brain of P7 mice at 48 hours post injection. 
Doses of endotoxin of 10  g/g and below were well tolerated; however, injections of 20 
 g/g  were  lethal.  The  time point  of  study  (48  hours  post  injection)  was  chosen  as 
previous studies have demonstrated that subcutaneous LPS injections in adult mice 
produce  a  dose dependent  increase  of  microglial  αMβ2  immunoreactivity  with  a 
maximal effect at 2 days after injection (Kloss et al 2001). The current study shows a 
similar response in αMβ2 integrin immunoreactivity in the neonatal mouse at doses 
between 0.5  g/g and 5  g/g. Morphologically this staining is consistent with increased 
microglial  αMβ2  expression.  At  a  dose  of  10   g/g,  in  addition  to  strongly 
immunoreactive  ramified  microglia,  there  were  multiple  small,  round  cells  seen 
especially within the cortex and thalamus which also stained strongly for αMβ2 integrin. 
In the control animals there was a slight variability in αMβ2 integrin expression across 
the different forebrain regions with greatest immunoreactivity in the hippocampus and 
least in the thalamus. This pattern of distribution is generally conserved with increasing 
doses of LPS; however, at doses of 5  g/g and 10  g/g cortical staining is especially 
increased. Some of the observed increase in cortical staining seen at 10  g/g (when 
staining intensity exceeds that of the hippocampus) is accounted for by the presence of 
the  small,  round  strongly  staining  cells.  Previous  studies  have  demonstrated  that 
microglial transformation into mature phagocytes is a multi stage process characterised 
by changes in morphology and cell surface markers (see Figure 3.12). This pattern of 
activation has been studied and characterised in mouse microglial monolayers using a 
co culture on top of a confluent astrocyte monolayer (Raivich et al 1999, Kloss et al 
2001).   
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Figure 3.12: Stages of activation of microglia. In the resting microglia there is a highly branched 
(ramified)  cell.  The  active  or  alert  phenotype  shows  a  reduction  in  complexity  of  branched 
structure and increase in αMβ2 immunoreactivity. Phagocytic microglia are deramified cells with 
an amoeboid morphology. Patterns of cell surface markers are also shown (w) weak staining 
(m)  moderate staining (s) strong staining (adapted from Raivich et al 1999) 
 
In this in vitro model, addition of LPS to cultured microglia resulted in a morphological 
activation of the cells with an increase in the α5, α4, αM and β1 immunoreactivity, and 
a decrease in α6 immunoreactivity. However, even after treatment with a sub lethal 
dose of LPS there was no increase in the phagocyte associated integrin  αXβ2 and 
there was no transformation of the ramified microglia into amoeboid phagocytes (Kloss 
et al 2001). In contrast, addition of brain membranes to the microglial monolayer led to 
rapid microglial deramification and transformation to small, rounded, macrophages with 
first  effects  at  1 3  hours,  and  full  transformation  at  24 48  hours.  Removal  of  cell 
membranes led to a similarly rapid process of re ramification. In this study, the small 
de ramified microglia were demonstrated to be phagocytic, with uptake of fluorescent 
labelled brain membranes, whereas there was no uptake into microglia with a ramified 
morphology (Bohatschek et al 2001).  
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It must be noted, however, that αMβ2 integrin may also be expressed on monocytes 
and  granulocytes;  therefore,  in  the  current  study  an  alternative  explanation  for  the 
presence of the small round de ramified cells would be the recruitment of peripheral 
white  blood  cells  into  the  brain.  Granulocytes  are  not  normally  found  within  brain 
parenchyma, but their entry into the damaged central nervous system is a common 
feature in several brain pathologies. Granulocyte recruitment has been described in 
infection,  stroke,  and  trauma.  Activated  granulocytes  contain  a  large  number  of 
cytotoxic  molecules  and  proteases,  and  play  an  important  role  in  the  phagocytic 
removal of pathogens and cellular debris, and in fighting infection within the central 
nervous system (Bohatschek et al 2001). Intraperitoneal injection of LPS in adult mice 
has previously been shown to result in the recruitment of granulocytes into the central 
nervous  system  with  maximal  effect  noted  between  1  and  4  days  after  injection.  
Furthermore these cells have been demonstrated to be blood borne in origin by pre 
labeling of circulating leukocytes using rhodamine B isothiocyanate (RITC) 48 h before 
the LPS injection.  In  this study, following LPS injection there was  co localisation of 
RITC and endogenous peroxidase, identifying these cells as granulocytes recruited into 
the  CNS  (Bohatschek  et  al  2001).    In  the  current  study,  in  order  to  consider  the 
possibility of granulocytes accounting for the small round αMβ2 immunoreactive cells 
seen in the forebrain of the neonatal mouse 48 hours after 10  g/g LPS, sections were 
stained for endogenous peroxidase using biotinylated tyramide. Biotinylated tyramide 
identified some granulocyte infiltration in the cortex, but only a few granulocytes within 
the  thalamus.  Of  note,  at  lower  doses  of  endotoxin  these  cells  were  not  seen. 
Therefore, whilst granulocytes are recruited into the brain of neonatal mice exposed to 
high dose  endotoxin  the  relatively  small  number  of  peroxidase positive  cells  seen 
suggests that some of the cells may indeed be phagocytic de ramified microglia. To 
confirm  this  hypothesis  immunohistochemical  staining  with  IBA1,  a  marker  of 
macrophages,  microglia  and  other  monocyte related  cell  types,  was  used.  Here  in 
addition  to  ramified  microglia,  multiple  non ramified  IBA1 positive  small  round  cells 
were seen in the cortex and thalamus in a similar pattern to that seen in the tissue  
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stained  for  αMβ2  integrin.  This  provides  further  evidence  that  these  cells  were  of 
monocyte  /microglia  lineage.  As  discussed  previously,  de ramification  of  resting 
microglia  to  amoeboid  phagocytes  requires  the  presence  of  debris  such  as  cell 
membranes  (Bohatschek  et  al  2001).  However,  the  current  study  was  unable  to 
demonstrate tissue damage as defined by TUNEL positive cells or histological injury. 
This raises the possibility that the observed cells are monocytes recruited from the 
peripheral blood, although the current study is unable to confirm this identity. 5 days 
after injection with 10  g/g LPS there was no increase in αMβ2 immunoreactivity over 
control, and no evidence of histological brain injury or TUNEL positive cells. There was 
also no persistence of the strongly activated microglia or the rounded αMβ2 / IBA1 
immunoreactive cells. This suggests that there is no ongoing injury following the initial 
microglial changes noted at 48 hours.  
 
These data, therefore, suggest that administration of systemic low dose LPS (0.5  g/g 
– 5  g/g) results in activation of microglia from a resting to alert / active phenotype 
without  de ramification  to  a  phagocytic  morphology,  without  evidence  of  neuronal 
damage and without evidence of recruitment of peripheral white blood cells into the 
central nervous system. Sublethal systemic LPS (10  g/g) additionally results in small 
round  αMβ2  immunoreactive  cells,  the  majority  of  which  also  stain  with  IBA1 
suggesting microglial / monocyte lineage. In the absence of evidence of histological 
neuronal damage, it is possible that these represent recruitment of peripheral blood 
monocytes.  Additionally,  there  is  also  recruitment  of  peripheral  blood  granulocytes 
which  stain  for  both  endogenous  peroxidase  and  αMβ2  integrin.  By  5  days  after 
systemic  LPS  administration  (10   g/g)  there  were  no  changes  identifiable  on 
histological examination (Nissl), TUNEL staining or αMβ2 immunohistochemistry.  
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Histological Effects of Carotid Occlusion and Timed Hypoxia  
Carotid occlusion and timed hypoxia at 8% oxygen in the mouse at postnatal day 7 
results in reproducible, duration related injury in the cortex, striatum, hippocampus and 
thalamus. There was a highly significant increase in the forebrain infarct size and injury 
score with increasing duration of hypoxia. Subjectively, long term histological outcome 
reflected the injury seen 48 hours post hypoxia ischemia. These data are consistent 
with previous studies which show increasing infarct volume with increasing duration of 
hypoxia  following  carotid  occlusion  (Rice  et  al  1981).  Previous  studies  have 
demonstrated that carotid ligation or hypoxia individually do not result in histological 
brain injury. However, when used in combination, brain injury occurs (Rice et al 1981). 
The current data also demonstrate a spectrum of  injury  with  increasing  duration of 
hypoxia, including damage to the cortex, hippocampus, thalamus, striatum and white 
matter. In the current study, there was a statistically significant difference between all 
three time points when quantified using infarct volume as well as injury score, when 
each  of  the  forebrain  regions  were  considered  together.  When  each  region  was 
analysed  separately,  on  post hoc  analysis,  there  was  still  a  statistically  significant 
difference  between  60 minute  hypoxia  and  30  or  45 minute  time points  for  infarct 
volume and injury scores. However, the post hoc difference between 30 and 45 minute 
scores and infarct volumes was not statistically significant probably due to the small 
sample size.  
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Histological  assessment  of brain injury  shows  a  close correlation between  areas of 
neuronal loss at both 2 and 28 days and changes in microglia at 2 days, with increased 
αMβ2  immunoreactivity,  de ramification  and  transformation  into  phagocytes.  As 
discussed previously, this de ramification only occurs in the presence of cell debris and 
is therefore likely to be a response to cell death in the forebrain. Within the white matter 
tracts of the corpus callosum and external capsule there are no neuronal cell bodies. 
However,  following  hypoxia ischemia  de ramified,  αMβ2  strongly  immunoreactive 
phagocytes were noted within these white matter tracts. Electron microscopy showed 
these phagocytes to contain vacuoles of amorphous debris further strengthening the 
suggestion that this transformation is a response to cell debris. Unsurprisingly, in the 
absence of neuronal cell bodies, there were no TUNEL positive nuclei noted within 
these  white  matter  tracts.  It  can  be  speculated  that  the  debris  could  be  damaged 
axons,  which  have  been  subsequently  phagocytosed  by  de ramified microglia.  This 
may  also  help  to  explain  the  presence  of  activated  microglia  extending  into  the 
contralateral tract with activation most evident adjacent to the midline and becoming 
less evident laterally. Alternatively, the presence of activated microglia within the white 
matter tracts in the absence of TUNEL positive nuclei may result from the presence of 
dead or damaged cells of the oligodendrocyte lineage without DNA fragmentation. In 
keeping with previous studies (Liu et al, 2002), the current study suggests increasing 
white matter damage with increasing duration of hypoxia (as measured by white matter 
injury score at 48 hours and dysruption in the normal pattern of myelin basic protein 
staining seen at 28 days). 
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Histological  examination  at  28  days  after  hypoxia ischemia  revealed  the  extent  of 
neurological damage to be similar to that observed at 2 days after insult. There was no 
ongoing microglial activation at this late time point. These data suggests that there is 
no progression of brain injury after 48 hours, but there is a maturation of the infarcted 
area  with  phagocytosis  of  dead  tissue,  formation  of  a  porencepahlic  cyst,  and  an 
associated  astrogliosis.  Consistently  there  was  also  enlargement  of  the  lateral 
ventricle, which may represent a compensation for loss of tissue volume in the injured 
hemisphere.  
 
Combined Effects of Endotoxin and Hypoxia Ischemia 
In this pilot study, low dose of intra peritoneal endotoxin given 4 hours prior to hypoxia 
ischemia dramatically increased the lethality of the hypoxic ischemic protocol. Survival 
was dependent on the dose of endotoxin, and for subsequent studies a dose of 0.3 
 g/g was used as this resulted in 67% survival. In comparison to animals pre treated 
with saline, endotoxin had a highly significant sensitising effect on brain injury occurring 
after carotid occlusion and hypoxia at 8% oxygen for 30 minutes. This observation is in 
keeping  with  a  number  of  previous  studies  (Eklind  et  al  2001)  and  was  consistent 
across all forebrain regions assessed. This sensitisation phenomenon will be explored 
further in Chapters 4 and 5.  
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Conclusion 
Carotid occlusion and timed hypoxia in the neonatal mouse at postnatal day 7 provides 
a reproducible model of hypoxic ischemic brain injury. The current study suggests early 
histological  outcome,  as  measured  by  infarct  volume  or  brain  injury  score,  to  be 
representative of long term histological outcome. Previous studies have demonstrated 
a correlation between long term histological outcome and neuro functional deficit (Ten 
et  al  2004).  This,  therefore,  suggests  that  early  histological  assessment  may  be  a 
valuable correlate of long term neurodevelopmental outcome, and provides an early 
measure appropriate for further assessment of neuro sensitising and neuro protective 
agents in the context of hypoxic ischemic brain injury.  
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Chapter 4: Inflammatory Sensitisation of the Developing Brain to Hypoxia 
Ischemia 
 
Introduction 
Maternal  /  fetal  infection  has  been  postulated  as  an  important  mediator  in  the 
development of perinatal brain injury. Epidemiological studies suggest maternal / fetal 
infection,  inflammation  and  possibly  endotoxin mediated  cytokine  release  as 
antecedent factors in the development of white matter injury in preterm neonates (Wu 
and  Colford  2000,  Volpe  2001,  Duncan  et  al  2002).  In  the  term  neonate,  a  meta 
analysis  considering  clinical  chorioamnionitis  and  cerebral  palsy  gave  a  summary 
relative risk of 4.7 (95% CI 1.3 16.2) (Wu and Colford 2000) based on two studies 
(Nelson  and  Ellenberg  1985,  Grether  and  Nelson  1997).  A  study  of  histological 
chorioamnionitis  in  neonates  with  neurological  impairment  showed  a  significant 
independent association (OR 13.2; 95% CI 1.2 144) (Redline and O’Riordan 2000). 
Additionally intrapartum fever has been shown to be independently associated with an 
increased risk of development of unexplained neonatal seizures (a strong predictor of 
neurological impairment in term infants) (OR 3.4 95%CI 1.03 10.9) (Lieberman et al 
2000) and neonatal encephalopathy (OR 4.72, 95% CI 1.28 17.4) (Impey et al 2001). 
 
Animal  studies  have  shown  that  either  whole  bacteria  or  endotoxin  can  result  in 
neonatal  brain  injury  when  administered  at  critical  periods  of  neurodevelopment 
(Hagberg  et  al  2002).  Endotoxin  may  be  active  via  the  transplacental  route  as 
demonstrated  by  the  administration  of  a  bolus  dose  of  endotoxin  to  pregnant  rats 
resulting  in  failure  of  cerebral  myelination  in  their  offspring  (Cai  et  al  2000).  The 
developing  brain  appears  to  be  particularly  sensitive  to  infection  when  it  is  at  a 
premyelination stage of maturation. This maturation dependent susceptibility is partly 
due the vulnerability of oligodendrocyte precursors to a variety of pro apoptotic stimuli, 
including pro inflammatory cytokines (Volpe 2001).    
117 
 
More recently, research has focused on the possible role of infection / inflammation in 
sensitising the developing brain to subsequent hypoxia ischemia (Peebles and Wyatt 
2002). Epidemiological data suggests that exposure to a combination of infection and 
hypoxia–ischemia  dramatically  increases  the  risk  of  developing  cerebral  palsy 
compared  with  either  event  alone  (OR  78;  95%  CI  4.8–406)  (Nelson  and  Grether 
1998). Rodent models have used endotoxin (lipopolysaccharide) as an inflammatory 
stimulus to sensitise the developing brain, and hence dramatically increase the lesion 
size following hypoxic–ischemia. This effect is seen when endotoxin is administered 
systemically, and or intracisternally (Eklind et al 201, Yang et al 2004, Coumans et al 
2003). In these models, the time interval between the inflammatory stimulus and the 
hypoxic ischemic  insult  has  been  shown  to  be  critical  in  the  sensitisation  of  the 
developing brain (Eklind 2005).  The mechanism of the interaction between endotoxin 
mediated inflammation, and hypoxia ischemia remains unclear, although studies have 
highlighted the role of microglia, specifically the Toll like receptor TLR4 (Lenhardt et al 
2003). Another mechanism by which endotoxin may sensitise the brain to subsequent 
hypoxia ischemia involves an opening of the blood brain barrier possibly mediated by 
inflammatory cytokines. Previous studies have shown that in adult animals systemic 
endotoxin opens the blood brain barrier allowing the passage of large proteins such as 
albumin  from  the  circulation  into  the  brain;  endotoxin  also  mediates  an  influx  of 
granulocytes into the brain via an ICAM1 dependent pathway (Bohatschek et al 2001). 
 
In order to study the interaction of inflammation and hypoxia ischemia a time course 
was  undertaken,  the  time  interval  between  endotoxin  administration  and  hypoxia 
ischemia  being  varied  to  establish  the  interval  that  resulted  in  maximal  histological 
brain injury. In an attempt to clarify the mechanism of interaction, cellular and vascular 
responses were examined following treatment with endotoxin alone, and the timing of 
the  responses  compared  to  the  time point  of  maximal  sensitisation  for  subsequent 
hypoxia ischemia. The effects of endotoxin on the integrity of the blood brain barrier 
were also studied.  
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Materials and Methods 
 
Endotoxin Hypoxia Ischemia Time course  
56 C57/Bl6 mouse pups at postnatal day 7 (P7) underwent unilateral carotid artery 
occlusion  followed  by  exposure  to  8%  oxygen  for  30  minutes.  Animals  were 
sequentially allocated to receive LPS (Escherichia coli, serotype 055:B5, Fluka) 0.3 
 g/g 0 hours  (n=12),  4 hours (n=12), 12  hours (n=11), or  24 hours  (n=11) prior to 
operation, or to receive vehicle (normal saline) 4 hours prior to operation (n=10). LPS 
injections were diluted in normal saline such that all animals received a single 10  l/g 
injection. The mice were then returned to their dams for 48 hours after which they were 
killed,  perfused,  and  their  brains  extracted  and  processed  as  described  previously, 
Sections were stained using cresyl violet and immunohistochemistry for αMβ2 integrin 
for injury quantification by infarct volume and injury score as described previously (see 
under General Materials and Methods).  
 
Endotoxin Time course  
The  brains  of  47  C57/Bl6  mice  at  postnatal  day  7  were  examined.  Animals  were 
sequentially allocated to receive LPS (Escherichia coli, serotype 055:B5, Fluka) 0.3 
 g/g, 0.5  g/g or vehicle (normal saline), 4 hours (0.3  g/g LPS n=5, 0.5  g/g LPS n=5, 
saline n=5), 12 hours (0.3  g/g LPS n=5, 0.5  g/g LPS n=5, saline n=5), or 24 hours 
(0.3  g/g LPS n=4, 0.5  g/g LPS n=4, saline n=4) prior to being culled. 5 naive  control 
animals  were  also  studied.  As  before,  all  injections  were  at  a  volume  of  10   l/g. 
Following  injections  the  mice  were  returned  to  their  dams  until  they  were  killed, 
perfused,  and  their  brains  extracted  as  described  previously  (see  under  General 
Materials and Methods). In order to study the effects of low dose endotoxin on different 
cell  populations,  sections  were  stained  using  immunohistochemisty  for  microglial 
activation (integrins α5, α6, αM, αX, β2, and the phagocytic marker IBA1) astrocyte  
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activation (CD44, GFAP), and vascular endothelial up regulation (ICAM 1, VCAM 1, α5 
and α6 integrins). Immunohistochemistry was performed as described previously (see 
under General Materials and Methods). 
Blood Brain Barrier Integrity 
 
In order to study the effects of endotoxin on the blood brain barrier, 18 C57/Bl6 mice 
were studied. Animals received an intra peritoneal injection at postnatal day 6 of 50  L 
10% human albumin (HAS) (Sigma) (n=7), 50  L of 10% human IgG (HIgG) (Sigma) 
(n=7)  or  50 L  of  normal  saline  (n=3).  24  hours  later,  animals  received  a  further 
injection of LPS (Escherichia coli, serotype 055:B5, Fluka) 0.3  g/g or vehicle (normal 
saline). The overall groups consisted of HAS – LPS (n=4), HAS – saline (n=3), saline – 
LPS (n=4), HIgG – LPS (n=4), HIgG – saline (n=3). 12 hours after the second injection, 
animals  were  killed,  perfused,  and  their  brains  extracted  as  described  previously. 
Histological  sections  were  stained  for  human  albumin  and  human  immunoglobulin 
using immunohistochemistry (see under General Materials and Methods).  
120 
 
Results 
 
Endotoxin Hypoxia  Ischemia Time Course 
The overall survival in the endotoxin hypoxia ischemia time course was 60% at time of 
perfusion  (48hours).    Highest  lethality  was  seen  in  animals  receiving  endotoxin 
immediately  prior  to  carotid  occlusion  (survival  4/12  (33%))  and  there  was  a  trend 
towards reduced mortality in animals with longer time intervals between endotoxin and 
subsequent hypoxia ischemia (see Figure 4.1). 
 
Infarct volume was measured as described before and expressed as percentage of the 
contralateral uninjured hemisphere.  Overall, a sensitising effect of endotoxin on the 
brain to subsequent hypoxia ischemia was seen within a time window of 4 12 hours 
before the onset of hypoxia, and was maximal when LPS was administered 12 hours 
prior to hypoxia ischemia (see Figure 4.2). 
 
 
Figure 4.1: Effect of Increasing Interval between Endotoxin and Hypoxia ischemia on Survival. 
Increasing the interval between endotoxin and hypoxia ischemia resulted in increasing survival 
to  48  hours.  Dose  intervals  of  12  and  24 hours resulted in  increased  survival  compared  to 
animals pretreated with normal saline 4 hours prior to hypoxia ischemia (control).  
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Figure 4.2: Effect of Increasing Interval between Endotoxin and Hypoxia ischemia on Infarct 
Volume. Endotoxin pretreatment resulted in increased forebrain damage when administered 4 
hours (n=6) and 12 hours (n=9) before hypoxia ischemia but not at 0 hours (n=4, p=0.81) or 24 
hours (n=9, p=0.16). (* p<0.05 by ANOVA with post hoc Tukey) 
 
When  the  individual  forebrain  regions  were  examined  there  was  a  trend  towards 
sensitisation  in  all  forebrain  regions  assessed  (cortex,  hippocampus,  thalamus  and 
striatum). The time course of sensitisation was the same across all forebrain regions 
with greatest level of injury seen when endotoxin was administered 12 hours prior to 
hypoxia ischemia. This analysis in the smaller sub samples did not reach statistical 
significance (see Figure 4.3).  
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Figure 4.3: Effect of Increasing Interval between Endotoxin and Hypoxia ischemia on Regional 
Infarct Volume. In all brain regions greatest brain injury was seen when LPS was administered 
12 hours prior to hypoxia ischemia  
 
Brain injury was also quantified using injury scores. Here again the same pattern of 
sensitisation was seen maximally at 12 hours with similar time course in all regions a 
trend  towards  reduced  brain  injury  was  noted  when  endotoxin  was  administered 
immediately before hypoxia ischemia. In the animals treated with endotoxin 24 hours 
prior to hypoxia ischemia sensitisation was no longer seen (see Figures 4.4 and 4.5). 
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Figure 4.4: Effect of Increasing Interval between Endotoxin and Hypoxia ischemia on Injury 
Score. Endotoxin pretreatment prior to hypoxia ischemia resulted in increased forebrain injury 
score maximal at 12 hours prior to hypoxia ischemia  p<0.05 ANOVA with post hoc Tukey 
 
On post hoc Tukey analysis only the 12 hour hypoxia was significantly increased over 
control (p<0.05). Of note, however, there was an apparent reduction in injury when 
endotoxin  was  administered  immediately  before  hypoxia ischemia  (P<0.05).  When 
compared to the 0 hour group there was a significant increase in injury score when 
endotoxin was administered 4 and 12 hours before hypoxia ischemia (p<0.05) but not 
24 hours prior to hypoxia ischemia (p=40) ANOVA with post hoc Tukey.  
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Figure 4.5: Effect of Increasing Interval between Endotoxin and Hypoxia ischemia on Regional 
Injury Score. In all brain regions greatest brain injury was seen when LPS was administered 12 
hours prior to hypoxia ischemia  
 
As noted previously, immunohistochemistry for αMβ2 integrin also revealed increased 
microglial  immunoreactivity  in  the  white  matter  of  the  corpus  callosum  and  internal 
capsule. In an attempt to quantify this effect, a second scoring system was used as 
previously  described  (see  Materials  and  Methods).  Pretreatment  with  endotoxin 
resulted in an increase in αMβ2 integrin immunoreactivity in the external capsule (see 
Figure 4.6). The effect was seen when endotoxin pretreatment occurred 4 hours and 
12 hours prior to hypoxia ischemia.  
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Figure 4.6: Effect of Increasing Interval between Endotoxin and Hypoxia ischemia on White 
Matter  Microglial  Activation  Score.    There  was  a  significant  increase  in  microglial  αMβ2 
immunoreactivity in animals pre treated with endotoxin 4 hours (p<0.05) and 12 hours (p<0.05) 
prior to mild hypoxia ischemia but not when pretreatment occurred immediately  or 24 hours 
prior to hypoxia ischemia (one way ANOVA with post hoc Tukey). 
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Endotoxin Alone Time Course 
In  order  to  examine  the  cellular  events  that  occur  during  the  sensitisation  phase 
following endotoxin, immunohistochemistry for α5, α6, αM, αX, and β2 integrins (IBA1; 
CD44)  GFAP,  ICAM  1,  and  VCAM  1  was  carried  0,  4  12  and  24  hours  after 
administration of endotoxin alone (see Figure 4.9). All animals survived the protocol; 
data were analysed using ANOVA with post hoc Tukey.  
 
No significant difference in immunoreactivity was seen for α5 integrin, αX integrin or 
GFAP at any time point in animals treated with 0.3  g/g or 0.5  g/g (see Figure 4.9). 4 
hours after administration of endotoxin there was an increase in α6 immunoreactivity 
with  0.5   g/g  (p<0.05);  although  there  was  a  trend  towards  increased  α6 
immunoreactivity with 0.3  g/g this did not reach statistical significance (p=0.12). At 4 
hours  after  administration  of  endotoxin  there  was  also  an  increase  in  ICAM1 
immunoreactivity in  animals treated with  0.3  g/g and 0.5   g/g compared to saline 
treated animals. This immunoreactivity was seen in a pattern consistent with vascular 
endothelium (see Figure 4.7). 
 
Figure  4.7:  Effect  of  0.5   g/g  Endotoxin  on  ICAM  1Immunoreactivity  at  12  hours.  
Immunoreactivity was increased in a pattern consistent with vascular endothelium throughout 
the forebrain (here shown in the hippocampus.  
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12 hours after endotoxin administration there was increased immunoreactivity in αMβ2 
integrin  in  animals  treated  with  0.3   g/g  (p<0.05)  but  not  0.5   g/g  (p=0.33). 
Histologically this immunoreactivity was seen in a pattern consistent with microglia (see 
Figure 4.8). Similarly, there was increased immunoreactivity in β2 integrin in animals 
treated with 0.3  g/g (p<0.05) but not 0.5  g/g (p=0.79). IBA1 immunoreactivity was 
reduced 12 hours after endotoxin, this change was statistically significant in animals 
treated with 0.5  g/g (p<0.05) but not 0.3  g/g (p=0.18). 
 
By 12 hours after endotoxin administration, ICAM1 immunoreactivity was increased in 
animals  treated  with  0.5   g/g  (p<0.05),  a  trend  towards  increased  ICAM1 
immunoreactivity was also seen at 0.3  g/g but this did not reach statistical significance 
(p=0.06). Similarly VCAM1 immunoreactivity 12 hours after endotoxin administration 
was increased in animals treated with 0.5  g/g (p<0.05); a trend towards increased 
ICAM1 immunoreactivity was also seen at 0.3  g/g but this did not reach statistical 
significance (p=0.06).  
 
Figure  4.8:  Effect  of  0.3   g/g  Endotoxin  on  αMβ2  Immunoreactivity  at  12  hours.  
Immunoreactivity was seen to localise to ramified cells with the appearance of microglia. 
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24  hours  after  endotoxin  administration  there  was  only  increase  in  α6  integrin 
immunoreactivity in animals treated with 0.3 and 0.5  g/g (p<0.05) (see Figure 4.9). 
 
Figure 4.9: Effect of Endotoxin on Immunoreactivity at 4, 12 and 24 hours. Immunoreactivity 
was measured using mean – standard deviation algorithm (see Materials and Methods) *p<0.05 
ANOVA with post hoc Tukey.  
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Blood Brain Barrier Integrity 
Pre treatment with 50  L 10% human albumin (HAS) 24 hours prior to either LPS or 
saline  resulted  in  a  statistically  significant  in  human  albumin  immunoreactivity 
throughout the forebrain both overall, and when each forebrain region was assessed 
individually. Post hoc analysis (Tukey) however demonstrated that this effect was the 
same  in  animals  treated  subsequently  with  LPS  or  control  and  that  there  was  no 
statistical  difference  if  animals  were  treated  with  LPS  or  saline  (see  Figure  4.10). 
Similarly pre treatment with 50  L 10% human IgG (HIgG) 24 hours prior to either LPS 
or saline resulted in a statistically significant in HIgG immunoreactivity throughout the 
forebrain both overall and when each forebrain region was assessed individually. Post 
hoc analysis (Tukey) however demonstrated that this effect was the same in animals 
subsequently treated with LPS or control (see Figure 4.10)  
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Figure  4.10:  Effect  of  Endotoxin  on  the  Integrity  of  the  Blood brain  Barrier.  A:  animals 
pretreated  with  saline  of  human  albumin  solution  (HAS)  24  hours  prior  to  saline  or  LPS 
injections.  Pretreatment  with  HAS  led  to  a  significant  increase  in  HAS  immunoreactivity  in 
animals subsequently treated with saline or LPS (p<0.05). There was no significant difference in 
the HAS immunoreactivity between animals subsequently treated with saline or LPS. B: animals 
pretreated  with  saline  of  human  immunoglobulin  (HIgG)  24  hours  prior  to  saline  or  LPS 
injections.  Pretreatment  with  HIgG  led  to  a  significant  increase  in  HIgG  immunoreactivity  in 
animals subsequently treated with saline or LPS (p<0.05). There was no significant difference in 
the HAS immunoreactivity between animals subsequently treated with saline or LPS.  
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Discussion 
 
Effects  of  Combined  Systemic  Endotoxin  and  Hypoxia  Ischemia  on  the 
Developing Brain 
Pretreatment  with  low  dose  systemic  endotoxin  sensitises  the  brain  to  subsequent 
hypoxia ischemia  when  administered  between  4  and  12  hours  before  hypoxia 
ischemia.  Significant  sensitisation  was  not  seen  when  endotoxin  was  administered 
immediately, or 24 hours before hypoxia ischemia. The overall survival in this study 
was 60% although this ranged in the different groups from 33% when endotoxin was 
administered  immediately  before  hypoxia ischemia  to  82%  when  endotoxin  was 
administered  12  or  24  hours  prior  to  hypoxia ischemia.  This  sensitisation  was 
statistically significant when injury was quantified using infarct volume. A similar time 
course  of  sensitisation  was  seen  when  injury  was  assessed  using  the  previously 
described  brain  injury  score;  however,  these  results  did  not  reach  statistical 
significance using the Student t test, possibly reflecting the relatively small sample size. 
It is likely that, following systemic endotoxin administration, a sequence of events occur 
possibly including the release of pro inflammatory cytokines, and time is required to 
sensitise the brain to subsequent hypoxia ischemia. These data suggest that the time 
interval between inflammatory and hypoxic ischemic insults is critical in defining the 
neurological sequelae; this is in keeping with previous studies which have shown both 
paradoxical  sensitising  and  neuroprotective  effects  of  endotoxin  under  different 
circumstances. In rats at postnatal day 7, low dose endotoxin administered 4 hours 
prior to hypoxia ischemia has been shown to have a sensitising effect with increased 
brain injury following mild hypoxia ischemia (Eklind et al 2001). Conversely, in adult 
rats  pre treatment  with  endotoxin  24  hours  prior  to  regional  cerebral  ischemia  by 
middle cerebral artery occlusion has been shown to reduce the volume of infarct. It now 
appears that this difference in effect is, at least in part, due to the difference in time 
interval between  the two insults. The effect of time interval  between endotoxin  and  
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hypoxia ischemia has also been recently studied in neonatal rats (Eklind et al 2005). In 
this study there was difference in the effect of endotoxin pretreatment dependent on 
the timing of insults and the severity of hypoxia. In animals undergoing mild hypoxia 
ischemia (20 minutes) on postnatal day 7, endotoxin pretreatment at 6 and 72 hours 
prior to hypoxia ischemia had a sensitising effect, whereas pretreatment at 2 hours or 
24 hours did not. In animals undergoing a more severe hypoxic ischemic insult (50 
minutes) pretreatment at 6 hours had a sensitising effect, whereas pretreatment 2 and 
72 hours did not. Intriguingly, in this severe hypoxia ischemia group, pretreatment with 
endotoxin 24 hours prior to hypoxia ischemia had a protective effect with amelioration 
of  infarct  volume.  In  the  same  study  hypoxia ischemia  at  day  10  in  rats  produced 
different  results  with  no  sensitisation  in  the  mild  hypoxia ischemia  group  and 
sensitisation  in  the  severe  hypoxia ischemia  group  (Eklind  et  al  2005).  It  seems 
therefore that the interaction of endotoxin with hypoxia ischemia is complex in nature, 
with both sensitising and preconditioning effects, and possibly a biphasic interaction 
dependent on time interval, severity of hypoxia ischemia and postnatal age at time of 
hypoxia ischemia. 
 
The results of the current study are, however, in keeping with those of other authors 
(Eklind 2001, Lenhardt 2003, Eklind 2005), with the additional finding that the peak of 
sensitisation  occurs  when  endotoxin  is  administered  12  hours  prior  to  hypoxia 
ischemia. This observation allows the further study of the cellular and humeral events 
occurring within the developing brain at these time points in an attempt to understand 
the mechanism of sensitisation. In addition, the current study also evaluated the time 
course of microglial activation within the white matter tracts of the corpus callosum and 
external  capsule.  Here  there  was  a  significant  increase  in  microglial  αMβ2 
immunoreactivity in animals pre treated with endotoxin 4 hours and 12 hours prior to 
mild hypoxia ischemia but not when pretreatment occurred immediately or 24 hours 
prior to hypoxia ischemia. Whilst this effect is similar to the observations in the infarct 
volume there was no increase in the magnitude of the effect between 4 and 12 hours.   
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Effects of Systemic Endotoxin on Cellular Activation within the CNS 
In order to maximize the chance of detecting small changes in immunoreactivity with 
endotoxin  alone,  doses  of  both  0.3   g/g  and  0.5   g/g  were  used.  The  effects  of 
endotoxin on microglial activation (integrins α5, α6, αM, αX, β2, and IBA1) astrocyte 
activation (CD44, GFAP), and vascular endothelial up regulation (ICAM 1, VCAM 1, α5 
and  α6  integrins)  were  examined  at  the  same  time points  as  for  the  sensitisation 
experiments. 4 hours after administration of endotoxin there was an increase in α6 
immunoreactivity  and  an  increase  in  ICAM1  immunoreactivity  both  in  a  pattern 
consistent with vascular endothelium. It is therefore apparent that there are detectable 
changes in vascular endothelium in response to endotoxin at 4 hours after systemic 
injection, within the same time window as sensitisation to subsequent hypoxia ischemia 
was observed in the previous study. 12 hours after endotoxin administration there was 
increased  immunoreactivity  in  αM  and  β2  integrins  in  a  pattern  consistent  with 
microglia.  Conversely  microglial  IBA1  immunoreactivity  was  reduced  12  hours  after 
endotoxin. Vascular ICAM1 immunoreactivity continued to be increased and there was 
also noted to be an increase in VCAM1. Of note in this study of the effects of endotoxin 
alone, the maximal increase in immunoreactivity of both vascular endothelial activation 
and microglial activation was seen at the 12 hour time point, the time point of maximal 
sensitisation  to  hypoxia ischemia  observed  in  the  previous  study.  24  hours  after 
endotoxin administration there was only an increase in α6 integrin immunoreactivity.  
No  significant  difference  in  immunoreactivity  was  seen  at  any  time point  for  the 
astrocyte activation markers CD 44 or GFAP. Additionally there were no effects of low 
dose endotoxin on α5 integrin, αX integrin  
It seems, therefore, that low dose endotoxin induces detectable changes in vascular 
endothelium and microglia in the developing brain in a time window consistent with 
sensitisation to hypoxia ischemia.  
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Microglia, the resident phagocytes of the brain, have many immune functions within the 
central nervous system. As described previously, in their resting state microglia are 
highly  ramified  cells,  which  have  a  unique  role  in  the  CNS  in  immune  surveillance 
(Raivich 2005). In response to various stimuli such as endotoxin, infection or ischemia, 
microglia  target  and  surround  the  injured  area.  There  is  also  a  change  in  their 
morphology  with  increased  integrin  immunoreactivity,  swelling  of  the  microglial  cell 
body, thickening of the proximal processes, and loss of the distal processes (Kloss et al 
2001).  The  recognition  that,  in  response  to  systemic  endotoxin,  microglia  in  the 
developing brain have changes in integrin immunoreactivity, which may represent up 
regulation to an ‘alert’ phenotype, raises the possibility that these cells may be key to 
sensitisation of the developing brain to subsequent hypoxia ischemia. It is at present 
unclear whether endotoxin travels directly to the brain and acts directly on microglia or 
if  there  is  a  systemic  response  which  ‘transduces’  the  signal  to  the  microglia.  It  is 
plausible  however,  as  endotoxin  is  a  small  (approximately  10KDa),  highly  soluble 
molecule, that at least some of the responses are a result of direct response to LPS 
within  the  brain.  From  in  vitro  studies,  endotoxin  is  known  to  be  able  to  activate 
microglia through the toll like receptors (Ebert et al 2005) resulting in the production of 
nitric oxide and TNFα. The role of microglia and toll like receptors has been previously 
studied in relation to endotoxin mediated neuronal damage (Lehnardt et al 2003). In 
this  study  endotoxin  was  demonstrated  in  vitro  to  cause  loss  of  axons, 
oligodendrocytes,  and  microglia  when  added  to  a  mixed  culture  of  CNS  cells. 
Interestingly, however, endotoxin had no effect on neuronal survival when added to a 
pure neuronal culture. In a combined neuronal and microglial culture endotoxin resulted 
in  almost  complete  loss  of  neurones.  This  suggests  that  the  previously  recognised 
endotoxin mediated  neuronal  toxicity  in  vivo  and  in  vitro  may  be  mediated  through 
microglia. This effect was further demonstrated using TLR4 mutant mouse with a loss 
of  functional  mutation  within  the  C terminal  part  of  TLR4.  This  mutant  is  known  to 
disrupt normal LPS induced signaling. Mutants and wildtype animals were pretreated 
with endotoxin 1 hour prior to carotid occlusion and exposure to 8% oxygen for 30  
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minutes. In the wildtype animals there was ipsilateral axonal and neuronal loss in the 
external capsule and overlying cerebral cortex, whereas in the TLR4 this damage was 
not seen (Lehnardt et al 2003). Interestingly this in vivo study used a time interval 
between endotoxin and hypoxia ischemia which has not been shown to sensitise the 
brain in other studies (Eklind et al 2005), furthermore the global TLR4 dysruption does 
not demonstrate the cell type responsible for sensitisation. Alternative pathways for the 
activation of microglia within the CNS following systemic administration of endotoxin 
have been previously considered (Hagberg and Mallard 2005, see Figure 4.11) 
 
Figure  4.11:  Lipopolysaccharide induced  systemic  inflammation  is  transferred  to  the  brain 
across  an  intact  barrier  via  receptor mediated  prostaglandin  production,  areas  with  an 
incomplete barrier and through rupture of the blood–brain barrier (BBB). Central inflammation 
and microglia activation elicit a cytokine/ trophic factor response, affect central nervous system 
(CNS)  functions, structure, cellular proliferation and vulnerability, and can produce brain lesions 
(from Hagberg and Mallard 2005 reproduced with permission). COX, cyclo oxygenase; CVO, 
circumventricular  organs;  IL,  interleukin;  INF,  interferon;  LPS,  lipopolysaccharide;  PG, 
prostaglandin; TLR, Toll like receptor; TNF, tumour necrosis factor.  
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It is of note that in the current study the first significant change in immunoreactivity 
following  systemic  endotoxin  is  the  up regulation  of  vascular  ICAM1.  This  effect  of 
endotoxin has been previously demonstrated in adult mice (Bohatschek et al 2001) and 
is part of a mechanism which allows granulocyte influx into the brain.  Adult animal 
studies  also  indicate  that  the  upregulation  of  vascular  endothelium  to  express  cell 
adhesion molecules and allow leukocyte recruitment in response to endotoxin is also 
mediated  by  microglia  (Zhou  et  al  2006).  In  this  study,  intra cerebroventricular 
administration of endotoxin resulted in significant rolling and adhesion of leukocytes in 
the brain post capillary venules. When the same study was repeated in TLR4 deficient 
mice this adhesion and rolling of leukocytes did not occur. Furthermore chimeric mice 
with  TLR4  positive  endothelium  and  microglia  but  TLR4  negative  leukocytes  had 
normal adhesion and rolling responses. Finally, this study showed that minocycline, a 
potent  microglial  inhibitor,  was  able  to  block  adhesion  and  rolling  responses  to 
endotoxin in vivo but did not affect activation of endothelium by endotoxin in vitro. The 
authors, therefore, suggest that vascular endothelial up regulation with increased cell 
adhesion molecules and hence leukocyte adhesion and rolling was a response to the 
activation of microglia by endotoxin and the resultant production of TNFα which then 
acts on the vascular endothelium (see Figure 4.12)  
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Figure  4.12:  Microglia  detected  bacterial  products and were rapidly  activated  and  releasing 
TNFα, which activates endothelium to express adhesion molecules and allows leukocytes to 
roll,  adhere,  and  enter  the  brain  parenchyma.  (from  Zhou  et  al  2006)  Copyright  2006.  The 
American Association of Immunologists, Inc. Reproduced with permission. 
 
Once activated, microglia can produce extracellular matrix degrading enzymes, major 
histocompatibility complex I & II, IL1α, IL1β, IL6, IL12, TNF, early components of the 
complement  cascade  and  nitric  oxide  and  prostaglandins  to  attack  invading  micro 
organisms (Chew et al 2006). If there was a subsequent hypoxic ischemic event this 
would then occur in a pro inflammatory environment with the potential for the observed 
increase  in  injury  resulting.  This  hypothesis  would  fit  with  the  current and  previous 
observations  that  there  is  a  delay  of  at  least  2  hours  between  administration  of 
systemic  endotoxin  and  the  onset  of  sensitisation  (Eklind  et  al  2005). Alternatively, 
recent in vitro studies have suggested that normally microglia have a neuroprotective 
role  and  activation  by  endotoxin  results  in  a  loss  of  this  effect.  In  cell  culture  the 
addition  of  microglia  to  neuronal  culture  which  is  then  exposed  to  oxygen glucose 
deprivation results in microglial migration, close cell to cell contact between microglia  
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and neurones, and confers significant neuroprotection. Thus, it is plausible that this 
effect is also present in vivo. Microglia, in addition to immune surveillance, cytokine 
production  and  phagocytosis,  may  normally  have  a  significant  supporting  role  to 
damaged neurones preventing cell death and cell survival. However, when exposed to 
endotoxin this effect may be lost, resulting in increased brain injury. 
Effects of Systemic Endotoxin on Blood brain Barrier 
The current study shows that systemically administered human albumin solution and 
human IgG are detectable throughout the forebrain of 7 day old mice 12 hours after 
injection. There was no detectable difference in immunoreactivity for human albumin or 
human  IgG  if  the  injection  was  followed  by  endotoxin.  This  study  was  unable  to 
demonstrate  a  change  in  the  integrity  of  the  blood brain  barrier  to  the  substances 
tested in response to endotoxin or saline. Previous studies in adult mice has shown 
that  systemic  injection  of  human  albumin  solution  resulted  in  detectable 
immunoreactivity for human serum albumin restricted to brain tissue surrounding the 
area  postrema  and  central  canal.  Animals  subsequently  treated  with  endotoxin 
demonstrated strong immunoreactivity for human serum albumin throughout the grey 
matter, and some immunoreactivity in the white matter tracts of the brain stem. These 
data suggest that, in adult animals, systemic endotoxin results in a disruption of the 
blood brain  barrier,  which  was  accompanied  by  an  ICAM1 mediated  influx  of 
granulocytes into the brainstem (Bohatschek et al 2001). Comparing the current study 
with  the  previous  adult  animal  study  suggests  that  the  blood brain  barrier  in  the 
neonatal mouse is apparently more permeable to human serum albumin. The blood 
brain  barrier,  in  the  form  of  complex  tight  junctions  between  endothelial  cells,  is 
structurally present from early embryological life. It is known that endogenous protein 
concentrations  within  the  immature  brain  are  much  higher  than  those  of  adults 
(Habgood et al 1992). Whilst previously this was interpreted as evidence of increased 
blood brain barrier permeability in the immature brain, the demonstration that, even in 
early development, the tight junctions form a functional barrier (Ek et al 2003) has led  
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to the suggestion that there may be a specific transcellular transfer process for proteins 
independent of that for small lipid insoluble molecules (Johansson et al 2006). In the 
embryonic rat the choroid plexus tight junctions are impermeable to small molecules as 
early  as  embryological  day  15,  confirming  a  functional  blood brain  barrier  in  early 
embryonic development (Johansson et al 2006). Interestingly, in this study the transfer 
of human serum albumin from the systemic circulation into the embryonic rat brain was 
4–5  times  greater  than  bovine  serum  albumin,  suggesting  selective  blood to CSF 
transfer. The authors conclude that there are different trans cellular mechanisms for 
protein and small molecule passage across the embryonic blood brain barrier. It is, 
therefore,  possible  that  the  current  data  reflects  this  apparent  specific  transfer  of 
human  serum  albumin  into  the  brain  at  early  stages  of  development  rather  than  a 
reflection  of  the  general  permeability  of  the  blood brain  barrier.  The  results  using 
human IgG also demonstrates free passage into the brains of neonatal mice without 
subsequent addition of endotoxin. It is possible that this small molecule is able to freely 
pass into the CNS without the requirement of a specific transport system. The current 
study is unable to demonstrate any changes in blood brain barrier integrity as a result 
of endotoxin; however, it also does not exclude such changes. 
 
Conclusions 
Low dose systemic endotoxin sensitises the developing brain to subsequent hypoxia 
ischemia within a time window of 4 12 hours after endotoxin administration. Within this 
time  window  low  dose  endotoxin  results  in  detectable  up regulation  in  adhesion 
molecules on the vascular endothelium and activation markers on microglia. Previous 
studies in adult animals suggest that LPS can act directly on microglia through toll like 
receptors resulting in the production of cytokines, including TNFα, which, in turn, result 
in the observed changes in vascular endothelium. The role of these humeral factors 
and  the  timing  of  their  expression  are  crucial  in  understanding  the  mechanism  of 
endotoxin sensitisation and will be subject to further discussion (see Chapter 5).  
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Chapter  5:  The  Role  of  the  TNF  Family  of  Cytokines  in  Inflammatory 
Sensitisation of the Developing Brain to Hypoxia Ischemia  
 
Introduction 
 
Growing evidence from epidemiological studies and animal models suggests that there 
may  be  a  synergistic  relationship  between  infection  /  inflammation  and  hypoxia 
ischemia as antecedents of perinatal brain injury and the subsequent development of 
cerebral  palsy  (Peebles  and  Wyatt  2002).  This  interaction  may  help  explain  the 
apparent  absence  of  significant  hypoxia ischemia  in  the  majority  of  children  who 
develop cerebral palsy (Badawi et al 1998, Blair 1988). Mediators of bacterial infection 
such  as  the  endotoxin  up regulate  pro inflammatory  cytokines  (Xiao  et  al  1996),  in 
contrast with hypoxia ischemia which results in the release of both pro inflammatory 
and  a  second    group  of  cytokines  which  are  considered  to  have  anti inflammatory 
properties  (Raivich  et  al  1999,  Kiefer  et  al  1995).  It  is  possible  that  the  balance 
between these pro  and anti  inflammatory cytokines within the brain at times may be 
critical in defining whether an injured neuron is able to survive or is committed to cell 
death.  
 
Previously,  we  have  demonstrated  the  potential  role  of  microglia  and  vascular 
endothelium in the mechanism by  which endotoxin, a potent inflammatory stimulus, 
sensitises the developing brain to hypoxia ischemia. In vitro studies also suggest that 
the mechanism of endotoxin mediated neuronal toxicity is dependent on the presence 
of microglia  through  activation  of  Toll like  receptor  4  (TLR 4)  (Lehnardt  et  al  2003, 
Zhou et al 2004). Furthermore studies have demonstrated that activation of microglia 
through Toll like receptors, results in the release of both tumour necrosis factor α and 
nitric  oxide  (Ebert  et  al  2004)  through  both  MyD88   dependent  and   independent 
pathways (Zhou et al 2003).  A recent in vitro study demonstrated that the pathway of  
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endotoxin mediated  cellular  toxicity  is  dependent  on  the  presence  or  absence  of 
different glial cells (Li et al 2008). Here, whilst microglia were essential for endotoxin 
mediated  cellular  toxicity,  as  shown  before  (Lehnardt  et  al  2003),  the  additional 
presence  of  astrocytes switched  the  mechanism  of  toxicity  from  one  dependent  on 
nitric oxide synthase and peroxynitrite, to one dependent on tumour necrosis factor α 
(Li et al 2008). In this context, it is interesting to note that children who subsequently 
develop cerebral palsy  have  been shown to have  raised levels of pro inflammatory 
cytokines, including tumour necrosis factor α, in blood samples taken in the neonatal 
period (Nelson et al 1998).  
 
Tumour necrosis factor along with lymphotoxin α (LTα), and LTβ form a subfamily of 
TNF related  ligands.  These  have  their  genes  linked  within  a  compact  2 kb  cluster 
inside  the  major  histocompatibility  complex  locus  (see  figure  5.1).  Previous  studies 
have  demonstrated  that  these  related  cytokines  have  a  number  of  distinct  and 
overlapping functions (see figure 5.2) (Kuprash et al 2002) 
 
Figure 5.1 The TNF cluster which is located within the Major Histocompatability complex 
 
 
Figure  5.2  Distinct  and  overlapping 
physiological functions of the TNF / LT family. 
Areas  on  the  diagram  symbolise  subsets  of 
functions mediated  by single molecules  or by 
their  combinations  (from  Kuprash  et  al  2002 
reproduced with permission).   
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Single nucleotide  polymorphisms in LTα  have been demonstrated to be associated 
with  the  development  of  cerebral  palsy  (Nelson  et  al  2005),  further  implicating  this 
family in the mechanism of perinatal brain injury. 
 
The current study aims to explore further the role of the TNF family of cytokines (TNFα, 
LTα and LTβ) in the aetiology of perinatal brain injury. First, the expression of these 
cytokines was studied in neonatal mice following endotoxin alone. To study the role of 
the TNF family of cytokines on endotoxin mediated microglial activation and vascular 
endothelial up regulation noted previously during the window of sensitisation, animals 
with  deletion  of  the  entire  TNF  cluster  were  treated  with  endotoxin  or  saline  and 
immunohistochemistry  for  αMβ2  integrin  and  ICAM1  performed  12  hours  after 
exposure. To explore further the role of the TNF family of cytokines in the mechanism 
of neonatal brain injury, animals with a deletion of the entire TNF cluster were exposed 
to endotoxin or saline 12 hours prior to carotid occlusion and hypoxia ischemia. Finally 
to examine the mechanism by which the TNF family mediates endotoxin sensitisation 
to hypoxia ischemia cytokine expression was compared in wildtype animals exposed to 
hypoxia  ischemia  alone,  and  following  endotoxin  pretreatment  12  hours  before 
hypoxia ischemia  
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Materials and Methods 
 
TNF Cluster Gene Expression 
To explore the role of the TNF family of cytokines in perinatal brain injury, the mRNA 
for TNFα, LTα and LTβ was quantified using a cDNA real time PCR 2, 4, 12 or 24 
hours after endotoxin 0.3  g/g (n=20) and compared to naive animals (n=5). Mice were 
killed by decapitation, their brains quickly removed, frozen in liquid nitrogen and kept at  
 80ºC until processed.  
 
RNA isolation and cDNA preparation  
 
The left (occluded) forebrain hemisphere was micro dissected in the frozen state and 
total RNA isolated using the RNeasy minikit (Qiagen West Sussex, UK) according to 
the manufacturer’s instructions. Briefly, the posterior half of the left hemisphere was 
suspended in RLT buffer with β mercaptoethanol and homogenized by passing though 
a  23  gauge  needle  10  times.  600   l  of  the  sample  was  then  centrifuged  and  the 
supernatant mixed with an equal volume of 70% ethanol. The sample was then applied 
to an RNeasy mini column which binds the RNA. The column was washed with RWI 
and RPE buffers before eluting the RNA in 50  l RNase free water. The quality of the 
RNA  was  checked  on  a  2%  agarose  gel,  and  the  amount  of  RNA  quantified  by 
measuring absorbance at 260nm (A260). Concentration was calculated as 40 x A260 x 
dilution factor. The RNA was normalised to 0.12  g/ l prior to DNase treatment for 1 
hour  at  37°C  using  RQ1  RNase  free  DNase  (Promega  cat  #M6101)  and  RNasin® 
(Promega cat #N2111). Samples then underwent citrate buffered phenol: chloroform 
extraction  and  RNA  precipitation:  Samples  were  mixed  with  an  equal  volume  of 
phenol:chloroform and thoroughly vortexed prior to centrifugation. The aqueous phase 
was then mixed with glycogen/tRNA to act as a carrier and the RNA precipitated using 
1:5 volume of 3M ammonium acetate and 2.5 volume of 100% ethanol on dry ice for 30  
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minutes. The RNA pellet was centrifuged, washed in 75% ethanol, dried in room air 
and re suspended in 15  l DEPC water. The resultant RNA was reverse transcribed by 
heating to 75°C with random hexamers for 5 minutes, cooled on ice and then incubated 
at 40°C with M MLV RT enzyme (Promega) and dNTPs. The cDNA produced by the 
reverse transcription reaction was checked using polymerase chain reaction (PCR) for 
the  ubiquitous  β actin  gene.  The  specific  oligonucleotide  primers  (Invitrogen)  used 
were: 
Forward primer: 5’  GCTCCGGCATGTGCAA   3’   
Reverse primer: 5' – AGGATCTTCATGAGGTAGT – 3’ 
 
The annealing temperature of the primers was 60˚C. The Taq polymerase used was 
from Applied Biosystems (5U/  l Cat. No. N808 0156). The resultant product molecular 
weight was 520 bp (See Figure 5.3).  
 
Figure 5.3: β Actin PCR of cDNA confirmed the Presence of cDNA 
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The  reverse  transcription PCR  reaction  was  performed  by  Dr  Dimitra  Dafou 
Translational Research Laboratory,  Institute for Women’s Health, University College 
London, on an ABI 7900HT genotyper using SDS2.1 software. Samples were run in 
triplicate on 96 well plates with an 18S control measured in each well.  
 
The  ‘relative  quantification  study’  programme  of  SDS2.1  software  was  used  for 
analysing  data.  First  the  cycle  number  at  which  the  increase  in  fluorescence  (and 
therefore cDNA) became exponential (Ct) for both the target gene and the control gene 
(18S) were measured and the difference in Ct between the control and target gene 
were  calculated  for  each  well  (delta  CT).  The  results  were  expressed  using  the 
comparative Ct or 2
–[delta][delta]Ct method, where:  
 
[delta][delta]Ct = [delta]Ct,sample   [delta]Ct,control        formula  5.1 
 
 
Here,  [delta]CT,sample  is  the  Ct  value  for  any  experimental  animal  normalised  to  the 
endogenous housekeeping gene and [delta]Ct, control is the Ct value for control animals 
also  normalised  to  the  endogenous  housekeeping  gene.  Expression  levels  of  each 
gene were calculated in this way for each time point as the average of the triplicates.  
 
Effects of TNF Cluster Deletion 
Animals homozygous for a deletion of the entire TNF cluster were a kind gift from K 
Pfeffer,  Institute  of  Medical  Microbiology,  University  of  Dusseldorf,  Germany.  The 
generation  and  phenotypic  analysis of  these mice with combined TNF  / LTα / LTβ 
deficiency has been previously described (Kuprash et al 2002). These animals were 
back crossed with C57/Bl6 (Charles River) for four generations to ensure the genetic 
background of the strain. The heterozygotes of F4 were bred and their offspring were 
used at postnatal day 7.  
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To  examine  the  effect  of  TNF  cluster  knockout  on  the  responses  to  endotoxin,  63 
offspring of animals heterozygous for TNF cluster deletion were studied at postnatal 
day 7. Animals were sequentially allocated to receive LPS (Escherichia coli, serotype 
055:B5, Fluka) at 0.3  g/g, or vehicle (normal saline), 12 hours prior to being culled. As 
before, all injections were at a volume of 10  l/g. Following injections, the mice were 
returned  to  their  dams  until  they  were  killed,  perfused,  and  brains  extracted  as 
described  previously.  Following  genotyping  (see  below)  the  brains  of  knockout  and 
wildtype animals were cut on a cryostat and stained using immunohistochemistry for 
microglial  activation  (αMβ2),  and  vascular  endothelial  up regulation  (ICAM1). 
Immunohistochemistry and staining intensity evaluation were performed as described 
previously (see under General Materials and Methods). 
 
To  examine  the  role  of  the  TNF  cluster  on  endotoxin mediated  sensitisation  to 
subsequent hypoxia ischemia 109 animals were sequentially allocated to receive intra 
peritoneal endotoxin (0.3  g/g) or vehicle (normal saline) 12 hours prior to hypoxia 
ischemia as described previously. At 48 hours, the brains were perfused, extracted and 
post fixed as described before. Animals were genotyped (see below) and the brains of 
knockout and wildtype  evaluated. 15 coronal sections from each forebrain (200  m 
apart) were stained with cresyl violet and the areas of intact staining in the cortex, 
hippocampus, striatum and thalamus were measured bilaterally. Infarct volumes were 
calculated and expressed as a percentage of the contralateral (uninjured) hemisphere. 
Statistical analysis was by ANOVA analysis of variance with post hoc Tukey test. 
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Genotyping 
DNA extraction from tail tips taken during perfusion fixation was performed using the 
“Wizard”  Genomic  DNA  purification  system  according  to  manufacturer’s  instructions 
(Promega, Cat. No: A1125). Briefly, tails were suspended in chilled 0.5 M EDTA and 
nuclei lysis solution. Samples were incubated overnight with proteinase K (Sigma) at 
55˚C. 3  l of RNase solution was added to each of the nuclear lysate samples and the 
samples incubated for 15 30 minutes at 37˚C. 200  l of protein precipitation solution 
was then added to each sample and the tubes were then thoroughly vortexed before 
being chilled on ice for 5 minutes. Samples were then centrifuged for 4 minutes and the 
DNA containing  supernatant  separated  off.  DNA  was  then  precipitated  using 
isopropanol, and then washed in 70% ethanol. The DNA pellets were allowed to air dry 
at room temperature before being rehydrated in 100  l of TE (Tris/EDTA) buffer. A 
1:200 dilution was used for genotyping by polymerase chain reaction. For the wildtype, 
the specific oligonucleotide primers (Invitrogen) used were: 
  Forward primer: 5’  CGGGTCTCCGACCTAGAGATC   3’   
Reverse primer: 5'    CCCACGCTCGTGTACCATAAC – 3’ 
The annealing temperature of the primers was 56˚C. The Taq polymerase used was 
from Applied Biosystems (5 U/ l Cat. No. N808 0156). The resultant product molecular 
weight was 400 bp (see Figure 5.4) 
 
Figure 5.4: Wildtype Genotyping for Deletion of the Entire TNF Cluster of animals 1 12    
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Figure 5.5: Knockout Genotyping for Deletion of the Entire TNF Cluster of animals 1 12   
 
For the knockout the specific oligonucleotide primers (Invitrogen) used were: 
Forward primer: 5’  CACCCACCCCCGTTTTCTTTCTTC   3’   
Reverse primer: 5'   CCACTTGTCCAGTGCCTGCTC – 3’ 
The annealing temperature of the primers was 56˚C. The Taq polymerase used was 
from Applied Biosystems (5 U/ l). The resultant product molecular weight was 320 bp 
(see figure 5.5). 
 
 
Timing of the Effects of TNF on Endotoxin Mediated Sensitisation 
Finally, to examine the whether up regulation of the TNF family of cytokines was critical 
prior to or after hypoxia ischemia the mRNA for TNFα, LTα and LTβ was quantified as 
before, 0 24 hours after hypoxia ischemia alone (n=25) or following pretreatment with 
0.3  g/g endotoxin 12 hours prior to hypoxia ischemia (n=25). Here again, levels of 
mRNA were compared to 5 naïve control animals.  
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Results 
 
TNF family Gene Expression Following Endotoxin:  
 
The expression of LTα, LTβ and TNFα mRNA was examined 2 24 hours following intra 
peritoneal endotoxin administration and expressed as 2
–[delta][delta]Ct (see formula 5.1). 
Following systemic endotoxin administration, a trend towards a rise in the expression of 
TNF α mRNA within the brain was seen 2 hours, 4 hours and 24 hours after endotoxin. 
In this small sample, the results did not reach statistical significance at any time point 
(2  hours  p=0.10,  4  hours  p=0.10,  12  hours  p=0.22).  At  12  hours  after  endotoxin 
administration there was no difference in the level of TNF mRNA compared to control 
(p=0.87) by Student t test (see Figure 5.6A). The expression of lymphotoxin α within 
the brain following systemic endotoxin administration appeared to be increased at 2 
hours and 12 hours after endotoxin but not a 4 and 24 hours. Here again however 
these results in this small sample did not reach statistical significance (2 hours p=0.21, 
4 hours p 0.87, 12 hours 0.58, 24 hours 0.43 Student t test) (see Figure 5.6B). The 
expression  of  lymphotoxin  β  within  the  brain  following  systemic  endotoxin 
administration  appeared  to  be  increased  at  2  hours,  4hours  and  24  hours  after 
endotoxin.  Here  again  at  12  hours  after  endotoxin  administration  there  was  no 
difference in the level of lymphotoxin β mRNA compared to control. These results in 
this small sample did not reach statistical significance (2 hours p=0.67, 4 hours p=0.37, 
12 hours p=0.85, 24 hours p=0.58 Student t test) (see Figure 5.6C). 
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Figure 5.6: mRNA expression of TNF (A), lymphotoxin α  (B) and lymphotoxin β (C) within the 
brain 2 24 hours after systemic endotoxin administration.  
 
Effects of TNF Cluster Deletion on in vivo Endotoxin Mediated Cellular Activation 
To  study  the  effect  of  TNF  family  of  cytokines  in  vivo  on  microglial  activation  and 
vascular  up regulation  following  systemic  endotoxin  administration,  63  animals  at 
postnatal day 7 were sequentially allocated to receive endotoxin or saline. All animals 
survived  to  perfusion  at  12  hours  and  genotyping  revealed  19  wildtype  (30%),  16 
knockout (25%) and 28 heterozygotes (44%) for the TNF cluster. As previously noted, 
12  hours  after  endotoxin  administration  there  was  increased  αMβ2  integrin 
immunoreactivity in the wildtype animals (p<0.05). In animals with a deletion of the TNF 
cluster  there  was  no  increase  in  αMβ2  integrin  following  endotoxin  treatment  (see 
Figure 5.7). 
  
151 
 
 
Figure 5.7: Effects of TNF cluster deletion on LPS mediated microglial activation. 12 hours after 
endotoxin  application  there  was  a  significant  increase  in  αMβ2  integrin  immunoreactivity  in 
wildtype animals. In animals with a deletion of the TNF cluster there was no LPS mediated 
microglial  activation  compared  to  saline treated  animals.  *  p<0.05  (ANOVA  with  post hoc 
Tukey); NS – Non Significant. 
 
When the different forebrain regions were analysed independently the same trend to 
increased  αMβ2  integrin  immunoreactivity  was  seen  in  the  cortex  (p=0.11) 
hippocampus (p=0.18) and striatum (p=0.12), as well as a significant increase in the 
thalamus  p<0.05).  No  LPS mediated  microglial  activation  seen  in  the  animals  with 
deletion of the TNF cluster (see Figure 5.8) 
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Figure  5.8:  Regional  Effects  of  TNF  cluster  deletion  on  Endotoxin  mediated  microglial 
activation. In the wildtype animals endotoxin treatment was associated with a treand towards 
higher  αMβ2 integrin immunoreactivity in all forebrain regions: cortex (p=0.11) hippocampus 
(p=0.18) and striatum (p=0.12) but this did not reach statistical significance. There, however, 
was  a  significant  increase  in  αMβ2  integrin  immunoreactivity  the  thalamus.  In  animals  with 
deletion of the TNF cluster, endotoxin treatment did not result in an increase in αMβ2 integrin 
immunoreactivity in any region compared with saline treated controls.  * p<0.05 (ANOVA with 
posthoc Tukey), NS – Non Significant 
   
As shown in the previous study, 12 hours after endotoxin administration there was a 
significant  increase  in  ICAM1  immunoreactivity  in  the  wildtype  animals  (p<0.05).  In 
animals with a deletion of the TNF cluster no increase in ICAM1 immunoreactivity 12 
hours after endotoxin application (see Figure 5.9).  
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Figure 5.9: Effects of TNF cluster deletion on Endotoxin mediated vascular endothelial ICAM1 
upregulation.  Endotoxin  pretreatment  resulted  in  a  significant  increase  in  ICAM1 
immunoreactivity in wildtype animals. No LPS mediated ICAM1 upregulation was seen in the 
animals with deletion of the TNF cluster. * p<0.05 (ANOVA with posthoc Tukey); NS – Non 
Significant. 
 
When the different forebrain regions were analysed independently there was significant 
endotoxin mediated  up regulation  of  ICAM1  in  wildtype  animals  in  the  cortex, 
hippocampus, striatum and thalamus (p<0.05). Here again, deletion of the TNF cluster 
abolished endotoxin mediated ICAM1 up regulation (see Figure 5.10).  
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Figure 5.10: Regional Effects of TNF cluster deletion on LPS mediated vascular Endothelial 
ICAM1  up regulation.  In  the  wildtype  animals,  endotoxin  treatment  resulted  in  significantly 
increased ICAM1 immunoreactivity in all forebrain regions analysed. In animals with deletion of 
the  TNF  cluster  there  was  no  increase  in  ICAM1  immunoreactivity  in  any  of  the  regions 
compared to saline treated control. * p<0.05, all other comparisons non significant (ANOVA with 
post hoc Tukey) 
 
To  study  the  effect  of  TNF  cluster  deletion  on  endotoxin mediated  sensitisation  to 
hypoxia ischemia  109  animals  at  postnatal  day  7  underwent  hypoxia ischemia  12 
hours after pre treatment with 0.3  g/g endotoxin. There was no significant difference 
in weight between the animals pretreated with saline or LPS at the outset. The values 
were: 3.81g±0.10g for the saline treated group (n=54) versus 3.82±0.10g for the LPS 
treated  group  (n=55)  p=0.97  by  Student  t test.  Overall  35  animals  died  during  the 
surgery or hypoxia (16 LPS, 19 saline). There was no significant difference in weight at 
time of perfusion. The values were 4.86±0.16g after saline treatment (n=36) versus 
4.53±0.15g after LPS treatment (n=38) p=0.15 by Student t test. Of the 74 animals 
surviving to perfusion genotyping revealed 14 wildtype (19%), 18 knockout (24%) and 
42 heterozygotes (57%) for the TNF cluster. Once stratified for genotype, there was no  
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difference in the weight of animals at the time of culling in any of the 4 groups: saline 
wildtype,  4.75±0.55g  (n=8);  saline  knockout,  4.83±0.51g  (n=4);  LPS  wildtype. 
4.90±0.52g (n=6); LPS knockout, 4.71±0.22g (n=14). As seen previously, pretreatment 
with  endotoxin  12  hours  prior  to  hypoxia ischemia  resulted  in  a  highly  significant 
increase in infarct volume from 3% to 22% (p<0.05) in the wildtype animals. However, 
in the animals  with a deletion  of the TNF  cluster, there was no overall increase in 
infarct  volume  with  endotoxin  pretreatment  1%  saline  v  5%  LPS  (p=0.58).  Overall, 
there was no difference in the infarct volume in the saline treated animals between 
wildtype and animals with deletion of the TNF cluster 1% v 3% (p=0.79) (see Figure 
5.11).  
 
 
Figure 5.11: Effect of TNF cluster Deletion on Endotoxin Mediated Sensitisation to Hypoxia 
Ischemia. In the wildtype, endotoxin pretreatment resulted in a dramatic increase in brain injury 
following hypoxia ischemia, as seen previously. In the animals with deletion of the TNF cluster 
there was no increase in injury with endotoxin pretreatment compared with hypoxia ischemia 
alone. *p<0.05 NS  non significant, (ANOVA with post hoc Tukey).  
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When the forebrain regions were analysed separately, endotoxin pretreatment resulted 
in increased infarct volume in the cortex from 2% to 24% (p<0.05) and striatum from 
5%  to  20%  (p<0.05)  in  the  wildtype  animals.  The  same  trend  was  seen  in  the 
hippocampus 5% to 35% (p=0.06) and thalamus 4% to 9% (p=0.56) but these did not 
reach statistical significance. Here again, deletion of the TNF cluster resulted in to an 
abolition of the sensitising effects of endotoxin to subsequent hypoxia ischemia in all 
regions analysed: cortex, 0% to 4%; striatum, 4% to 6%; hippocampus, 10% to 13%; 
and thalamus, 5% to 4% (see Figure 5.12).  
 
 
Figure 5.12: Regional Effects of Endotoxin from E.coli (serotype 055:B5) pretreatment prior to 
Hypoxia ischemia. Endotoxin pretreatment resulted in a significant increase in infarct volume in 
the cortex and striatum of wildtype animals. The  same trend was  seen in the hippocampus 
(p=0.06)  and  thalamus  (p=0.56).  No  increase  in  infarct  volume  was  seen  with  endotoxin 
pretreatment in the animals with a knockout for the TNF cluster (ANOVA with posthoc Tukey) 
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Timing of the Effects of TNF family on Endotoxin Mediated Sensitisation 
Finally the mRNA levels of TNFα, LTα and LTβ were quantified in the brains of animals 
0 24  hours  after  pure  hypoxia ischemia  or  hypoxia ischemia  with  pretreatment  with 
endotoxin 12 hours prior to onset of hypoxia ischemia. There was a significant increase 
in the levels of TNFα mRNA 2 – 24 hours after hypoxia ischemia (p<0.05) and 2 12 
hours after combined endotoxin and hypoxia ischemia (p<0.05).  There was a trend 
towards  a  reduction  in  the  TNF  mRNA  levels  0 4  hours  after  hypoxia ischemia  in 
animals pretreated with endotoxin but this did not reach statistical significance (0 hours, 
p=0.55; 2 hours, p.0.19; 4 hours, 0.33 Student t test) (see Figure 5.13). 
 
 
 
Figure 5.13: Relative quantification of TNFα mRNA in the hours following hypoxia ischemia 
alone (control) or with endotoxin pretreatment 12 hours prior to hypoxia ischemia (endotoxin). 
Note  that,  although  levels  of  TNFα  mRNA  are  increased  in  all  groups  following  hypoxia 
ischemia there is a trend towards a smaller increase in those animals pretreated with endotoxin 
prior to hypoxia ischemia at 0, 2 and 4 hours. 
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Similarly, there was a trend towards an increase in the levels of lymphotoxin β mRNA 0 
– 12 hours after hypoxia ischemia (0 hours, p=0.43; 2 hours, p=0.1; 4 hours, p=0.07; 
12 hours, p=0.06) and a significant increase after 24 hours p<0.05. After combined 
endotoxin and hypoxia ischemia a trend to increased levels was also seen but this did 
not  reach  statistical  significance  at  any  time point.    Here  again  there  was  a  trend 
towards  a  reduction  in  the  lymphotoxin  β  mRNA  levels  2     4  hours  after  hypoxia 
ischemia in animals pretreated with endotoxin compared to those exposed to hypoxia 
ischemia alone  (2 hours, p=0.11; 4 hours, p=0.06 by Student t test), see Figure 5.14. 
Lymphotoxin  α  mRNA  was  not  reliably  detected  in  any  animals  following  either 
hypoxia ischemia or with endotoxin pretreatment 12 hours prior to hypoxia ischemia 
 
 
Figure 5.14: Relative quantification of Lymphotoxin β mRNA in the hours following hypoxia 
ischemia  alone  (control)  or  endotoxin  pretreatment  12  hours  prior  to  hypoxia ischemia 
(endotoxin).  Note  that  although  levels  of  lymphotoxin  β  mRNA  are  increased  in  all  groups 
following  hypoxia ischemia  there  is  a  trend  towards  a  smaller  increase  in  those  animals 
pretreated with endotoxin prior to hypoxia ischemia at 2 and 4 hours. 
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Discussion 
This study suggests a key role of the TNF family of cytokines in endotoxin mediated 
sensitisation of the developing brain to subsequent hypoxia ischemia in a mouse model 
of  neonatal  hypoxic ischemic  brain  injury.  In  the  wildtype  animal,  systemic 
administration of endotoxin resulted in the up regulation of TNF, lymphotoxin α and 
lymphotoxin β mRNA  in the  hours following endotoxin  administration.  Whilst these 
results did not reach statistical significance this is likely to be due to the small sample 
sizes used in the current study. It must, however, be recognised that the presence of 
mRNA  does  not  necessarily  indicate  the  presence  of  protein,  especially  if  there  is 
disruption  of  protein  synthesis  in  areas  of  damaged  brain.  However  it  can  be 
speculated that the levels of these pro inflammatory cytokines are indeed raised in the 
neonatal  brain  in  the  hours  following  endotoxin  administration.  Furthermore  it  is  of 
particular  note  that  there  may  be  a  biphasic  response  in  mRNA  levels  following 
endotoxin administration and it is interesting to speculate that this may correspond to 
the biphasic nature of sensitisation occurring in the hours following hypoxia ischemia 
demonstrated  by  other  authors  (Eklind  et  al  2006).  Additionally,  it  is  likely  that  the 
timing of changes in mRNA levels do not correspond exactly to the timing of changes in 
protein levels due to the rate of protein synthesis, and it is therefore possible that the 
apparent peak in mRNA levels seen at 4 hours corresponds to the peak in sensitisation 
shown in the current study 12 hours after endotoxin administration. Whilst the changes 
in  mRNA  levels  do  not  reach  statistical  significance,  deletion  of  the  TNF  cluster 
prevents the increase in microglial αMβ2 integrin immunoreactivity, and the increase in 
vascular  endothelial  ICAM1  immunoreactivity  previously  demonstrated  following 
endotoxin administration.This suggests that these cytokines are upregulated following 
systemic endotoxin administration, and that these changes were mediated by a TNF 
family dependent pathway. 
 
  
160 
 
The current and previous studies have demonstrated that endotoxin has a sensitising 
effect on the developing brain to subsequent hypoxia ischemia. In the previous chapter 
this  effect  was  seen  to  be  maximal  when  endotoxin  was  given  12  hours  prior  to 
hypoxia ischemia. In the current study, the role of the TNF family of cytokines was 
explored at this time point of maximal sensitisation. Here, deletion of the entire TNF 
family of cytokines was shown to completely abolish endotoxin mediated sensitisation 
of the  developing  brain  to subsequent  hypoxia ischemia,  again  suggesting  that this 
sensitisation is mediated by a TNF family dependent pathway. This is in keeping with 
the findings of other authors that endotoxin mediated cellular toxicity is dependent on 
both microglia (Lehnardt et al 2003) and on a TNF dependent pathway (Li et al 2008). 
It is of note that following hypoxic ischemic encephalopathy high levels of TNFα have 
previously been detected within the blood and CSF. Moreover, the presence of a high 
TNFα CSF / plasma ratio suggests that this cytokine may indeed be produced in the 
brain  of  term  neonates  with  hypoxic ischemic  encephalopathy  (Silveira  et  al  2003). 
Taken  together,  these  findings  provide  strong  evidence  that  endotoxin mediated 
inflammatory  sensitisation  is  a  TNF  family dependent  pathway.  This  conclusion  is 
further supported by the clinical studies demonstrating increased incidence of spastic 
cerebral  palsy  in  neonates  exposed  to  both  the  pro inflammatory  environment  of 
chorioamnionitis, and  hypoxia ischemia (Nelson et  al  1998). It is of interest that  no 
difference in infarct volume was detected in the current study between wildtype animals 
and  those  with  the  TNF  cluster  deletion  when  exposed  to  hypoxia ischemia  alone. 
There are at least two possible explanations for this finding. Firstly that there was a 
reduction in injury in the TNF cluster deletion animals, because of the small infarct size 
detected  in  the  hypoxia ischemia  alone  groups,  the methodology  was  not  sensitive 
enough to detect this difference. Alternatively, whilst it would be expected that there 
would be increased levels of TNF cytokines following hypoxia ischemia in this model 
these cytokines may not have a direct role in neuronal injury and, hence, no difference 
in infarct volume would be expected between the groups.  
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Taken  together,  these  data  suggest  a  number  of  possible  mechanisms  by  which 
endotoxin may sensitise the developing brain to subsequent hypoxia ischemia. First 
endotoxin may enter the brain bind to TLR4 on microglia resulting in local production of 
cytokines, including the TNF family, which, in turn, further activate microglia, vascular 
endothelium  and  results  in  enhanced  susceptibility  to  hypoxia ischemia  (see  Figure 
5.15 A).  Alternatively, endotoxin may have a predominantly systemic role resulting in 
raised systemic levels of pro inflammatory cytokines, including the TNF family. These 
mediators may then cross the blood brain barrier and result in microglial and vascular 
endothelial up regulation for a period of 4 12 hours after endotoxin administration (see 
Figure  5.15  B).  If  the  brain  is  then  exposed  to  hypoxia ischemia  within  this  critical 
period  the  up regulated  vasculature  and  activated  microglia  facilitate  enhanced 
neuronal injury through various mechanisms. The presence of raised levels of mRNA 
for the TNF family of cytokines demonstrated in the current study may give further 
evidence  for  the first  hypothesis. It  is of  particular note that,  in  the hours following 
hypoxia ischemia, levels of mRNA for TNF and LTβ appear to be lower in animals pre 
treated  with  endotoxin  compared  to  those  preteated  with  saline.  This  finding  may 
suggest that the action of the TNF family of cytokines is predominantly in the period 
between endotoxin administration and hypoxia ischemia and not in the hours following 
hypoxia ischemia.  This  further  suggests  that  the  cellular  activation  previously 
demonstrated  in  the  hours  after  endotoxin  administration  may  be  critical  to  the 
observed sensitisation phenomenon.  
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Figure  5.15:  Potential  mechanisms  for  Systemic  Endotoxin Mediated  Sensitisation  of  the 
Neonatal Brain to Hypoxia ischemia. (TNF: tumour necrosis factor, TLR 4: Toll like receptor 4)  
 
Microglia  have  previously  been  shown  to  be  activated  by  tumour  necrosis  factor 
through  the  TNF  receptor  1,  resulting  in  further  production  of  TNF  and  other 
inflammatory cytokines (Kuno et al 2005). The authors suggest that this apparently 
autocrine  activation may  represent  a mechanism for  prolonged microglial  activation 
following stimulation. Interestingly, TNF mediated activation of microglia as quantified 
by CD11b (αMβ2 Integrin) mRNA correlates with production of mRNA for TNF p75 
receptor following transient middle cerebral artery occlusion (Lambertson et al 2007). 
This  provides  further  evidence  that  TNF,  possibly  from microglia,  is  able  to  further 
stimulate microglia with the upregulation of αMβ2 integrin. Furthermore, deficiency in  
TNF  receptors  1  and  2  using  double  knockout  mice  has  been  shown  to  result  in 
suppression  of  microglial  activation  following  exposure  to  the  neurotoxin  MPTP  (1 
methyl 4 phenyl 1,2,3,6 tetrahydropyridine) (Sriram et al 2006). A recent study has also 
demonstrated  that  in  an  ex-vivo  model  using  neonatal  hippocampal  brain  slices, 
deletion  of  TNF  receptor  1  prevented  endotoxin mediated  sensitisation  to  oxygen  
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glucose deprevation (Markus et al 2008). These observations provide further support 
for the hypotheses shown in Figure 5.15. 
 
The  identification  of  pro inflammatory  cytokines  as  critical  in  the  synergy  between 
infection  and  hypoxia ischemia  further  raises  the  potential  role  of  individual 
polymorphisms in the cytokine network. Such polymorphisms which make an individual 
more  prone to  a  pro inflammatory  cytokine  response may,  as  described  earlier,  be 
involved  in  both  the  onset  of  preterm  labour  and  in  sensitising  the  fetal  brain  to 
hypoxia ischemia.  In  the  context  of  the  current  study,  the  identification  of  an 
association between polymorphisms in the maternal lymphotoxin α gene and increased 
risk of the development of cerebral palsy is of particular note (Nelson et al 2006).  
 
Conclusions 
Low dose systemic endotoxin sensitises the developing brain to subsequent hypoxia 
ischemia through a pathway dependent on the TNF family of cytokines. Levels of the 
mRNA for these cytokines are raised in the brain of neonatal mice in the hours after 
systemic endotoxin administration. Furthermore deletion of the genes coding for the 
TNF family of cytokines also prevents endotoxin mediated up regulation of vascular 
endothelium and microglia within the central nervous system.  
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Chapter 6: Intracellular pH in Perinatal Hypoxic ischemic Brain Injury 
Introduction 
 
It is recognised that the most direct assessment of fetal wellbeing during labour comes 
from  assessment  of fetal  blood  pH,  carbon  dioxide  and  base  deficit  /  excess.  This 
potentially  can  be  performed  during  the  latter  stage  of  labour  by  fetal  scalp  blood 
sampling, or in the immediate postnatal period from the umbilical cord blood. It is also 
recognised that the metabolic component of any acidosis (using base deficit) has the 
strongest association with long term neurological outcome (ACOG Committee Opinion 
2006). Clinical studies have shown that moderate or severe postnatal complications 
occur in infants with an umbilical arterial base deficit of more than 12mmol/L, and to be 
of increasing severity with increasing base deficit (Low et al 1997). Consistent with the 
findings  of  acidosis  in  the  circulation,  an  intracellular  brain  acidosis  has  also  been 
demonstrated during hypoxia ischemia using proton magnetic resonance spectroscopy 
in  the  newborn  piglet  which  was  proportional  to  the  rise  in  intra cerebral  lactate 
(Penrice et al 1997). This rise in lactate is a consequence of anaerobic glycolysis that 
occurs during periods of hypoxia ischemia. The degree of metabolic acidosis in the 
blood and within the brain is related to the magnitude of the hypoxic ischemic insult, 
and the neurodevelopmental outcome in the neonate. Interestingly, however, acidosis 
in  vitro  using  mixed  neuronal  and  glial  cell  cultures  only  resulted  in  cell  death  on 
exposure to lactic acidosis of pH 5.2 for 1 hour (Goldman et al 1989), much more 
severe  and  prolonged  than  would  be  compatible  with  neonatal  survival.  These 
observations suggest that acidosis itself, whilst a marker of injury severity, may not be 
the direct cause of neuronal injury.  
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The effects of reperfusion on brain intracellular pH (pHi) have been extensively studied 
using animal models of cardiac arrest and resuscitation which produces reversible total 
cerebral ischemia. These studies have shown that, following reperfusion, there is a 
rapid  return  of  brain  pHi  to  normal  (LaManna  1996).  Following  transient  carotid 
occlusion  in  adult  rats,  there  is  also  a  rapid  normalisation  of  brain  pHi  during 
reperfusion, although the time required appears to relate to the magnitude of the insult 
(Hoffman et al 1994). In the reperfusion phase, following this normalisation of pHi, there 
is a period during which the intracellular pH of the brain is relatively alkalotic compared 
to baseline; this is termed rebound alkalosis (Mabe et al 1983, LaManna 1996). Further 
studies using transient forebrain ischemia have demonstrated that the time course of 
both the onset and duration of rebound alkalosis is dependent on the magnitude of the 
initial insult (Chopp et al 1990). This rebound alkalosis has also been demonstrated in 
human neonates following hypoxic ischemic encephalopathy (Robertson et al 1999). 
Interestingly, the magnitude and persistence of this rebound alkalosis has been shown 
to correlate with the long term neurodevelopmental outcome for the infant (Robertson 
et al 2002). These observations may suggest that the magnitude of acidosis predicts 
the magnitude and duration of alkalosis, which, in turn, is a determinant of long term 
neurodevelopmental outcome. From an experimental perspective, however, the rodent 
models  demonstrating  rebound  alkalosis  during  reperfusion  after  hypoxia ischemia 
have all been carried out in adult animals, and the changes in pHi in rodent models of 
neonatal  hypoxia ischemia have not  been studied to date. The use  of 3   amino m 
dimethylamino 2 methylphenazine  hydrocloride  (neutral  red)  (see  Figure  6.1)  as  an 
intracellular indicator of pH in rodent brain was first described in 1984 (LaManna & 
McCracken  1984).  Neutral  Red  is  a  relatively  non toxic  and  blood brain  barrier 
permeable dye which is preferentially taken up into the intracellular brain compartments 
after systemic (intrapertioneal) injection. It absorbs visible light in 2 different wavelength 
maxima depending on pH; the protonated acid form absorbs primarily at 530   550 nm 
(green), the free base form at 430 – 470 nm (blue) (see Figure 6.2).  
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Figure 6.1: Chemical structure of 3  amino m dimethylamino 2 methylphenazine hydrochloride 
(neutral red) 
 
Although  first  studies  using  neutral  red  were  done  using  differential  absorption  of 
transmitted light at 550/470 on tissue slices in vitro (LaManna et al 1980), a similar 
technique based on pH selective Neutral Red absorption was adapted to light spectra 
reflected from frozen tissue derived from animals injected with Neutral Red (Hoffman et 
al  1994).  Thus,  light  reflected  from  tissue  with  normal  or  basic  pH  would  show 
preferential reduction  in the  blue  bandwidth, and light  reflected form tissue  with  an 
acidotic pH would show preferential reduction in the in green bandwidth.  
 
 
Figure  6.2:  Absorbance  of  3   amino m dimethylamino 2 methylphenazine  hydrochloride 
(neutral red) at different pH (From Arregui et al 2003  © 2003 IEEE)  
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Mathematically, this reduction in the amount of reflected light (R) can be treated in a 
way similar to the more familiar, absorption mediated decrease in transmitted light (T). 
Considerable help with the derivation of the following mathematical formulae was given 
by  Professor  Raivich.  In  a  very  thin  slice  of  absorbing  medium,  the  reduction  in 
transmitted light  – dT is proportional to light  intensity, slice thickness  (dx), and the 
concentration (c) and specific extinction coefficient (ε) of the absorbing agent, or  
 
 dT = T * c * ε * dx,      or,    dT/T = c * ε * dx      (formula 6.1) 
 
Integrating this over total depth (x) of absorbing medium gives rise to: 
 
  Tx       x 
  ∫T
 1dT  =  ∫ c * ε * dx,   or   ln (Tx/T0) =   c * ε * x    (formulas 6.2, 6.3) 
  T0       
0 
 
or in reverse form to: 
 
Tx = T0 * e
 c*ε*x                  (formula 6.4) 
 
In  other  words,  specific  absorption  (c*ε)  is  proportional  to  the  natural  logarithm  of 
transmitted (Tx) to initial light intensity (T0). As transmitted light passes through many 
thin optical layers, a reverse process takes place, causing reflection of a fraction of 
transmitted  light.  Neglecting  surface  reflection  and  assuming  a  simple  proportional 
factor (rp) between reflected (R) and transmitted (T) light, light reflection becomes a 
function of T(x) and e
 c*ε*x, integrated over medium depth of x. T(x) already contains  
e
 c*ε*x,  but  a  second  term  needs  to  be  included,  as  some  of  the  reflected  light  will 
become absorbed on its way back to the surface of the object: 
       x                 x 
R = rp *  ∫T(x) * e
 c*ε*x dx  = rp * T0  ∫ e
 2*c*ε*x  dx      (formula 6.5) 
     
0               
0 
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In the final form, this becomes: 
                x 
R =   rp/(c*ε) * T0 
* │e
 2*c*ε*x│  =  T0* rp/(2*c*ε) * │1   e
 2*c*ε*x│    (formula 6.6) 
                       
0 
 
Assuming that almost all light is absorbed within the tissue and does not bounce from 
the  back end  of  the  tissue  back  to  the  front  (i.e.  lim  e
 2*c*ε*x  →  0),  the  formula  for 
reflected light obtains the form of: 
 
R = T0* rp/(2*c*ε), or simply   R = T0* rp/A          (formula 6.7) 
 
with A representing the previous double absorption term 2*c*ε. In this context, light 
reflected within the tissue is inversely proportional to tissue absorbance (AT). Assuming 
that the absorbance due to Neutral Red (ANR) is simply additive, i.e. does not interfere 
or synergise with tissue absorbance, reflected light from tissue containing Neutral Red 
(RNR) would be defined by the formula: 
 
RNR = T0* rp/(AT + ANR)               (formula 6.8) 
 
and reflected light (RT) from naïve tissue not containing Neutral Red as: 
 
RT = T0* rp/AT                      (formula 6.9) 
 
Under these conditions, the ratio of reflected light from tissue not containing (RT) to 
tissue containing Neutral Red (RNR) will simply represent the ratio of AT + ANR to AT: 
 
RT/RNR= (AT + ANR)/AT  or   RT/RNR= 1+ ANR/AT                (formulas 6.10, 6.11) 
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and subtracting 1 on both sides, this resolves into: 
 
(RT   RNR)/RNR= ANR/AT            (formula 6.12) 
 
In  the  context  of  current  work,  measuring  the  relative  reduction  in  reflected  light 
intensities  at  550/470nm  in  tissue  stained  in  vivo  with  neutral  red,  compared  with 
unstained, “naïve” tissue, thus provides a straightforward approach to identify current 
tissue  pHi  and/or  relative  changes  in  acid  or  base  balance  by  comparing  this 
absorbance to that in brain homogenates of known pH mixed with Neutral Red. To date 
this technique has been predominantly used to demonstrate changes in pHi in the adult 
rat following cardiac arrest and resuscitation.  
 
While this technique does allow regional changes in pHi to be deduced, for example in 
cortex,  striatum  and  hippocampus  (Crumrine  et  al  1991),  it  has  two  important 
limitations. For reasons of consistency one needs to compare the same region treated 
in  exactly  the  same  way,  in  naïve  and  Neutral  Red  injected  animals,  doubling  the 
number of animals needed. Moreover, it does not allow a high degree of structural 
resolution, as all calculations are performed on the basis of comparing regions in 2 
different sets of brains and not on the basis of data coming from a single image. 
 
Here, a two pronged approach was taken, studying quantitative changes in hypoxic 
and  post hypoxic  brain  using  a  conventional  technique  described  above,  and  by 
developing methodology to allow generation of high resolution images on brain pHi 
based on data provided by simultaneous RGB 3 channel recordings of frozen brain 
sections  from  animals  injected  with  Neutral  Red.  Since  Neutral  Red  absorbs  only 
weakly in the part of the visible spectrum recorded by the red channel in the Sony AVT 
Horn  RGB  video  camera  (hence  the  name,  Neutral  Red),  a  modified  function  of 
reflected red light intensity could potentially provide a useful surrogate marker for the 
“naïve” intensity of light illumination and tissue absorbance in green and blue channels,  
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in order to generate high resolution pHi maps based on RGB channel recordings from 
individual brain sections. In the current study, both of these techniques were then used 
to provide quantitative data, and sufficient structural resolution to visualise specific local 
as well as global pHi changes after hypoxia ischemia in the P7 mouse using the Rice 
Vannucci model of neonatal hypoxia ischemia (Rice et al 1981). 
 
 
Materials and Methods 
 
Surgery 
As described previously, experiments were performed at postnatal day seven (P7) on 
C57/Bl6  mice  (see  Materials  and  Methods).  Under  isoflurane  anaesthesia,  the  left 
carotid artery was permanently ligated and, after two hours of recovery, the animals 
were exposed to 8% oxygen in 92% nitrogen for 15 to 90 minutes. 
 
Neutral Red 
100mg  of  3   amino m dimethylamino 2 methylphenazine  hydrochloride  (neutral  red) 
was diluted to 10ml in sterile 0.9% saline to give a 1% solution and then filtered prior to 
use. Animals received a 200  l intraperitoneal injection of neutral red 2 hours prior to 
tissue collection. Control animals for measuring baseline light reflection without Neutral 
Red were injected with saline. 
 
Tissue Preparation 
pHi measurements were made in naïve animals, immediately after carotid occlusion 
(without hypoxia), after 60 minutes hypoxia alone (without preceding carotid occlusion) 
and after combined carotid occlusion and 15 60 minutes hypoxia. Re oxygenation was 
studied after carotid occlusion and 90 minutes hypoxia at 0h, 1h, 2h, 3h, 4h, 6h, 12h 
and 24h of re oxygenation. Animals were killed by decapitation and their heads snap 
frozen in isopentane at  20ºC on dry ice. Once frozen, the heads were stored at  80ºC  
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until required. To measure pHi, heads were mounted and cut on a cryostat at  20ºC. 
Starting from the olfactory bulbs photographic images of the cut surface of the brain 
were taken at 400  m intervals. 
 
Regional pHi Quantification 
A calibration curve for pH against relative green / blue absorption (A550/A470) was 
constructed using brain homogenates at known pH and a best fit algorithm defined for 
the range of pH 5.0 to 8.0 as described previously (LaManna & McCracken 1984). 
Homogenates of fresh brain tissue in 0.9% saline were prepared by passing the tissue 
sequentially through 20 gauge (0.9mm), 23 gauge (0.6mm) and 26 gauge (0.45mm) 
needles. In a microtitre plate (Nunc), 200  l standard brain homogenate solutions were 
made containing 10% brain homogenate, in 0.1M phospho boric acid buffer corrected 
to known pH (5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0) with 15  l of 0.1% neutral red.  
 
Images of standard brain homogenate solutions, or cut brain surface from Neutral Red 
or control saline injected animals were captured using a Sony AVT Horn video camera 
with narrow bandwidth RGB (red 570 630nm, green 510 570nm, and blue 440 500nm) 
filters mounted on a Carl Zeiss dissecting microscope illuminated from above with a 
shadow free, ring fibre optic illuminator (Dolan – Jenner Fibre Optics). Scanned images 
were imported into Optimas 6.2 image analysis software, mean intensity of reflected 
light in the green and blue channels in anatomically defined brain regions at every 400 
 m  interval  were  measured  and  averaged  for  each  region  using  area size  based 
weighting. The relative absorbance, based on relative reduction in reflected light ((RT 
RNR)/RNR, formula 6.12) in green and blue channels was determined in comparison to 
the same brain tissue areas from naïve animals not injected with Neutral Red. Regional 
tissue pHi values were deduced based on the green to blue relative absorbance ratio 
using the best fit algorithm defined from the standard brain homogenates at known pH 
(see Figure 6.3 and Formula 6.13). 
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Figure  6.3:  Callibration  for  pH  measurement:  A.  Photographic  images  of  10%  brain 
homogenate,  in  0.1M  phospho boric  acid buffer  corrected  to known  pH, with  15  l  of 0.1% 
neutral red. B: standard curve (black line) and best fit algorithm (red line) for absorbance at 
550nm/ absorbance at 470nm against pH. 
 
6.35+LOG((5.85 (A550/A470))/( 5.85+(A550/A470)+5.22)              (formula 6.13) 
 
Intracellular  pH  (pHi)  was measured  in  all  regions  of  the forebrain  (olfactory  bulbs, 
cortex, striatum, hippocampus and thalamus). Average measurements were taken from 
right and left hemispheres from 15 images. Recorded images were subsequently used 
to determine the colour balance (Green Red, Blue Red, Blue Green) in brain section 
images from naïve mice without Neutral Red and to create pseudo colour pHi maps 
from mice injected with Neutral Red using Optimas 6.2 image analysis software. Blue 
Red (Bb r) balance for each individual pixel of the image (760x570pixel) was calculated 
by subtracting the Optical Luminosity Values (OLV, 0 255, 8bit) for Red (OLVred) from 
that for blue (OLVblue). Similar formulas were also used for the Green – Red and Blue 
– Green balance. In the case of Green  Red (Bb r), 30 points were added, as the 8bit 
Optimas  calculations  only  support  operations  in  the  0 255  range  and  luminosity  in 
green is lower than in red: 
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Bb r = OLVblue – OLVred            (formula 6.14) 
Bb g = OLVblue – OLVgreen           (formula 6.15) 
Bg r = OLVgreen + 30 – OLVred          (formula 6.16) 
 
For processing RGB images from Neutral Red injected mice for pHi map data, red 
derived Blue (rdB) value was calculated by starting with OLVred/nr and adding the Blue 
– Red balance, and, in case of red derived Green (rdG), the Green – Red balance 
 
rdB = OLVred/nr + Bb r             (formula 6.17) 
rdG = OLVred/nr  30 + Bg r             (formula 6.18) 
 
The relative absorption in the blue bandwidth (Abl) was calculated according to formula 
6.12  by  substracting  OLVblue/nr  from  rdB  and  dividing  it  by  OLVblue/nr;  that  for 
absorption in green (Agr) by substracting and dividing it with OLVgreen/nr. Relative 
absorption in green to blue (Agr/bl) was obtained by dividing the two: 
 
Abl = (rdB   OLVblue/nr)/OLVblue/nr         (formula 6.19) 
Agr = (rdG   OLVgreen/nr)/OLVgreen/nr        (formula 6.20) 
Agr/bl = Agr/Abl              (formula 6.21) 
 
For imaging purposes, the Agr/bl absorption ratio pixel map of the brain sections was 
multiplied by 32 points, the resulting map converted using a pseudo colour filter 60 and 
then  compared  side  by  side  with  images  of  Neutral  Red  pH  calibration  in  brain 
homogenates processed using the same algorithm. 
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Results 
 
Timecourse of pHi following Hypoxia Ischemia   
 
pHi was measured in 40 animals in total. Measurements were made in naïve animals 
(n=3) after carotid occlusion alone without hypoxia (n=5), after carotid occlusion and 
subsequent hypoxia for 15 minutes (n=3), 30 minutes (n=3), 60 minutes (n=5) and 90 
minutes (n=5). To examine the changes in pHi during re oxygenation, animals that had 
undergone carotid occlusion and subsequent hypoxia for 90 minutes were studied at 1 
hour (n=3), 2 hours (n=2), 4 hours (n=2), 6 hours (n=2), 12 hours (n=2) and 24 hours 
(n=2)  after  hypoxia.  An  additional  3  animals  were  studied  following  60  minutes  of 
hypoxia alone without preceding carotid occlusion. 
 
There was no significant difference in pHi between naive animals and following carotid 
occlusion without subsequent hypoxia in either the left (occluded) hemisphere pHi  7.07 
v 7.05 (p=0.4), or right (non occluded) hemisphere pHi 7.07 v 7.06 (p=0.8) using the 
Student  t test.  Additionally  following  carotid  occlusion  without  subsequent  hypoxia 
there was  no significant difference in pHi between the forebrain regions  (F4,32=0.34 
p=0.88),  between  occluded  (left)  and  non occluded  right  hemispheres  (F1,32=0.17 
p=0.71) or between individual animals (F3,32=0.40 p=0.99) see Fig 6.4. 
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Figure 6.4: Intracellular pH (pHi) following left sided carotid occlusion prior to hypoxia. There 
were no significant differences between regions, hemispheres or animals (ANOVA) 
 
Carotid occlusion and hypoxia resulted in a significant fall in pHi on the occluded side 
from 7.05 to 6.9 after 15 minutes of hypoxia, 6.9 after 30 minutes of hypoxia, 6.7 after 
60 minutes of hypoxia and 6.59 after 90 minutes hypoxia. On the non occluded side, 
pHi was unchanged after 15 minutes hypoxia (7.07 to 7.05; p=0.13) and then fell to 
7.02 after 30 minutes, 6.88  after 60 minutes and  6.67 after  90 minutes of  hypoxia 
(p<0.05; Student t test). Following re oxygenation pHi returned to baseline by 2 hours. 
By 6 hours of re oxygenation a significant rebound alkalosis was detected on both the 
occluded (pHi 7.15 p<0.05) and the non occluded side (pHi 7.16 p<0.05). The observed 
rebound alkalosis resolved by 12 hours (see Figure 6.5). Pure hypoxia for 60 minutes 
without preceding carotid occlusion also resulted in a significant bilateral acidosis with 
a pHi of 6.96 in the left hemisphere (p<0.05), and pHi   of 6.97 (p<0.05) in the right 
hemisphere. Of note there was no significant difference between the two sides (p=0.19 
see Figure 6.5).  
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Figure 6.5 Time course of pHi changes following hypoxia ischemia: Following carotid occlusion 
(CROC) and hypoxia there was a significant intracellular acidosis on the occluded (left) side. On 
the  non occluded (right  side) there  is relative preservation  of  pHi following  short duration of 
hypoxia (15 30 minutes). However between 60 and 90 minutes of hypoxia, significant acidosis 
was seen. Following re oxygenation, pHi rapidly recovered with a significant rebound alkalosis 
seen on both sides after 6 hours or re oxygenation (* p<0.05 compared with baseline, # p<0.05 
between occluded and non occluded side ANOVA). 
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pHi Brain Map Imaging 
Single image processing technique 
Since both basic and acidic forms of Neutral Red absorb only weakly in the red part of 
the visible spectrum compared with their maxima in blue and green, respectively, the 
potential of using the red channel from the same section as a surrogate marker for 
green and blue light reflected from tissue in the absence of Neutral Red was explored. 
As shown in Figure 6.6 A, colour balance analysis using brain section images from 
mice subjected to unilateral carotid occlusion and 90 minutes of relative hypoxia with 
8% oxygen, showed very similar mean values for the blue to red balance averaged 
across the brain for the occluded (left) and non occluded (right side). A similar absence 
of significant difference was also observed for the average green to red, and blue to 
green balances between the occluded and non occluded side for the whole forebrain 
(see Figure 6.6 A), as well as in individual brain sections taken at different depths. 
Further analysis also showed very similar levels of intra image, pixel to pixel standard 
deviations on the occluded, as well as the non occluded side (see Figure 6.6 B). These 
inter pixel standard deviations were also relatively moderate, i.e. at most 4 OLV points 
or just 10 20% of the absolute colour balance values. 
 
Figure 6.6: Colour Balance following Carotid Occlusion (CROC) and 90 minutes Hypoxia of the 
Left (occluded) and Right (non–occluded) hemispheres. There was no difference in the average 
green  to  blue,  green  to  red,  and  blue  to  green  balances  between  the  occluded  and  non 
occluded side for the whole forebrain A. Means, B. standard deviations (SD).  
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To determine whether these balances stay the same or change before, during or after 
a hypoxic ischemic insult, the changes in the green to red, blue to red and green to 
blue colour balance in unoperated control animals, after carotid occlusion alone, after 
90 min hypoxia and after 2, 4, 6 and 24 hours re oxygenation were examined (see 
Figure  6.6A C).  Again,  none  of  the  very  minor  side to side  differences  were 
significantly different. As shown in Figure 6.7 A, there was also very little overall effect 
on the green to red balance, on the unoperated or operated side. In contrast, the blue 
to red balance increased, from approx 17.5 points for the right and left side in control 
animals, peaking at approx 25 points after 90min of hypoxia, decreasing to 13 points at 
6h of re oxygenation and returning to approx 23 points at 24hours (Figure 6.7 B). As 
expected, reverse changes were observed for the green to blue balance, with a peak in 
control  animals  and  6h  re oxygenation,  and  a  trough  following  90  min  of  hypoxia 
(Figure 6.7 C). To avoid systemic errors, and for reasons of consistency, all pHi map 
calculations were, therefore, based on settings derived from naïve mice not injected 
with  Neutral  Red  but  that  experienced  the  same  hypoxic ischemic  insult  and  re 
oxygenation conditions as the animals injected with Neutral Red. 
 
Pseudocolour pHi maps for animals following carotid occlusion, carotid occlusion and 
15   90 minutes hypoxia and following 1   24 hours of re oxygenation were constructed 
according to formulas 6.17 6.21. As shown in fig. 6.4 and 6.5, animals that underwent 
left sided carotid occlusion alone without subsequent hypoxia showed no change in pHi 
on either the occluded or non occluded side in the quantitative analysis. The same 
absence of effect was also observed with pseudocolour maps, showing a symmetrical 
pHi throughout all forebrain regions with no apparent effect of the surgical ligation (fig. 
6.8 A).  
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Figure 6.7: A: Green, B: Blue and C: Green to Blue Colour Balance in naïve animals, following 
carotid occlusion (CROC), carotid occlusion and 90 minutes Hypoxia (CROC HY) and following 
2 24 hours re oxygenation. No difference was seen between the Left (occluded) and Right (non 
occluded) hemispheres.  
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The acidic shift in brain pHi following carotid occlusion and exposure to 8% oxygen 
increased with time but was already observed at 15 min of hypoxia. At this early time 
point, a clear acidic shift was evident in the superficial dorsal cortex on the occluded 
side, with milder changes in the ventral cortex, ventrolateral thalamus, and throughout 
the  hippocampus  on  the  occluded  side.  The  contralateral  hemisphere  remained 
unaffected. At 30 minutes of hypoxia, the acidic shift in the ipsilateral cortex became 
more  widespread,  with  clear  changes  in  the  ipsilateral  hippocampus, thalamus  and 
striatum and a start of  acidosis in the contralateral superficial dorsal cortex. At 60 
minutes, the ipsilateral hemisphere showed generalised acidosis, most severely in the 
ventral  lateral  cortex,  hippocampus  and  thalamus.  A  generalised  acidosis  also 
extended to the contralateral hemisphere but with relative preservation of the dorsal 
cortex,  hippocampus  and  thalamus.  At  90  minutes,  all  forebrain  regions  showed 
general acidosis with no obvious difference between the hemispheres, consistent with 
the previous quantative analysis (see Figure 6.7 a e). All re oxygenation studies were 
performed after carotid occlusion and 90 minutes of hypoxia at 8% oxygen. One hour 
of re oxygenation resulted in a dramatic normalisation of the pHi throughout the brain, 
with mild residual acidosis most notable in the ipsilateral posterior cortex hippocampus 
and thalamus. After 2 hours of re oxygenation, slight residual acidosis was confined 
predominantly to the ipsilateral ventral cortex and hippocampus and to a lesser extent 
the contralateral ventral cortex and hippocampus. After 4 hours of re oxygenation some 
rebound  alkaline  shift  is  seen  in  brain  pHi, most  notable  in  the  contralateral  dorsal 
cortex and dorsal hippocampus. A similar, but less pronounced, effect was seen in the 
ipsilateral  dorsal  cortex  and  dorsal  hippocampus.  6  hours  of  re oxygenation  was 
associated with generalised bilateral rebound alkalosis, most apparent in the dorsal 
cortex and hippocampus. After 12 hours, the general pHi of the brain had returned to 
normal. However, there was an apparent relative acidic shift in the ipsilateral dorsal 
cortex and hippocampus in sections 8 15; the ipsilateral dorsal acidic wedge. By 24 
hours, there was a generally symmetrical distribution of pHi similar to that seen prior to 
hypoxia, with the reduction in the dorsal acidic wedge (see Figure 6.8 F K).  
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Figure 6.8A: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion alone.  
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 Figure  6.8  B:  Pseudo colour  reconstruction  of  coronal  brain  sections  demonstrating 
intracellular brain pH (pHi) following carotid occlusion and 15 minutes of hypoxia at 8% oxygen.  
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Figure 6.8 C: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion and 30 minutes of hypoxia at 8% oxygen. 
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Figure 6.8 D: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion and 60 minutes of hypoxia at 8% oxygen. 
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Figure 6.8 E: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion and 90 minutes of hypoxia at 8% oxygen.  
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Figure 6.8 F: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion, 90 minutes of hypoxia at 8% oxygen and 1 hour of re 
oxygenation.  187 
 
 
Figure 6.8 G: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion, 90 minutes of hypoxia at 8% oxygen and 2 hours of 
re oxygenation.  188 
 
 
Figure 6.8 H: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion, 90 minutes of hypoxia at 8% oxygen and 4 hours of 
re oxygenation.   
189 
 
 
 
Figure 6.8 I: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion, 90 minutes of hypoxia at 8% oxygen and 6 hours of 
re oxygenation.   
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Figure 6.8 J: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion, 90 minutes of hypoxia at 8% oxygen and 12 hours of 
re oxygenation.   
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Figure 6.8 K: Pseudo colour reconstruction of coronal brain sections demonstrating intracellular 
brain pH (pHi) following carotid occlusion, 90 minutes of hypoxia at 8% oxygen and 24 hours of 
re oxygenation.   
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Discussion 
The current study used blue, green and red waveband channel light absorption by the 
blood brain permeable pH indicator Neutral Red, to assess regional brain pHi during 
and after a hypoxia ischemia. Carotid occlusion alone had no effect on pHi whereas 
carotid occlusion combined with hypoxia led to a rapid, biphasic decline in ipsilateral 
pH  with  a  first  drop  at  15 30,  and  second  one  at  60 90  minutes  after  initiation  of 
hypoxia. The perfusion territory of the ipsilateral middle cerebral artery (Zhang et al., 
1997, Maeda et al., 1998) (dorsal cortex, hippocampus, striatum and thalamus) was 
the most affected. The contralateral side initially showed a small decline in pHi after 15 
minutes of hypoxia, but became progressively more acidic with the increasing duration 
of hypoxia. Re oxygenation after carotid occlusion combined with hypoxia resulted in a 
global mild alkalotic shift at 6 hours (a pHi value 0.1 0.15 above baseline).  
 
Intracellular Acidosis during Hypoxia ischemia 
 
Unsurprisingly, hypoxia ischemia achieved by a combination of carotid occlusion and 
exposure to a hypoxic environment results in a progressive acidosis on the occluded 
side proportional to the duration of hypoxia. Previous animal studies of transient middle 
cerebral artery occlusion in rats (Mabe et al 1983), and transient carotid occlusion with 
hypoxia  in  piglets  (Penrice  et  al  1997)  have  demonstrated  a  similar  acidosis 
proportional  to  the  accumulation  in  cerebral  lactate.  It  is  therefore  likely  that  the 
acidosis  observed  in  the  current  study  also  results  from  anaerobic  glycolysis  and 
lactate production. It is interesting to note, that carotid occlusion alone does not result 
in a change in pHi, with no significant difference between occluded and non occluded 
hemispheres, or between naïve and operated animals. Indeed this observation is in 
keeping  with  the  current  and  previous  studies  that  have  not  identified  histological 
damage with carotid occlusion alone in the rat (Rice et al 1981) or mouse (Sheldon et 
al 1998).  
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Previous studies of cerebral perfusion,  in  immature rats, following  carotid  occlusion 
using Indian ink trapped in cerebral vessels and measurement of [
14C]iodoantipyrine 
([
14C]IAP) extraction into the brain have demonstrated that permanent unilateral carotid 
occlusion  alone reduces [
14C]IAP accumulation in the ipsilateral hemisphere by only 
20%, whereas carotid occlusion in combination with 2 hours hypoxia at 8% reduced 
[
14C]IAP  accumulation  by  70%  (Silverstein    et  al  1984).  This  suggests  that  carotid 
occlusion alone has only a mild impact on cerebral perfusion which is consistent with 
the current study showing no change in pHi.  
 
Mild hypoxia (15 minutes) in addition to carotid occlusion resulted in ipsilateral acidosis 
in the distribution of the middle cerebral artery; this may suggest that the observed 
preservation of anterior and posterior pHi results from contralateral supply through the 
circle of Willis. More prolonged hypoxia (30 minutes) resulted in a more generalised 
acidosis on the ipsilateral side with a small confined area of acidosis in the contralateral 
dorsal cortex. It is not possible from the current study to deduce the mechanism of this 
contralateral acidosis. However, it may be speculated that it may result from either a 
vascular steal phenomenon with resultant ipsilateral perfusion failure, or from the start 
of a generalised cardiovascular decompensation, with a fall in systemic blood pressure 
and  acidosis  in  a  watershed  area  of  the  murine  brain.  It  is  clear,  however,  that  in 
prolonged hypoxia (60   90 minutes) there is a worsening bilateral acidosis which is not 
significantly different  between the hemispheres. The most  likely explanation for this 
observation is cardiovascular decompensation with impairment of cardiac contractility, 
fall in blood pressure and reduced general cerebral perfusion. Further evidence for this 
mechanism can be seen following 60 minutes of pure hypoxia alone, without preceding 
carotid occlusion. In these animals, there is a bilateral acidosis of equal magnitude on 
both sides. It is interesting to correlate the pattern of changes in pHi shown in the 
current  study  with  histological  injury  as  described  earlier  (see  chapter  3).  It  is 
interesting to note that the areas of maximal histological injury on the ipsilateral side 
correspond to the areas of greatest acidosis in the current study (dorsal cortex and  
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dorsal hippocampus). Moreover larger cortical infarcts were only seen after 60 minutes 
of  hypoxia ischemia  despite  significant  acidosis  seen  during  shorter  duration  of 
hypoxia.  Additionally,  whilst  contralateral  acidosis  is  noted  after  a  relatively  short 
duration of hypoxia ischemia (30 minutes) evidence of contralateral histological injury is 
not  seen  even  after  prolonged  (60  minute)  hypoxia ischemia.  Furthermore,  in  the 
human neonate, it is recognised that there is a threshold of systemic acidosis which, if 
exceeded  results  in  multi organ  damage  (Low  et  al  1997).  Taken  together,  these 
observations are in keeping with the suggestion that acidosis is not the direct cause of 
neuronal injury and are consistent with the in vitro evidence that neurones are relatively 
resistant to lactic acidosis (Goldman et al 1989). 
 
Previous  studies  have  suggested  that  mice  exposed  to  the  same  hypoxic ischemic 
insult may, in the long term, demonstrate either mild atrophy of the brain ipsilateral to 
the  carotid  occlusion  with  intact  contralateral  side,  or  severe  cerebral  atrophy  with 
formation of a large porencephalic cyst, loss of the ipsilateral cortex, and contralateral 
ventriculomegaly and thinning of the cortex (Ten et al 2004). Whilst the current study 
was not large enough to study this phenomenon it is known that C57/Bl6 mice have 
differing patency of circle of Willis in C57/Bl6 (McColl et al. 2004). It can, therefore, be 
speculated that mice may have differing abilities to compensate for unilateral carotid 
occlusion by flow through the circle of Willis dependent on the arteries present (see 
Figure 6.8).  
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Figure 6.9 Differing patency of the Circle of Willis. Ant Com – Anterior Communicating Artery, 
Post Com – Posterior Communicating Artery, ACA – Anterior Cerebral Artery, MCA – Middle 
Cerebral Artery, BA – Basilar Artery (from McColl et al 2004, reproduced with permission). 
 
Re Oxygenation and Rebound Alkalosis 
Consistent  with  clinical  observations  following  stroke  (Hugg  et  al  1992),  neonatal 
encephalopathy (Robertson et al 1999, Robertson et al 2002), and adult animal models 
of middle cerebral artery occlusion (Mabe et al 1983, Chopp et al 1990), the current 
study  demonstrates  rebound  alkalosis  in  neonatal  mice  following  hypoxia ischemia. 
Previous evidence suggests that the rapid normalisation of pHi seen in animal models 
during reperfusion following cardiac arrest is mediated by the Na
+/H
+ exchanger, which 
is known to be present on the cell membranes in various isoforms (Masreel et al 2003). 
Furthermore, blockade of this transporter has been shown to delay normalisation of pHi 
during  reperfusion  (Ferimer  et  al  1995).  It  has  been  suggested,  therefore,  that  the 
rebound alkalosis following hypoxia ischemia may arise because of a failure to switch 
off  the  Na
+/H
+  exchanger  resulting  in  excess  hydrogen  ion  extrusion  from  cells 
(LaManna 1996). 
 
10% of animals      60% of animals    30% of animals  
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In the  current study,  a statistically significant rebound alkalosis is  detected 6 hours 
following re oxygenation.  Previous  studies in  the human  neonate following hypoxic 
ischemic  encephalopathy  demonstrate  that  the  magnitude  and  duration  of  rebound 
alkalosis  correlates  with  worsening  neurodevelopmental  outcome  (Robertson  et  al 
2002). A number of mechanisms have been postulated by which rapid normalisation of 
pHi and rebound alkalosis may be responsible for this association. Mild acidosis (both 
extra  and  intracellular)  during  reperfusion  after  transient  hypoxia ischemia  has 
previously been shown to protect the brain (Simon et al 1993, Vannucci et al 2001). 
Conversely  an  alkaline  pHi  may  exacerbates  excitotoxic  neuronal  injury  due  to 
increased N methyl D aspartate activation (Traynelis et al 1990, Giffard et al 2002) and 
activation  of  phospholipases  and  proteases,  which  have  an  alkaline  pKa  (Mellgren 
1987). Changes in pHi also result in alterations of the delicate balance of pro  and anti 
apoptotic triggers in mitochondria. Alkalinisation has been shown to: (i) activate Bax (a 
pro apoptotic protein), inducing its mitochondrial translocation (Khaled et al 1999); (ii) 
inhibit the import of ADP into mitochondria, which impairs the synthesis of ATP (Khaled 
et al 2001) and (iii) transform the mitochondrial permeability transition pore into a high 
conductance state, a critical step leading to cell commitment to death (Lemasters et al 
1997). Interestingly, however, in the current study rebound alkalosis is detected over 
the whole brain, not just the region of expected histological injury from previous studies 
(see  chapter  3).  This  raises  a  number  of  questions  about  both  the  mechanism  of 
rebound  alkalosis  and  its  role  in  neuronal  injury.  Of  note  in  the  current  study,  re 
oxygenation was examined after 90 minutes of hypoxia during which there is a global 
bilateral acidosis and therefore the global rebound alkalosis may indeed be a rebound 
phenomenon. However, from the pseudocolour maps, it appears that alkalosis was 
most evident in regions of the brain away from the regions of greatest acidosis and 
expected  tissue  damage  (ipsilateral  dorsal  cortex  and  hippocampus).  Although 
previous studies have examined regional changes in pHi following cardiac arrest, these 
studies examined pHi changes after a global hypoxic ischemic insult in contrast to the 
current study, which uses unilateral carotid occlusion and global hypoxia. In the human  
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neonatal studies, the 
31P MR spectra from which pHi was calculated were acquired from 
a  large  voxel  (at  least  125cm
3),  which  encompassed  both  the  right  and  left  basal 
ganglia,  as  well  as  white  matter  (Robertson  et  al  2002).  Here  again,  these 
measurements  followed  global  hypoxia ischemia.  The  identification  of  maximal 
rebound alkalosis away from the region of expected tissue damage may suggest that 
alkalosis,  like  acidosis  is  not  a  direct  cause  of  neuronal  injury.  However  it  can  be 
speculated  that  this  alkalosis  may  have  a  direct  impact  of  neuronal  survival  by  a 
number  of  mechanisms.  It  is  recognised  that  a  rise  in  pHi  leads  to  an  increase  in 
neuronal excitability and increased susceptibility to epileptiform activity both in vitro and 
in vivo (Chesler 2003). Seizures in neonates following a hypoxic ischemic event are 
associated  with  a  worse  prognosis,  often  distinguishing  babies  having  mild  and 
moderate encephalopathy (Sarnet et al 1976). It is of note, therefore, that in the human 
neonate the timing of onset of seizures is often delayed to 6 24 hours after the insult, 
and  corresponds  to  the  timing  of  secondary  energy  failure  and  rebound  alkalosis 
(Penrice et al 1997). An alternative possibility is that the presence of a large infarct may 
disrupt  the  cellular  processes  that  cause  rebound  alkalosis;  hence,  the  pattern  of 
alkalosis  identified  may  be  specific  to  this  model  and  not  be  applicable  to  human 
neonatal  encephalopathy  where  large  infarctions  are  rare.  It  is  of  note  that,  in 
experimental models of middle cerebral artery occlusion, rebound alkalosis is detected 
in  the  penumbral  region  during  reperfusion  whilst  the  infarct  core  remains  acidotic 
(Back et al 2000). Whilst, in the current study, the entire brain becomes alkalotic, this 
may only be of consequence where there are damaged neurones where, through the 
mechanisms described above, alkalosis may result in cell death whereas normal pHi or 
even mild acidosis may be neuroprotective. The role of manipulation of pHi following 
hypoxia ischemia as a neuroprotective strategy will be considered further in chapter 7.  
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Conclusions 
Clinical studies and animal models demonstrate progressive acidosis during hypoxia 
ischemia and a rebound alkalosis in the reperfusion phase in both adult stroke and 
neonatal hypoxia ischemia. Growing evidence suggests that alkalosis correlates with 
outcome.  The  current  study  demonstrates  that  these  changes  occur  in  a  murine 
neonatal of neonatal hypoxia ischemia. Moreover alkalosis is most evident in regions of 
the  brain  away  from  the  greatest  acidosis  and  tissue  damage.  Previous  studies  of 
neonatal and adult hypoxic ischemic brain injury have concentrated on the infarcted 
region  and,  in  animal  models,  the  penumbra.  The  current  study  may  suggest  that 
events in the remainder of the brain may have a direct influence on the fate of the 
injured  region  and,  hence,  therapeutic  interventions  aimed  altering  /  preventing 
rebound alkalosis  in the  uninjured regions  of the brain may confer neuroprotection. 
Moreover, if this is true then the use of drugs that prevent rebound alkalosis may be 
effective in the post injury phase as these regions of the brain have an intact normal 
blood supply and there is a therapeutic window in the early reperfusion phase prior to 
the onset of rebound alkalosis.   
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Chapter  7:  N methyl isobutyl amiloride  Ameliorates  Brain  Injury  when 
Commenced Prior to Hypoxia Ischemia in Neonatal Mice. 
 
Introduction 
 
Over  the  last  20  years,  studies  using  phosphorus  (
31P)  and  (
1H)  proton  magnetic 
resonance spectroscopy (MRS) in both infants with neonatal encephalopathy (Hope et 
al 1984, Younkin et al 1984, Laptook et al 1989) and experimental models (Lorek et al 
1994,  Penrice  et  al  1997),  have  characterised  the  biphasic  disruption  of  cerebral 
energetics that  occurs  in  the  hours  following  hypoxia ischemia.  These  observations 
have led to the concept of a “therapeutic window” following hypoxia ischemia, during 
which intervention may ameliorate the severity of brain injury. There has, until recently, 
been  no  intervention  which  has  improved  the  outcome  following  perinatal  hypoxia 
ischemia.  Recently,  however,  the  results  from  the  first  randomised  trials  of  mild 
hypothermia have been published (Gluckman et al 2005, Shankaran et al 2005, Eicher 
et al 2005). Considerable work is still required to optimise cooling strategies in the 
newborn. However there is a growing impression that optimum neuroprotection may 
involve  the use  of more than one therapy,  targeting  different molecular  events that 
occur after hypoxia ischemia.  
 
A  remarkable  observation  from  the 
31P  MRS  studies  in  infants  with  neonatal 
encephalopathy was that during the second phase of energy decline that occurred from 
8 24 hours following birth, brain intracellular pH (pHi) was alkaline (pHi 7.1 7.4). Under 
physiological conditions, brain pHi is maintained at around 7.03; the Na
+/H
+ exchanger 
(NHE) tightly regulates both pHi and cell volume by extruding protons from and taking 
sodium up into cells (Masereel et al 2003). Some evidence suggests that excessive 
activation of this transporter following hypoxia ischemia is responsible for the observed 
rebound alkalosis (Wakabayashi et al 1992). Adult clinical studies have demonstrated 
brain alkalosis in areas of chronic infarction after stroke (Hugg et al 1992, Levine et al 
1992)  with  a  significant  correlation  between  brain  alkalosis  and  subsequent  poor  
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clinical outcome
 (Welch et al 1990). A similar relationship between alkalosis and the 
severity of brain injury in term infants with neonatal encephalopathy has also been 
observed
 (Robertson et al 2002). Infants with the most alkaline brain pHi had more 
severe  changes  on  MRI  within  the  first  2  weeks  after  birth,  and  the  worst 
neurodevelopmental outcome at one year. Interestingly, this brain alkalosis was seen 
to persist for some months in those with the worst outcome (Robertson et al 1999).  
 
These observations led to the hypothesis that prevention of rebound alkalosis would 
reduce the severity of brain injury observed after perinatal hypoxia ischemia. Further 
evidence for this hypothesis comes from an in vitro tissue culture model (Vornov et al 
1996)  and  ex  vivo  brain  slices  model  (Robertson  et  al  2005).  In  these  studies, 
prevention of rebound alkalosis using an inhibitor of the Na
+/H
+ exchanger resulted in 
reduced  cell  loss  and  preservation  of  brain  energetics  whilst  the  tissue  remained 
alkalotic. If these finding can be replicated in vivo, blockade of the Na
+/H
+ exchanger 
may represent a therapeutic intervention to ameliorate brain injury in neonatal hypoxia 
ischemia. To establish a proof of concept, amiloride, a drug known to block the action 
of  the  Na
+/H
+  exchanger,  was  administered  prior  to  a  hypoxic ischemic  insult  and 
continued 8 hourly after hypoxia ischemia until histological examination at 48 hours. N 
methyl isobutyl amiloride  (MIA)  was  used,  as  this  analogue  is  known  to  cross  the 
blood brain barrier (Ferimer et al 1995).  
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Materials and Methods 
 
Surgery 
As described previously experiments were performed at postnatal day seven (P7) on 
C57/Bl6  mice  (see  Materials  and  Methods).  Under  isoflurane  anaesthesia,  the  left 
carotid artery was permanently ligated and then the animals exposed to 8% oxygen in 
92% nitrogen for 30 minutes (moderate insult) or 60 minutes (severe insult). 
 
 
N methyl isobutyl amiloride administration 
10mg of N methyl isobutyl amiloride (MIA) was dissolved in 150  l 350mM acetic acid 
and then diluted to 40ml in sterile 0.9% saline to give a final concentration of 250  g/ml. 
Aliquots were stored at  80°C until required. Animals were sequentially allocated to 
receive intra peritoneal injections of MIA (2.5 mg/kg, 10  l/g) or an equivalent volume 
of 0.9% saline every 8 hours, commencing 30 minutes before hypoxia. 
 
 
Tissue Preparation 
Animals were killed 48 hours after moderate and severe hypoxia ischemia by intra 
peritoneal  injection  of  pentabarbitone,  perfused,  post fixed  and  frozen  as  described 
previously  (see  Materials  and  Methods).  15  sections  from  each  forebrain  (200   m 
apart)  were  stained  with  cresyl  violet.  In  the  moderate  insult  group,  five  coronal 
sections  per  brain  (600   m  apart),  were  stained  using  immunohistochemistry  for 
microglial and macrophage activation  using  the  rat monoclonal  5C6 αMβ2  antibody 
(Serotec). Five further coronal sections per brain, with the same spacing, were stained 
using  Terminal  transferase  mediated  d UTP  Nick  End Labelling  (TUNEL)  and  brain 
injury  was  quantified  using  infarct  volume  and  brain  injury  scoring  as  described 
previously (see Materials and Methods).  
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Results 
Severe Insult 
Twenty animals underwent the severe insult protocol. Four animals died during the 
hypoxia (2 MIA, 2 saline). Four animals died in the subsequent 48 hours (1 MIA, 3 
saline). Animals were weighed every 8 hours until they were sacrificed. There was no 
significant  difference  in  weight  between  the  two  groups  at  the  onset  of  treatment 
(4.43g±0.30g in the saline treated group, n=10;4.49±0.34g in the MIA treated group 
n=10). Both groups of animals lost weight in the first 24 hours after hypoxia ischemia, 
(0.39±0.24g in the saline treated group;  0.34g±0.21g in the MIA treated group), and 
then  plateaued.  There  was  no  significant  difference  in  weight  loss  between  the  2 
groups during the 48 hour period (ANOVA). 
 
The separate regions of the forebrain (cortex, hippocampus, striatum and thalamus) 
showed  different  sensitivity  in  their  response  to  the  carotid  occlusion  and  1  hour 
hypoxia  (F3,21=47.7  p<0.05,  ANOVA).  The  effects  were  particularly  severe  in  the 
hippocampus and much milder in the cortex, striatum and thalamus. No change was 
observed  in  the  hypothalamus  or  brainstem.  There  was  no  significant  difference 
between litters in their response to the hypoxia ischemia.  
 
Pretreatment with MIA resulted in an increase in surviving brain tissue, from 44% to 
67% (p<0.05) in the affected forebrain regions, compared to the contralateral side (see 
Figure 7.1). Pretreatment with MIA resulted in increase in surviving brain tissue in the 
cortex from 50% to 76% (p<0.05), and an increase in the hippocampus from 10% to 
19% (p<0.05). Treatment also resulted in an increase in tissue survival in the thalamus 
from 56% to 64% and an increase in the striatum from 34 47% but these did not reach 
statistical  significance  (see  Figure  7.2).  However,  ANOVA  common  factor  analysis 
revealed  MIA  to  have  a  highly  significant  overall  protective  effect  against  carotid 
occlusion  and  1  hour  of  8%  hypoxia  across  the  different  brain  regions  (F1,21=11.2, 
p<0.05).  
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Figure 7.1: Effects of MIA following severe hypoxia ischemia: A. Cresyl violet stained coronal 
sections 48 hours following carotid occlusion and 1 hour hypoxia. Note the substantial loss of 
cortical tissue and the maintenance of the hippocampal dentate gyrus. Ventral cortex, amygdala 
and  hypothalamus  appear  unaffected.  B.  Pretreatment  with  MIA  resulted  in  a  significant 
increase  in  surviving  total  forebrain  hemispheric  tissue  expressed  as  percentage  of  the 
unaffected hemisphere (n=7 MIA / n=5 saline), (*p<0.05 by Student t test).  
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Figure  7.2  Effects  of  MIA  following  severe  hypoxia  ischemia  on  different  forebrain  regions: 
Treatment  with  MIA  resulted  in  a  significant  increase  in  cortical  (p<0.05)  and  hippocampal 
(p<0.05) tissue expressed as percentage of unaffected hemisphere but not in the thalamus and 
striatum. 
 
Moderate Insult 
Twenty animals underwent the moderate insult protocol. Three animals died during the 
hypoxia (2 MIA, 1 saline). There was no significant difference in weight between the 
two groups at the onset of treatment (3.62±0.71g in the saline treated group n=10; 
3.77±0.74g in the MIA treated group n=10). Both groups of animals continued to gain 
weight  over  the  48  hours  following  hypoxia ischemia  and  there  was  no  significant 
difference in weight gain between the 2 groups at 48 hours (+0.35±0.54g in the saline 
treated group, +0.27±0.46g in the MIA treated group). Histological damage was only 
observed in the hippocampus with loss of neurons predominantly within CA1 and CA2. 
There  was  a  relative  preservation  of  neurons  within  the  dentate  gyrus. 
Immunohistochemistry  for  αMβ2  integrin  demonstrated  both  macrophage  activation 
and the presence of deramified phagocytes in the same regions as histological damage 
(see Figure 7.3).  
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Figure 7.3: Sequential coronal sections stained with Nissl (A) and immunohistochemistry for 
αMβ2 integrin (B) in the hippocampus following carotid occlusion and 30 minutes hypoxia. Mild 
neuronal loss is seen in CA1 (arrow). Immunohistochemistry reveals macrophage activation and 
the presence of deramified phagocytes (dashed arrows). Note the activation in CA1 and CA4 
with maintenance of CA2 and dentate gyrus (DG). 
 
Pretreatment  with  MIA  resulted  in  a  reduction  in  the  mean  injury  score  in  the 
hippocampus, from 3.1±1.8 to 0.7±1.1 (p<0.05) and a reduction in the average injury 
score across all affected forebrain regions from 1.0±0.6 to 0.2±0.3 (p<0.05). Treatment 
also resulted in reduced injury scores in the cortex, thalamus and in the striatum but 
these did not reach statistical significance (see Figure 7.4).  
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Figure 7.4: Effects of MIA following moderate hypoxia ischemia on different forebrain regions: 
Treatment  with  MIA  (2.5mg/Kg)  resulted  in  a  significant  decrease  in  average  injury  score 
(p<0.05) and  in  the  hippocampus  (p<0.05).  A neuroprotective trend  was  seen  in  the  cortex 
thalamus and striatum (n=9/7; Student t test). 
 
Following  the  moderate  insult,  TUNEL  staining  only  showed  significant  DNA 
fragmentation  in  CA1  and  CA2  of  the  hippocampus  in  the  injured  hemisphere. 
Occasional TUNEL positive cells were seen in other regions such as the dentate gyrus 
and cerebral cortex; however, no difference was observed between the injured and 
contralateral  hemisphere  or  between  treatment  groups  in  other  brain  regions. 
Pretreatment with MIA resulted in a reduction in the average number of TUNEL positive 
within the hippocampus, from 241±262 cells/mm
2 to 21±55 cells/mm
2 (p<0.05) (see 
Figure 7.5).  
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Figure 7.5: Effects of MIA on TUNEL positive cells within the Hippocampus. A. TUNEL stained 
cells in the CA1 of the hippocampus (arrows); note occasional TUNEL positive cells within the 
dentate  gyrus  (DG).  B.  Pretreatment  with  MIA  results  in  a  significant  reduction  in  TUNEL 
positive cells, (n=9/7 * p<0.05 Student t test). 
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Discussion 
Treatment  with  MIA  commenced  prior  to  hypoxia ischemia  ameliorated  histological 
brain  injury  at  48  hours  following  hypoxia ischemia  in  a  neonatal  mouse  model. 
Importantly, neuroprotection was seen following hypoxia ischemia of varying severity. 
The results are consistent with the increasing evidence that NHE blockade may be 
beneficial to cell survival after hypoxia ischemia. Blockade of the NHE has previously 
been  shown  to  confer  neuroprotection  in  adult  rats  when  administered  immediately 
after  focal  cerebral  ischemia  (Horikawa  et  al  2001).  In  a  tissue  culture  model  of 
cerebral  ischemia, the  prevention of rebound alkalosis using  amiloride  after  in vitro 
hypoxia ischemia delayed the onset of injury for as long as the cells remained acidotic 
(Vornov et al 1996). Recent studies in an ex vivo model of neonatal rat brain slices 
demonstrated a preservation of brain slice energetics over several hours in those brain 
slices exposed to amiloride. Of note, this preservation of brain slice energetics with 
amiloride was similar to that observed in brain slices maintained under hypothermic 
conditions  (Robertson  et  al  2005).  Further  in  vivo  studies  in  neonatal  models  are 
required  to  demonstrate  whether  amiloride  retains  its  neuroprotective  effect  when 
treatment is commenced after hypoxia ischemia, and whether its neuroprotective effect 
is enhanced in combination with other strategies, such as hypothermia. 
 
In this study, the dose of 2.5mg/kg MIA was selected as a similar dose in adult rats has 
been shown to cross the blood brain barrier and to be a potent inhibitor of the NHE 
(Ferimer et al 1995). The absence of enhanced weight loss in MIA treated animals, 
suggests that, at this dose, the drug is non toxic and well tolerated. As amiloride is 
currently used on occasion in the clinical setting as a potassium sparing diuretic and is 
not teratogenic or toxic, it may be possible in the future to use amiloride analogues 
clinically,  especially  if  they  retain  their  neuroprotective  effects  when  given  after 
hypoxia ischemia. However, as amiloride crosses the placenta, it also may be possible 
to administer it to high risk mothers prior to delivery to provide protection from brain 
injury during reperfusion.   
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One of the mechanisms by which amiloride is neuroprotective may be by preventing 
rebound alkalosis through blockade of the NHE. Inhibition of the NHE has been shown 
to block phospholipase activation in the ischemic / reperfused rat cerebral cortex as a 
consequence of its stabilising effect on acidotic pHi and prevention of alkalosis (Phillis 
et  al  2000).  As  described  in  the  previous  chapter,  mild  acidosis  (both  extra  and 
intracellular) during reperfusion after transient hypoxia ischemia has previously been 
shown to protect the brain (Simon et al 1993, Vannucci et al 2001). Additionally, an 
alkaline  pHi  may  exacerbate  injury  during  reperfusion  by  various  mechanisms, 
including increased N methyl D aspartate activation (Traynelis et al 1990, Giffard et al 
2002)  activation  of  phospholipases  and  proteases,  which  have  an  alkaline  pKa 
(Mellgren  1987)  and  changes  the  balance  of  pro   and  anti apoptotic  triggers  in 
mitochondria. This mechanism of increased apoptosis in the alkaline state would be in 
keeping with the finding of the current study where a significant reduction in TUNEL 
positive cells was noted in the MIA treated group following mild hypoxia ischemia.  
 
Further  mechanisms  of  neuroprotection  by  amiloride  may  relate  to  a  reduction  in 
energy consumption and calcium influx into the cell. As well as influencing pHi, the 
excessive action of the NHE after hypoxia ischemia leads to an increase in intracellular 
Na
+ concentration and subsequent activation of the Na
+/K
+ ATPase, consuming cellular 
energy.  The  high  intracellular  Na
+  level  also  activates  the  sarcolemmal  Na
+/Ca
++ 
antiporter leading to a rise in intracellular Ca
++ (Manev et al 1990, Masreel et al 2003).  
This overload of intracellular calcium leads to a variety of deleterious effects as part of 
the  neurotoxic  cascade  seen  following  hypoxia ischemia  including  mitochondrial 
accumulation of calcium, activation of proteolytic enzymes, free radical production and 
lipolysis.  
 
In addition to these direct effects on neuronal pHi and ion transport, it is also possible 
that the neuroprotective effects of amiloride may be mediated through interaction with  
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other  cell  types,  including  blood  vessel  endothelia,  astrocytes,  and  neutrophil  / 
granulocytes. An amelioration of endothelial cell dysfunction after transient ischemia 
has been observed with NHE inhibition (Horikawa et al 2001). NHE inhibition was also 
associated  with  reduced  blood brain  barrier  disruption,  improved  post ischemic 
perfusion, and neuroprotection (Horikawa et al 2001). In astrocyte cultures, oxygen and 
glucose deprivation resulted in a large increase in intracellular sodium and an increase 
in cell volume (Masreel et al 2003). NHE inhibition or genetic ablation of NHE1 reduced 
the increase in intracellular sodium and astrocyte swelling (Kintner et al 2004). Finally, 
NHE inhibition influences neutrophil granulocytes, which are known to invade central 
nervous system tissue after direct trauma or ischemia (Hudome et al 1997). Neutrophil 
chemotaxis is associated with cytoplasmic alkalinisation; NHE disruption or amiloride 
(Simchowitz  et  al  1986,  Fukushima  et  al  1996)  inhibits  such  chemotactic  behavior. 
Following phagocytosis, neutrophils undergo an NHE mediated rebound alkalosis that 
is associated with an increase in the generation of superoxide radicals (Fukushima et 
al 1996, Simchowitz 1985). The precise neutrophil pHi after phagocytosis is believed to 
play a pivotal role in the regulation of neutrophil apoptosis (Coakley et al 2002). The 
role of neutrophils in the generation of brain injury is further emphasised by a study of 
neonatal rats that were rendered neutropenic with an anti neutrophil serum and that 
displayed a 70% reduction in brain swelling after hypoxic ischemic injury (Hudome et al 
1997).  It  is  still  unclear,  however,  whether  this  is  the  direct  effect  of  amiloride  or 
secondary to brain injury amelioration. Nevertheless, all three cell types (endothelia, 
astrocytes, and the newly recruited blood borne neutrophil granulocytes) may provide 
additional non neuronal targets for a neuroprotective action of NHE inhibitor drugs such 
as amiloride. 
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Summary 
The current study supports the increasing in vitro, ex vivo and in vitro evidence that 
NHE blockade, with resultant delay in the rapid return of pHi and prevention of rebound 
alkalosis, may be beneficial to cell survival after hypoxia ischemia. Drugs that cross the 
blood brain  barrier  and  result  in  NHE  blockade  may  therefore  represent  a  useful 
therapeutic intervention following neonatal hypoxia ischemia. If changes in brain pHi 
account  for  the  observed  neuroprotective  effect  of  MIA,  further  clinical  implications 
include neonatal resuscitation protocols which do not currently aim to achieve a slow 
return of pHi to baseline or prevent rebound alkalosis.  
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Chapter 8: General Discussion 
In  addition  to  the  discussion  and  conclusions  drawn  in  the  individual  chapters,  a 
number  of  further  conclusions  can  be  made  when  this  study  is  considered  in  its 
entirety.  
 
The Neonatal Mouse Model of Hypoxia ischemia  
Taken in the context of previous studies the current study demonstrates changes in 
both  the  white  and  grey  matter  of  the  brain  following  significant  hypoxia ischemia. 
These  findings  underline  the  role  of  this  model  in  the  study  of  neonatal  hypoxic 
ischemic injury, which also affects both the white matter and the deep grey matter of 
the  basal  ganglia.  The  presence  of  amorphous  debris  on  electron  microscopy  of 
microglia within the white matter following hypoxia ischemia is of particular interest and 
in need of further study to help unlock the question of whether white matter injury is 
predominantly  an  axonopathy  or  as  a  result  of  oligodendrocyte  damage.  Whilst  a 
number  of  cellular  processes  such  as the  neurotoxic  cascade,  changes  in  cerebral 
energetics, changes in intracellular brain pH and the release of cytokines have been 
demonstrated in the hours after a hypoxic ischemic insult, much work is still required to 
identify how these different processes are interrelated, and therefore how interventions 
may modify the neurological outcome. It is of note, however, that the current study 
demonstrates that in this model, prolonged hypoxia ischemia has global effects on the 
brain at least in changes in intracellular pH, and it is only in these circumstances that 
large  cererbal  infarcts  occur.  Whilst  neither  this  nor  previous  studies  have 
demonstrated  significant  histological  injury  in  the  hemisphere  contralateral  to  the 
carotid occlusion, both hemispheres of the brain are affected by the insult given. This 
would, however, tend towards underestimating injury when comparing occluded and 
non occluded hemispheres and, therefore, tend towards non significant results.  
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Inflammatory Sensitisation of the Developing Brain to Hypoxia ischemia 
It is clear from retrospective studies that the majority of children who develop brain 
injury such as cerebral palsy thought to arise in the perinatal period, have not been 
exposed to hypoxia ischemia of sufficient severity to explain their neurodevelopmental 
outcome. The possibility of modulating factors that sensitise the brain to subsequent 
mild or moderate levels of hypoxia ischemia, which may be part of a normal labour, has 
been  suggested  from  both  epidemiological  studies  (Nelson  and  Grether  1998)  and 
animal  models  (Eklind  et  al  2001).  Infection  and  the  resultant  fetal  inflammatory 
response has remained the single most identifiable factor which may alter cellular and 
humeral  responses  to  hypoxia ischemia  and  may,  therefore,  affect  the  resultant 
neurodevelopmental outcome. Previous studies in adult and neonatal models of brain 
injury have shown apparently paradoxical sensitising and pre conditioning effects of 
endotoxin pretreatment prior to hypoxia ischemia. From these studies, it appears the 
effect is dependent on a number of factors including the age of the animal, the time 
interval  between  inflammatory  and  hypoxic ischemic  insults  and  the  severity  of 
hypoxia ischemia (Ahmed et al 200, Eklind et al 2001, Eklind et al 2005). This intriguing 
observation forms the basis of the current study which attempts to identify some of the 
cellular and humeral events that occur following an inflammatory stimulus, which, in 
turn, may  be crucial in the mechanism of perinatal brain  injury.   The  current  study 
identifies a specific time window of 4 12 hours after a single  injection  of endotoxin 
during which the brain is sensitised to mild hypoxia ischemia. This finding is similar to 
that of other authors who have described a phase of sensitisation in the neonatal rat 
occurring between 4 and 6 hours after endotoxin but not at 2 or 24 hours (Eklind et al 
2001, Eklind et al 2005). Additionally, the current study demonstrates that the peak 
sensitisation  occurs  around  12  hours  after  endotoxin  injection.  Furthermore,  the 
recognition  from  this  and  previous  studies  that  sensitisation  is  not  instantaneous, 
possibly  taking  more  than  2  hours,  suggests  that  endotoxin  injection  results  in  a 
number of events including the up regulation over 1500 genes (Eklind 2006), some of 
which may form the basis of the observed sensitisation. In the current study, a number  
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of  changes  were  detectable  in  expression  of  adhesion  molecules  on  vascular 
endothelium  and  microglia,  within  the  neonatal  brain,  following  low  dose  endotoxin 
administration and during the sensitisation window to subsequent hypoxia ischemia. It 
is interesting to speculate on how the effects of endotoxin identified in the current and 
previous  studies  may  be  linked  in  an  attempt  to  identify  the  mechanism  by  which 
endotoxin mediated  sensitisation  occurs.  Endotoxin  is  known  to  bind  to  Toll like 
receptors (TLR) on macrophages (including microglia) as part of the innate immune 
response,  and  triggers  intracellular  signaling  mechanisms  which  result  in  the 
production of pro inflammatory cytokines (Miyake 2004, Gay et al 2007) (see Figure 
8.1).  Furthermore,  it  appears  that  it  is  through  this  TLR  signaling  that  endotoxin 
sensitises  the  neonatal  rodent  brain  to  subsequent  hypoxia ischemia  with  no 
sensitisation seen in TLR deficient mice (Lehnardt et al 2003). Whilst endotoxin may 
itself cause neuronal damage in cell culture, this effect is dependent on the presence of 
microglia (Lehnardt et al 2003), again suggesting that it is the activation of the innate 
immune system through TLR4 that is critical in endotoxin mediated injury. However in 
the  current  model,  low  dose  endotoxin  did  not  result  in  neuronal  loss  in  vivo  or 
histological  brain  injury.  Whilst  it  is  clear  from  clinical  observations  that  severe 
infections,  particularly  meningitis,  may  result  in permanent  brain  injury,  this form of 
brain injury was not investigated as part of the current study. In contrast, oxygen and 
glucose deprivation can directly result in neuronal loss in pure neuronal cell culture; 
however, the addition of microglia to the culture confers significant neuronal protection 
to oxygen glucose deprivation, associated with microglial migration and close cell to 
cell contact with neurons (Neumann et al 2006). Interestingly this neuroprotective effect 
of microglia is lost if they are pretreated with endotoxin. In the animal model used in the 
current study, it has not been proven that endotoxin exerts its effects directly within the 
central nervous system. Alternatively, the changes within the central nervous system 
seen after systemic endotoxin may result from the systemic inflammatory response, 
mediators  of  which  may  cross  the  blood brain  barrier  and  in  turn  sensitise  the 
developing brain to subsequent hypoxia ischemia (Hagberg and Mallard 2005).   
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Figure 8.1: Lipopolysaccharide signaling via Toll like receptor 4. (IKK    IκB kinase, IRAK    
interleukin 1 receptor associated kinase, IRF3   interferon response factor 3, LBP – LPS binding 
protein,  LPS  –  lipopolysaccharide,  Mal     MyD88  adaptor like,  MD2     co receptor  of  TLR4, 
MyD88   myeloid differentiation primary response protein 88, NF κB, nuclear factor κ B, TLR4 – 
Toll like receptor 4, TRAF6   TNF receptor associated factor 6, TRAM   TRIF related adaptor 
molecule, TRIF   TIR domain–containing adaptor protein inducing interferon β). From Gay et al 
2007, reproduced with permission. 
 
In the current study, systemic endotoxin has been demonstrated to result in changes in 
both microglia and vascular endothelium within the window of sensitisation along with 
up regulation  of  genes  for  pro inflammatory  cytokines  including  TNFα  (Eklind  et  al 
2006). TNFα has been previously shown to up regulate vascular endothelial adhesion 
molecules such as ICAM1 and P selectin, resulting in leukocyte adhesion, rolling and  
216 
 
migration into the central nervous system (Bohatschek et al 2001, Zhou et al 2006). In 
the  current  study  deletion  of  the  entire  TNF  cluster  (TNFα,  lymphotoxin  α  and 
lymphotoxinβ)  abolishes  both  sensitisation  to  subsequent  hypoxia ischemia  and  the 
effects of endotoxin on both microglia and vascular endothelium. Whilst the current 
study does not demonstrate that abolition of endotoxin mediated ICAM1 up regulation 
in animals with deletion of the TNF cluster is directly related to the loss of endotoxin 
mediated sensitisation, it is possible that ICAM1 has a specific role. In the current study 
migration  of  blood  borne  macrophages  into  the  CNS  was  not  seen  with  low  dose 
endotoxin (0.3  g/g) but this was suggested in the pilot studies using high dose (10 
 g/g)  (see  Chapter  3).  However,  it  is  possible  that  the  ICAM1  expression  on  the 
vascular endothelium seen following low dose endotoxin facilitates increased migration 
of leukocytes into the CNS if the animal is subsequently exposed to hypoxia ischemia. 
The presence of increased numbers of leukocytes may, in turn, result in an increase in 
neuronal loss.  
 
Similarly, the current study,  whilst  demonstrating changes  in  integrin expression  on 
microglia  following  low  dose  endotoxin,  does  not  directly  demonstrate  their  role  in 
endotoxin mediated  sensitisation  of  the  developing  brain.  As  described  previously, 
microglia have specific roles within the CNS, including immune surveillance, cytokine 
production  and  phagocytosis.  Integrins  are  a  large  family  of  heterodimeric 
glycoproteins that play a crucial role in cell adhesion during development, inflammation, 
and tissue repair (see Figure 8.2).  
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Figure 8.2: Integrin subunit association. Integrin subunits, subunit combinations and ligands of 
the known αβ heterodimers (adapted from Kloss et al 1999 eproduced with permission). Col, 
collagen; Fb, fibrinogen; Fbu, fibulin; Fib, fibrillin; Fn, fibronectin; FX, factor X; Gel, gelatin; iC3b, 
inactivated complement factor 3b; ICAM, intercellular adhesion molecule; Ln, laminin; MAdCAM, 
mucosal  addressing  cell  adhesion  molecule;  Opn,  osteopontin;  Tn,  tenascin;    sp, 
thrombospondin; VCAM, vascular cell adhesion molecule; Vn, vitronectin; vWF, vonWillebrand 
factor. 
 
Previous  studies  have  described  the  detection  of  a  set  of  integrins  on  microglia 
following neuronal injury with different temporal profiles (Kloss et al 1999). It appears 
that the patterns of integrin expression coincide with early activation (αMβ2), homing 
and adhesion (α5β1, α6β1), or bystander activation (α4β1, αMβ2). In the current study, 
low dose endotoxin appears to have its effects predominantly on αMβ2, suggesting an 
early activation. Whilst a significant rise in α6 was detected, this was histologically in a 
pattern consistent with vascular endothelium. Here again, it is interesting to note the 
loss of αMβ2 integrin up regulation in animals with a deletion of the TNF cluster. It is 
also interesting that, in the current study, the brain injury score used following hypoxia  
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ischemia, which includes an assessment of both αMβ2 integrin immunoreactivity and 
microglial morphology, correlates well with quantative injury measures such as infarct 
volume. It can therefore be speculated that endotoxin pretreatment begins the process 
of  microglial  activation  which,  without  a  second  insult,  has  no  implication  for  the 
developing brain. If, however, whilst the microglia are activated there is a period of 
hypoxia ischemia the resultant brain injury is much greater than would be the case if 
the microglia were in a resting state.  
 
In summary, this and previous studies have demonstrated that, in the hours following 
administration of systemic endotoxin, there is a window of sensitisation during which 
the  neonatal  brain  is  sensitised  to  hypoxia ischemia.  It  appears  that  the  toll  like 
receptor  TLR4  and  the  TNF  family  of  cytokines  are  critical  components  in  this 
sensitisation phenomenon. As endotoxin binds to TLR4 on microglia and results in the 
release  of  pro inflammatory  cytokines,  including  TNFα,  and  the  current  study 
demonstrates  increased  levels  of  the  mRNA  for  these  cytokines  within  the  brain 
following endotoxin administration, it can be postulated that this sequence is at least a 
part of the events that trigger the sensitisation of the brain to subsequent hypoxia 
ischemia. Furthermore, it is likely that microglia play a key role in this sequence of 
events either though direct activation by endotoxin, or by indirect activation from the 
systemic  inflammatory  response  that  occurs  after  endotoxin  administration.  Once 
activated to an ‘alert’ phenotype, competing theories for the downstream mechanism of 
sensitisation  to  subsequent  hypoxia ischemia  include  loss  of  normal  microglial 
neuronal  support  and,  hence,  reduced  neuroprotection  (Neumann  et  al  2006)  or  
increased  brain  injury  resulting  from  the  production  of  further  mediators,  including 
oxygen free radicals (Hagberg and Mallard 2005). It is, of course, entirely possible that 
both these mechanisms play a role in the observed effects. 
 
This sensitisation of the brain may account for some of the children that develop brain 
injury of perinatal origin without evidence of a significant hypoxic ischemic insult. It can  
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be speculated that, if the presence of a sub clinical inflammatory response could be 
identified, for example by analysis of the maternal cytokine profile in early labour, this 
could be used to guide the clinician in decisions regarding intervention. Specifically, if it 
could be identified that a neonate was at low risk for hypoxic ischemic injury, moderate 
changes  in  the  fetal  heart rate  or  fetal  scalp  blood  gas  profile  may  be  acceptable. 
Conversely,  in  the  presence  of  a  significant  inflammatory  response,  it  may  be 
preferable  to  proceed  to  operative  delivery  in  an  attempt  to  reduce  the  risk  of 
permanent  brain  injury,  even  in  early  labour  prior  to  the  onset  of  clinical  findings 
suggestive of hypoxia. Such stratification in the assessment of women during labour 
has the potential to both reduce unnecessary medical intervention, and to reduce the 
incidence of perinatal brain injury. Furthermore, additional information may come from 
assessment of differences in individual inflammatory responses caused, for example, 
by  specific  cytokine  genetic  polymorphisms  which  may  put  individual  neonates  at 
increased risk of injury from a variety of insults. Such assessment may, in the future, be 
possible prior to labour and allow informed discussion regarding method of delivery 
dependent on the progress of the pregnancy and labour. In addition to guiding the 
clinician and woman regarding method of delivery, the identification of the TNF family 
of cytokines as key mediators in perinatal brain injury raises the prospect of therapeutic 
strategies aimed at these molecule using clinical preparations already available, such 
as anti tumour necrosis factor. It is of note that recent clinical observations in women 
with  rheumatoid  arthritis  and  inflammatory  bowel  disease  suggest  that  anti tumour 
necrosis factor  may  be  safe  to  administer throughout  pregnancy  (Roux  et  al  2007, 
Rosner et al 2007). Finally, in neonates with clinical evidence of perinatal brain injury, 
such  as  neonatal  encephalopathy,  identification  of  infection  as  part  of  their 
neuropathology may present further neuroprotective strategies in the hours following 
birth by modulating the neonatal inflammatory response away from a pro inflammatory 
state towards an anti inflammatory state, hence, theoretically, reducing the amount of 
neuronal loss and maximising neurodevelopmental outcome.  
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The Role of pH Changes in the Developing Brain Following Hypoxia ischemia 
The current study has demonstrated the changes in intracellular pH that occur within 
the neonatal mouse brain during hypoxia and in the hours following reoxygenation. 
This  has  confirmed  the  finding  from  human  and  other  animal  studies  which 
demonstrate  acidosis  during  hypoxia  due  to  anaerobic  respiration  and  the 
accumulation of lactic acid. During the hours after reoxygenation, there is a transient 
period during which the intracellular pH of the brain is relatively alkalotic compared to 
baseline.  Previous  authors  have  suggested  that  this  alkalosis  is  mediated  by  the 
Na
+/H
+ exchanger (LaManna 1996) and that the magnitude and duration of alkalosis 
correlates  to  the  severity  of  neurodevelopmental  outcome  in  the  human  neonate 
(Robertson  et  al  2002).  In  this  context,  it  is  interesting  that  the  current  study 
demonstrates that  blockade of the the Na
+/H
+ exchanger  using  amiloride is able to 
confer significant neuroprotection in vivo which is in keeping with previous ex vivo brain 
slice data (Robertson et al 2005). It is possible, therefore, to speculate that the effects 
of amiloride seen in the current study are a result of a modulation of the pH changes 
that occur following hypoxia ischemia, and that alkalosis may indeed result in a worse 
histological outcome in areas of brain tissue damaged by hypoxia ischemia. This has 
both implications for specific therapeutic intervention in the neonatal period and in best 
practice for the care of neonates affected by hypoxic ischemic encephalopathy. These 
will be considered further in Chapter 8: Further Work.  
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Chapter 8: Further Work 
 
The current study suggests a number of interesting areas potentially requiring further 
investigation.  
 
Primary Prevention 
A  growing  body  of  evidence  now  supports  that  infection  /  inflammation  acts  as  a 
sensitising agent for subsequent hypoxia ischemia and the hypothesis of a continuum 
of worsening inflammation  resulting in permanent brain  injury from minimal  hypoxia 
such as may occur in a normal labour (Peebles et al 2002) is intriguing. The challenge 
from a primary prevention perspective is the identification of such mild inflammatory 
responses in the mother and / or fetus so as to alert the obstetrician to avoid even 
minimal  intrapartum  hypoxia.  This  and  previous  studies  have  used  endotoxin  from 
E.Coli as the basis for an inflammatory stimulus. In the clinical context of obstetrics, 
E.Coli bacteraemia is very rare, and unlikely to be the cause of any endotoxaemia. 
Intriguingly, a number of organisms which make up the perioral flora in humans can 
produce endotoxin, which raises the possibility of a transient sub clinical bacteraemia / 
endotoxaemia following oral instrumentation, for example teeth scaling. The effect of 
these endotoxins in sensitising the developing brain to hypoxia ischemia has yet to be 
studied.  
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Mechanisms of Injury  
The current study shows a window of sensitisation between 4 and 12 hours following 
endotoxin administration. Other studies suggest that there may be a biphasic response 
to  endotoxin  with  sensitisation  seen  6  hours  and  72  hours  but  not  24  hours  after 
endotoxin when animals are exposed to mild hypoxia ischemia. Interestingly, in this 
study,  when  animals  were  exposed  to  a  more  severe  hypoxic ischemic  insult, 
sensitisation  was  seen  at  6  hours  after  endotoxin,  neuroprotection  was  seen  at  24 
hours after endotoxin and no effect was seen when endotoxin was given 72 hours prior 
to  hypoxia ischemia  (Eklind  et  al  2005).  This  biphasic  response  warrants  further 
investigations, specifically to identify the cellular and humeral events which mimic this 
biphasic response suggesting their role in a sensitising or neuroprotective effect. The 
possibility that, in certain circumstances, endotoxin can be neuroprotective may help 
unlock  the  critical  events  of  sensitisation  and  may,  therefore,  allow  therapeutic 
interventions in the future. 
 
The  identification  of  ICAM1  upregulation  as  the  earliest  detectable  central  nervous 
system change following endotoxin administration raises the question of the role of this 
adhesion molecule in inflammatory sensitisation. ICAM1 deficient mice have previously 
been shown to have impaired influx of granulocytes into the brain following systemic 
endotoxin  in  adult  animals  (Bohatschek  et  al  2001).  Repeating  the  sensitisation 
experiments in ICAM1 deficient animals would help unlock the role of this molecule in 
the observed sensitisation phenomenon.  
 
The current study examining the role of the TNF family of cytokines raises the potential 
that one or more of these cytokines (TNFα / LTα / LTβ) may be the critical mediator in 
sensitising the developing brain to subsequent hypoxia ischemia. An examination of 
animals  with  single  cytokine  knockouts  which  could  then  be  cross bred  to  produce 
double  deletions  and  triple  deletion  would  help  to  identify  the  role  of the  individual 
cytokines. Furthermore, the use of conditional knockouts, for example using the Cre lox  
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system, would also allow the identification of the cell types involved in the sensitisation 
pathway.  Unfortunately,  at  present,  it  is  not  possible  to  identify  whether  resident 
macrophage in the brain or recruited circulating phagocytes are involved. Under other 
circumstances, the use of bone marrow chimera animals can answer such questions, a 
technique  which  is  not  possible  in  the  study  of  neonatal  animals.  If,  as  may  be 
suspected from the body of evidence implicating TNF as the major cytokine involved, 
the possibility of therapeutic intervention is interesting. As mentioned previously, the 
use  of  anti TNF  monoclonal  antibodies  during  pregnancy  has  been  reported  in  the 
literature (Rosener et al 2007, Roux et al 2007). The potential for anti TNF monoclonal 
therapy or soluble TNF receptor could be further explored in the neonatal mouse model 
of both hypoxia ischemia and combined endotoxin hypoxia ischemia as the first stage 
of this investigation.  
 
pH Studies 
The identification of both rebound alkalosis in the neonatal model of hypoxia ischemia 
and the development of new method to visualise regional brain pH raises a number of 
exciting possibilities for further investigation. In the current study, the changes in pHi 
during reoxygenation were studied after a prolonged period of hypoxia ischemia, which 
was demonstrated to produce a global brain intracellular acidosis. Further investigation 
should  examine  the  changes  in  pHi  following  shorter  periods  of  hypoxia ischemia, 
similar to those in adult animals (Chopp et al 1990). Furthermore, in an attempt to 
understand the mechanism of rebound alkalosis, a number of investigations should be 
undertaken. The amiloride studies suggest that the Na
+ / H
+ exchanger (NHE) is critical 
in this mechanism. Investigating the timecourse of pHi changes in animals with specific 
mutations of NHE subtypes would be exceptionally valuable in understanding the role 
of this transporter in both rebound alkalosis and in perinatal hypoxic ischemic brain 
injury.  From  a  potential  therapeutic  angle  further  studies  of  amiloride  and  NHE 
blockade  are  essential.  Firstly  using  the  techniques  described  in  this  study  to 
investigate the changes in pHi after hypoxia ischemia in animals pretreated with of N  
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methyl isobutyl amiloride (MIA) would help to demonstrate the mechanism by which 
this drug confers neuroprotection. Furthermore, the use of other agents with differential 
blockade  of  different  NHE  subtypes  may  allow  the  realisation  of  maximal 
neuroprotection from preventing rebound alkalosis. The techniques described in this 
study would also allow the mechanism of cell signaling that underlies NHE activation. 
For example, the role of MEK signaling may be unlocked by examining changes in pHi 
after hypoxia ischemia in animals with MEK blockade, such as animals with a dominant 
negative construct. 
 
Identification of the association between changes in intracellular pH and severity of 
brain  injury  and  the  sensitising  effect  of  endotoxin  on  the  developing  brain  to 
subsequent hypoxia ischemia suggests that examining changes in pHi after endotoxin 
and combined endotoxin / hypoxia ischemia would be of interest. This association of 
pHi  changes and outcome raises a number of questions about the clinical practice of 
intravenous sodium bicarbonate to correct systemic metabolic acidosis in the hours 
after hypoxia ischemia. Investigating the changes in intracellular brain pH, especially 
during the early re oxygenation phase, in animals treated with sodium bicarbonate or 
saline immediately after hypoxia ischemia may give some information about the effect 
of current clinical practice.   
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Chapter 11 Appendix: 
 
0.5 M Phosphate Buffer (PB) 
40 ml NaOH,142 g NaH2PO4, made up to 2 litres with double distilled H2O pH adjusted 
to 7.4 7.5 with H3PO4 
 
0.1 M PB  
200 ml 0.5 M PB made up to 1 litre with double distilled H2O 
 
10 mM PB 
50ml 0.1M PB made up to 500 ml with double distilled H2O 
 
Phosphate buffered saline (PBS):  
8.5 g NaCl, 20 mls 0.5 M PB made up to 1 litre with double distilled H2O pH adjusted to 
7.4 with H3PO4 
 
20% Paraformaldehyde (PFA) 
400 mg NaOH, 200 ml PFA made up to 1 litre with double distilled H2O pH adjusted to 
7.4 with H3PO4. Stored at 4ºC. 
 
4% PFA (for perfusion) 
200 ml 20% PFA 8.5 g NaCl, 20 mls 0.5 M PB made up to 1 litre with double distilled 
H2O. Stored at 4ºC, but freshly made each time. 
 
4% PFA (for immunohistochemistry and Nissl) 
2 ml 37% formaldehyde (BDH), made up to 50 ml with 0.1M PB 
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30% Sucrose 
30 g sucrose (Fluka) 2 mls 0.5 M PB made up to 100ml with double distilled H2O. 
Stored at 4ºC but freshly made each time. 
 
0.1% Bovine Serum Albumin in PB (PB/BSA) 
500 mg BSA, made up to 500 ml with 0.1 M PB stored at 4ºC and used within 48 
hours. 
 
5% goat serum 
50  L goat serum, 1 ml 0.1M PB 
 
‘ABC’ solution (Vector Labs) 
50  L A, 50  L B, 5 ml 0.1M PB. Left to incubate at room temperature for at least 30 
minutes before use. 
  
0.05% diaminobenzidine (DAB) in the presence of 0.01% hydrogen peroxide 
 25 mg DAB made up to 50ml with 10mM PB filtered. 16.7  l 30% hydrogen peroxide 
added prior to use 
 
0.05% diaminobenzidine (DAB) in the presence of 0.01% hydrogen peroxide with 
cobalt nickel enhancement 
25 mg DAB, 0.5 ml cobalt sulphate, 0.5 ml nickel chloride made up to 50 ml with 10 
mM PB and filtered.16.7  l 30% hydrogen peroxide 
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Cacodylate Buffer 
3.64 g TRIS in 80 ml double distilled H2O, 29.96 g Cacodylate. pH adjusted to 7.5 with 
HCl. 0.24 g cobalt chloride added pH adjusted to 7.2 with HCl made up to 100 ml with 
double distilled H2O. Stored at 4ºC 
  
TdT solution 
1  L TdT (Roche), 1.5  L dUTP biotyinlated (Roche), 100  L cacodylate buffer, 897.5 
 L double distilled H2O kept on ice and used immediately. 
 
TUNEL stop solution 
300 mM NaCl (1753.2 mg / 100 ml double distilled H2O) 30 mM sodium citrate (882.3 
mg/100 ml double distilled H2O). 
 
Cresyl Violet (BHD) 
4 g cresyl violet dissolved in 40 mls 100% ethanol in a closed 50 ml falcon tube for 15 
minutes. Add to 360mls warm double distilled H2O and mixed on a warming stirrer plate 
for 20 minutes. Filter and use immediately. 
 
Biotinylated Tyramide solution  
0.1% biotinylated tyramide, 0.001% hydrogen peroxide in 10 mM PB 
 
 